Timing of gestational arrest prior to miscarriage by Mukherjee, Sudeshna
  
 
 
TIMING OF GESTATIONAL ARREST PRIOR TO MISCARRIAGE 
By 
Sudeshna Mukherjee 
Dissertation 
Submitted to the Faculty of the Graduate School of Vanderbilt University 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
in 
Epidemiology 
December, 2014 
Nashville, Tennessee 
Approved: 
Digna  R.Velez Edwards, PhD 
Katherine E. Hartmann, M.D., Ph.D. 
Aaron M. Kipp, Ph.D. 
Pingsheng Wu, Ph.D. 
  
ii 
 
 
 
 
 
 
 
 
 
Copyright © 2014 by Sudeshna Mukherjee 
All Rights Reserved   
iii 
 
 
DEDICATION 
 
 
 
 
 
To my family, 
Sankar, Swapna and Sucharita Mukherjee, 
And to my grandfather, 
Dr. Kali Sankar Banerjee, 
Who have each given me love, support and unwavering faith to pursue my dreams 
 
 
 
 
  
iv 
 
ACKNOWLEDGEMENTS 
I would like to recognize the Right from the Start study participants, staff and funding 
agencies, without whom this dissertation research would not be possible. This research was 
supported in part by the Institute for Medicine and Public Health, the doctoral Epidemiology 
program, and the Women’s Health Research fund at Vanderbilt University.  
I also want to thank the members of my committee, Drs. Digna Velez Edwards, 
Katherine E. Hartmann, Aaron M. Kipp and Pingsheng Wu, for their advice and support in 
completing this work. I am grateful to the feedback and direction they provided throughout the 
course of this thesis research. In particular, I would like to acknowledge my mentors, Dr. 
Hartmann and Dr. Velez Edwards, for sharing their knowledge, providing guidance and helping 
me to think, interpret, analyze, write and communicate as a scientist. My training is that much 
more complete because of their dedication to research and their willingness to teach.   
 I want to thank my father, Sankar Kumar Mukerjee, and my grandfather, Dr. Kali Sankar 
Banerjee, who each emphasized the importance of education. Through their example, I have 
learned the values of persistence, hard work and personal sacrifice. My father and grandfather 
admired in equal measure a keen mind and a kind soul. Their love continues to drive, inspire and 
lift me every day. This dissertation is dedicated in memory of them both. I hope I have made 
them proud. I also especially want to thank my mother, Swapna Mukherjee, and my sister, 
Sucharita Mukherjee, for loving and believing in me when I needed it most, and all the times in 
between. I gain strength from their love and faith in me. Finally, to my family, friends and feline 
companion (ginger ale) your love, support, guidance, faith, laughter, friendship, encouragement 
and enthusiasm have been a blessing to me. This work is possible because of you. My world is a 
better place for having you beside me.  
v 
 
TABLE OF CONTENTS 
 
Page 
DEDICATION ............................................................................................................................... iii 
ACKNOWLEDGEMENTS ........................................................................................................... iv 
LIST OF TABLES ....................................................................................................................... viii 
LIST OF FIGURES .........................................................................................................................x 
LIST OF ABBREVIATIONS ........................................................................................................ xi 
ABSTRACT .....................................................................................................................................1 
Chapter 
I. Introduction and Specific Aims ....................................................................................................3 
II. Background .................................................................................................................................8 
Challenges to study miscarriage .............................................................................................9 
Embryologic markers and miscarriage risk ..........................................................................10 
Race and miscarriage risk .....................................................................................................12 
Heterogeneity in miscarriage risk .........................................................................................15 
Classifying types of miscarriage ...............................................................................17 
Importance of estimating gestational age .............................................................................18 
Clinical approaches to estimate gestational age....................................................................19 
Early studies estimating gestational age from crown-rump length .......................................23 
Potential measurement errors in crown-rump length assessment .............................24 
Variations in crown-rump length measurements ......................................................25 
Crown-rump length measurement in threatened miscarriages ..................................25 
Alternative fetal measurements to estimate gestational age .................................................26 
Changes in ultrasound technology to estimate gestational age .............................................27 
Transvaginal vs. transabdominal ultrasounds ...........................................................28 
Rationale for transvaginal ultrasounds in assessing miscarriage risk .......................29 
Exposures and miscarriage risk ............................................................................................30 
Smoking ....................................................................................................................31 
Vitamins ....................................................................................................................36 
III. Methods....................................................................................................................................40 
Methods overview .................................................................................................................40 
RFTS Study population.........................................................................................................42 
Exclusions .............................................................................................................................44 
vi 
 
Estimating gestational age from ultrasound ..........................................................................45 
Characterizing developmental stage at ultrasound ...................................................45 
Estimating GAAD and the GAAD gap in RFTS ......................................................47 
Rationale for chosen nomograms..............................................................................49 
Specific aim 1: Determining GAAD gap, exploratory analysis ...........................................50 
Specific aim 1: Hypothesis .......................................................................................51 
Sensitivity analyses for Specific aim 1: ................................................................................51 
Women with prior or recurrent miscarriage history .................................................51 
Miscarriage pre and post-interview ..........................................................................51 
Miscarriage within 3 days of enrollment ..................................................................52 
Specific aim 2: Comparing GAAD models with LMP models ............................................52 
Specific aim 2: Hypotheses .......................................................................................53 
Rationale for Cox Models .....................................................................................................53 
Exposures ..............................................................................................................................54 
Smoking ....................................................................................................................55 
Vitamin use ...............................................................................................................55 
Outcome ................................................................................................................................56 
Confounders ..........................................................................................................................57 
Pregnancy intention ..................................................................................................63 
Bootstrapping to compare models (GAAD vs. LMP) for miscarriage risk ..........................67 
Power calculations for chosen exposures .............................................................................67 
Smoking ....................................................................................................................67 
Vitamin use ...............................................................................................................68 
Sensitivity analyses for specific aim 2: .................................................................................69 
Estimating GAAD for women with loss prior to ultrasound ....................................69 
Specific aim 3: Comparing GAAD gap by race and if risk of loss associated with common 
early pregnancy exposures are modified by race ..................................................................69 
Race and pregnancy intention interaction .................................................................70 
Specific aim 3: Hypothesis .......................................................................................71 
Handling missing data and correlated data in analysis .........................................................71 
Potential considerations in analysis ......................................................................................72 
Early ultrasounds for abnormal development ...........................................................72 
Early ultrasounds after reported date of loss ............................................................72 
Follicular phase length for scans ≥45 days from self-reported LMP ........................73 
vii 
 
Differences in fetal growth by race for chosen nomograms .....................................73 
IV. Estimating the Gap Between Time of Gestational Arrest and Clinical Symptoms of   
Miscarriage ..............................................................................................................................75 
Abstract .................................................................................................................................75 
Introduction ...........................................................................................................................77 
Materials and Methods ..........................................................................................................78 
Results ...................................................................................................................................84 
Discussion .............................................................................................................................86 
V. Comparing Models for Timing of Miscarriage Using Common Early Pregnancy       
Exposures ...............................................................................................................................101 
Abstract ...............................................................................................................................101 
Introduction .........................................................................................................................103 
Materials and Methods ........................................................................................................106 
Results .................................................................................................................................111 
Discussion ...........................................................................................................................114 
VI. Racial Differences in Risk of Miscarriage Associated with Common Early Pregnancy   
Exposures ...............................................................................................................................124 
Abstract ...............................................................................................................................124 
Introduction .........................................................................................................................126 
Materials and Methods ........................................................................................................128 
Results .................................................................................................................................134 
Discussion ...........................................................................................................................137 
VII. Conclusions and Future Directions ......................................................................................149 
Overall study conclusions ...................................................................................................149 
Study strengths ....................................................................................................................150 
Potential limitations of study ..............................................................................................152 
Study implications ..............................................................................................................154 
Future directions .................................................................................................................156 
APPENDIX ..................................................................................................................................158 
Appendix 1. Defining common reproductive terminology .................................................158 
Appendix 2. Right from the Start ultrasound form .............................................................160 
Appendix 3. Selected questions from first-trimester interview ..........................................162 
REFERENCES ............................................................................................................................165 
 
  
viii 
 
LIST OF TABLES 
Table                          Page 
2-1. Studies addressing race and miscarriage risk ........................................................................ 13 
2-2. Defining pregnancy loss by gestational age and ultrasound (modified from Silver et al.) ... 18 
2-3. Summary of previous studies estimating gestational age ...................................................... 21 
2-4. Expected first-trimester ultrasound characteristics by gestational week ............................... 27 
2-5. Studies on miscarriage risk and smoking .............................................................................. 33 
2-6. Studies on miscarriage risk and vitamin use ......................................................................... 38 
3-7. Overview of specific aims, study population, and statistical analyses .................................. 41 
3-8. Right from the Start study phase and eligibility criteria ........................................................ 43 
3-9. Estimating gestational age at arrest (GAAD) in Right from the Start ................................... 46 
3-10. Covariates for analysis......................................................................................................... 62 
3-11. Coding pregnancy intention in Right from the Start ........................................................... 65 
4-12. Estimating Gestational Arrest at Development (GAAD) for women with miscarriage within 
Right from the Start, 2000-2012 ................................................................................................... 91 
 4-13. Characteristics of participants who experienced miscarriage within Right from the Start, 
2000-2012 ..................................................................................................................................... 92 
4-14. Estimating gestational age in pregnancies with miscarriage based on ultrasound 
characteristics for self-reported LMP and GAAD within Right from the Start, 2000-2012 ......... 95 
4-15. Characteristics of participants by median gestational age at arrest of development (GAAD) 
gap in Right from the Start, 2000-2012 ........................................................................................ 96 
 4-16. Further analyses and restrictions to evaluate gestational age at arrest of development 
(GAAD) in Right from the Start, 2000–2012 ............................................................................... 99 
ix 
 
5-17. Comparing common characteristics by pregnancy outcome among Right from the Start, 
2000–2012................................................................................................................................... 118 
5-18. Common early pregnancy exposures and consistency of use in Right from the Start, 2000–
2012............................................................................................................................................. 120 
5-19. Models for miscarriage risk associated with common early pregnancy exposures using 
gestational age based on self-reported LMP or GAAD among Right from the Start, 2000–2012
..................................................................................................................................................... 121 
5-20. Bootstrap analysis bias ratio for risk of miscarriage associated with common early 
pregnancy exposures in Right from the Start, 2000–2012 .......................................................... 122 
6-21. Characteristics by race of Right from the Start participants, 2000–2012 .......................... 141 
6-22. Ultrasound characteristics by race for women who experienced miscarriage within Right 
from the Start, 2000-2012 ........................................................................................................... 144 
6-23. Estimating gestational age of pregnancy loss based on self-reported LMP and GAAD by 
race and pregnancy intention among women who experienced miscarriage within Right from the 
Start, 2000-2012 ......................................................................................................................... 145 
6-24. Models for miscarriage risk associated with vitamin exposure stratified by race, within 
Right from the Start, 2000-2012 ................................................................................................. 146 
6-25. Bootstrap analysis bias ratio for risk of miscarriage associated with vitamin exposure, 
stratified by race in Right from the Start, 2000–2012 ................................................................. 147 
 
  
x 
 
LIST OF FIGURES 
 
Figure               Page 
2-1. Explaining pregnancy loss (modified from Macklon et al., 2002) .......................................... 8 
2-2. Causal model for race and miscarriage risk ........................................................................... 16 
3-3. Timeline of Right from the Start activities and estimating GAAD ....................................... 44 
3-4. Directed acyclic graph of smoking exposure and miscarriage risk ....................................... 58 
3-5. Directed acyclic graph of vitamin use and miscarriage risk .................................................. 59 
3-6. Power and detectable hazard ratio for miscarriage risk in smokers compared to never 
smokers in Right from the Start .................................................................................................... 68 
4-7. Aim 1: Study subject inclusion criteria ............................................................................... 100 
5-8. Aim 2: Study subject inclusion criteria ............................................................................... 123 
6-9. Aim 3: Study subject inclusion criteria ............................................................................... 148 
xi 
 
LIST OF ABBREVIATIONS 
aHR  Adjusted hazard ratio 
BMI  Body mass index 
BPD  Biparietal diameter  
BPM  Beats per minute for fetal heart rate 
CRL  Crown rump length    
CI   Confidence interval 
DAG  Directed acyclic graph  
EGA  Estimated gestational age based on self-reported last menstrual period  
FHR  Fetal heart rate  
FTI  First-trimester interview 
GAAD  Gestational age at arrest of development   
hCG  Human chorionic gonadotropin 
HR   Hazard ratio  
IVF  In vitro fertilization  
LMP  Last menstrual period 
MSD  Mean sac diameter  
NC  North Carolina 
xii 
 
NFGS   National family growth survey   
OR  Odds ratio 
RFTS  Right from the Start 
RR  Risk ratio 
SAB  Spontaneous abortion (i.e. miscarriage) 
SD  Standard deviation  
TN  Tennessee 
TAUS  Transabdominal ultrasound 
TVUS  Transvaginal ultrasound 
TX  Texas
  
1 
 
ABSTRACT 
Risk of miscarriage (i.e. a pregnancy loss before 20 completed weeks of gestation) is 
known to differ by race but timing of loss is not well established in the literature. The gap 
between biological pregnancy loss identified by ultrasound and clinical manifestation of that loss 
may bias effect estimates for early-pregnancy exposures associated with miscarriage. Right from 
the Start (RFTS) is a unique and diverse prospective pregnancy cohort that captures uniform 
early first-trimester ultrasound information and pregnancy-related behaviors from first-trimester 
interviews in order to study the distribution of this gap.  
Nearly 13% of women in this cohort experienced a pregnancy loss (n=697), the majority 
of whom have ultrasound data available (73%, n=509). Ultrasounds were conducted between 40 
and 95 days gestation from last menstrual period (LMP) for this cohort. Gestational arrest prior 
to miscarriage was observed in 38.7% of losses (n=197). The mean gap between LMP and 
estimated gestational age at arrested development (GAAD) was 19.3 ± 15.0 days (median 
GAAD gap was 19 days). The GAAD gap did not differ by race or pregnancy intention. 
 In order to determine if failing to account for this gap influences effect estimates we 
assessed exposures commonly associated with pregnancy loss. We compared models that 
estimated gestational age based on self-reported LMP and models that incorporated gestational 
age at time of arrested development (GAAD). We used bootstrap methods to determine the 
magnitude of bias for both models. Smoking during pregnancy was not modified by race and was 
not associated with miscarriage risk within this cohort for either current or former smokers 
compared to never smokers in either model. Stratified by race and adjusted for confounding, the 
protective effect of vitamin use on miscarriage risk was stronger among White women than 
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Black women when using the LMP models (Whites aHR=0.34,  95% CI [0.21, 0.54]; Blacks 
aHR=0.53,  95% CI [0.33, 0.84]), while no substantial difference by race was observed with the 
GAAD models (Whites aHR=0.43,  95% CI [0.24, 0.76]; Blacks aHR=0.44,  95% CI [0.26, 
0.74]).  
Models that use self-reported LMP to estimate gestational age underestimate the true 
value of first-trimester smoking exposure on miscarriage risk by as much as 15% for current 
smokers and 5% of former smokers when compared to models that use GAAD (the bootstrap 
bias ratio between models for current smokers ratio=0.85, 95% CI [0.75, 0.94]; for former 
smokers ratio=0.95, 95% CI [0.92, 0.97]). When stratified by race, the bias was nearly 20% for 
both Whites and Blacks for miscarriage risk associated with early pregnancy vitamin exposure 
(Whites bias ratio= 0.79, 95% CI [0.62, 0.87]; Blacks bias ratio=1.19, 95% CI [1.13, 1.45]). 
These results suggest that early-pregnancy exposures associated with miscarriage risk are 
influenced by proper classification of gestational arrest prior to loss, and that the magnitude and 
direction of bias differs by race. By more accurately identifying which insults have occurred 
prior to pregnancy arrest and differentiating them from exposures that occur after developmental 
arrest but before the onset of bleeding, we have a more optimal method to assess miscarriage risk 
by not mis-assigning exposure time.  
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CHAPTER I  
INTRODUCTION AND SPECIFIC AIMS 
Between 10-15% of all clinically recognized pregnancies end in miscarriage (gestation < 
20 completed weeks). However, more than a fifth of all conceptions may result in early 
pregnancy loss, between implantation and the anticipated time of menses when detecting losses 
by human chorionic gonadotropin (hCG) levels from daily urine samples.
1
 Pregnancy loss can 
be determined by laboratory tests, symptoms such as bleeding or cramping, and ultrasound 
confirmation. Traditionally, pregnancy and the timing of loss is dated from the first day of a 
woman’s last reported menstrual period (LMP), and is often referred to as gestational age.  
However, embryologic development may stop days to weeks prior to the onset of clinical 
recognition of miscarriage. Basing timing of miscarriage on the time from LMP to the clinical 
recognition of loss alone ignores the developmental state of the embryo prior to the loss. This is 
potentially problematic if a pregnancy had, as is common, arrested earlier. For example a 
pregnancy loss based on self-reported LMP dates at 11 weeks may be a loss that is 11 weeks 
along in gestational development when assessed immediately prior to the loss by ultrasound. It 
is also possible that a loss at 11 weeks may in fact be a pregnancy that arrested at five weeks 
based on early embryonic development verified on ultrasound. Alternatively, it is also possible 
that a self-reported 11 week loss may be a loss that is only nine weeks along in gestation when 
confirmed by ultrasound in part due to inaccurate dating of LMP.  In reproductive 
epidemiology, and particularly studies of miscarriage, early exposures during pregnancy are 
treated the same in terms of exposure time (i.e. 11 weeks), regardless of which of the scenarios 
described above truly occurred. Misattributing exposure time may result in overestimation of 
4 
 
certain risk factors and lead to biased estimation of the effect of exposures associated with 
miscarriage.    
 Further, we know that timing of loss differs between Blacks and Whites. Blacks are more 
likely to have a clinical loss later in gestation compared to Whites. Black women are overall 
more likely to experience pregnancy loss compared to White women (adjusted hazard ratio 
(aHR) 1.57, 95% confidence interval (CI) 1.27, 1.93), with a nearly two-fold greater risk of 
clinically recognized loss during gestational weeks 10-20 (aHR 1.93, 95% CI 1.48, 2.51).
2
 
Currently, little is known regarding the relationship between the actual timing of arrest in fetal 
development and the clinical recognition of miscarriage and whether this timing may explain 
differences observed in pregnancy loss by race. Furthermore, key embryologic markers of 
growth may differ by race during early pregnancy and may influence timing and recognition of a 
clinical loss.   
A better understanding of embryologic and fetal development in relation to miscarriage 
timing, including differences by race, are important in epidemiologic studies when studying 
factors in early-pregnancy that may cause or prevent pregnancy loss. My objective is to gain 
further insight into the patterns of timing of loss and determine if mean differences between 
ultrasound developmental stage at arrest and clinical onset of symptoms for miscarriage exists 
between Blacks and Whites during early fetal development. Such research has potential to 
advance overall knowledge about causes of pregnancy loss and help to identify risks that may 
be preventable.  
Right from the start (RFTS) is a unique and diverse prospective cohort of women 
recruited in early pregnancy. Beginning in 2000, RFTS enrolled women who were either 
pregnant or were trying to become pregnant using community-based recruitment from nine 
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metropolitan sites in three states. 
3
 RFTS captures uniform early first-trimester transvaginal 
ultrasound (TVUS) data, a baseline interview at enrollment, a detailed first-trimester interview 
(FTI), including reproductive and medical history and pregnancy-related behaviors on all study 
participants. TVUS information is available for nearly three-quarters (74%) of women who 
experienced a miscarriage in RFTS. For remaining women who reported a pregnancy loss, 
miscarriage occurred prior to ultrasound (26%). RFTS is well suited to address timing of 
miscarriage risk.  
Using data from RFTS, I aim to accomplish the following objectives: 
 
1. To determine the variation and distribution in the number of days between ultrasound estimated 
developmental stage at arrest and clinical onset of symptoms of miscarriage among women who 
experience a pregnancy loss  
Miscarriages are classified based on developmental stage at loss. Developmental stage at 
loss (also referred to as fetal demise or embryologic loss) is characterized initially in the 
following way: women who are considered to have normal fetal development (i.e. fetal pole 
with normal heart rate) and women who are considered to have abnormal or arrested 
development (i.e. either fetal pole with abnormal or no heart rate, or anembryonic gestation) at 
time of transvaginal ultrasound. I estimate gestational age at arrest based on developmental 
stage on ultrasound.  For each woman with loss I assign developmental stage at arrest, estimated 
in days gestation based on a pre-specified nomogram calculated from ultrasound measures. This 
is referred to as the gestational age at arrest of development (GAAD). I then determine the mean 
difference in days between estimated gestational age at clinical loss based on LMP and 
estimated GAAD based on ultrasound for all women who had a loss. This difference will be 
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referred to as the GAAD gap. I report and describe the distribution of the GAAD gap within this 
cohort. Given that the known prevalence of anembryonic arrest is 40% in RFTS,
2
 I hypothesize 
that the GAAD gap will be greater than 10 days for women with a pregnancy loss in this cohort. 
Furthermore I investigate if predictors of long than median vs. shorter than median GAAD gap 
differ within our cohort.  
 
2. To investigate if GAAD influences estimates of common putative factors (e.g. smoking and 
prenatal vitamin use) associated with miscarriage  
Because embryologic development may stop days or weeks prior to the onset of clinical 
symptoms or diagnostic recognition of miscarriage, I hypothesize that the proper classification of 
gestational age at arrest will result in attenuated risk estimates of miscarriage associated with 
either smoking or vitamin use when compared to models that use estimated gestational age based 
on LMP alone. These exposures were chosen to compare the two models since they have been 
established in the literature as factors that may either cause (e.g. smoking) or prevent (e.g. 
vitamin use) miscarriage and RFTS captures in detail both these early pregnancy exposures. I use 
Cox proportional hazard models to test the association between smoking and vitamin use with 
miscarriage risk controlling for potential confounders. Because risk of miscarriage declines with 
increasing gestational age, women who enter the study later will have less opportunity for 
miscarriage to be observed, I left truncate the gestational age at study enrollment for each 
woman. I compare hazard ratios from models that use GAAD with models that use traditional 
self-reported LMP for gestational age. I determine the extent of overestimation and potential bias 
in our prior reported estimates for both models using bootstrap methods.     
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3. To determine if the GAAD gap differs by race and if risk of loss associated with common early 
pregnancy exposures are modified by race   
Blacks and Whites have different gestational ages at clinical loss, with Black women 
having greater risk between weeks 10 and 20 in gestation.
2
 In order to determine if the observed 
later losses in Blacks are due to difference in developmental stage at loss, I compare the GAAD 
gap between Blacks and Whites. I hypothesize that the GAAD gap will be greater in Blacks 
compared to Whites. Furthermore, I use Cox proportional hazard models to determine if risk of 
loss associated with common early pregnancy exposures are modified by race. I compare 
models that use GAAD with models that use traditional self-reported LMP to estimate 
gestational age. If effect modification by race is found, I report stratified estimates in both 
models and determine the extent of potential bias in our prior reported estimates and in the 
literature.  
Finally, as a secondary analysis I plan to assess the impact of pregnancy intention on the 
GAAD gap and its interaction with race within this cohort. Pregnancy intention varies by race
4-6
 
in the U.S. general population and women with unintended pregnancies may be less sure of their 
LMP dates and may have greater variability in their GAAD estimates based on developmental 
stage at ultrasound when compared to women who are planning a pregnancy. I hypothesize that 
Black women will have more unintended pregnancies than White women and that GAAD gap 
will be greater for unintended pregnancies than intended pregnancies among these women.  
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CHAPTER II  
BACKGROUND 
Miscarriage is a complex biological process. Approximately 10 to 15% of recognized 
pregnancies end in miscarriage (also sometimes referred to as spontaneous abortion) and 
defined as a pregnancy loss before completion of 20 weeks of gestation.
1,7,8
 Up to 70% of all 
conceptions are lost prior to live birth. 
9
 As many as 25% of all conceptions may end in early 
pregnancy loss when taking into account unrecognized losses (Figure 2-1).
1
 The majority of 
these losses occur prior to the time of missed menstrual period and are usually unrecognized 
losses. Pregnancy loss can be detected by both biomarkers (urine hCG) and ultrasound 
characteristics.  
 
Figure 2-1. Explaining pregnancy loss (modified from Macklon et al., 2002) 
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Challenges to study miscarriage  
Epidemiologic studies of the causes of miscarriage are challenging, because of the 
difficulty in identifying large numbers of women before or very early in pregnancy. Delayed 
maternal recognition of pregnancy increases the incidence of undetected losses and decreases 
the incidence of clinically recognized loss. The identification of the onset of pregnancy is 
subject to uncertainty by the woman herself, and over half of women who conceive do not 
actively plan the pregnancy.
7
 There is no consistent timing for enrollment in prenatal care in the 
United States, which poses a practical challenge for researchers to identify large numbers of 
women very early in pregnancy. Additionally, the clinical challenge to observe the course of 
early pregnancy is limited, with the timing of losses often not clear without special diagnostic 
efforts. The study of miscarriage requires careful assessment of gestational time at study entry 
because women who enter a study later will have less opportunity for a miscarriage to be 
observed. Recruiting women who are planning a pregnancy provides a larger window of time 
for enrollment without losing information about either early pregnancy exposure or losses.  
During pregnancy, fetal development is traditionally dated from the first day of a 
woman’s last reported menstrual period. This method of dating is often referred to in the  
literature as gestational age.  Additionally, gestational age can be further verified in part based 
on key embryologic developmental markers during ultrasound examination. These markers can 
be used to determine fetal (or embryologic) stages of growth. Fetal growth is important both 
clinically and in epidemiologic studies relating to reproductive  outcomes, such as miscarriage, 
preterm birth and low birth weight. Basing timing miscarriages solely the LMP ignores the 
developmental state of the fetus prior to the loss.
10
 Gestational timing based on ultrasound is 
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traditionally not used for miscarriage studies since most pregnancy losses occur very early in 
gestation, and recruiting women prior to pregnancy may be difficult.  
Embryologic markers and miscarriage risk  
Researchers have conducted studies to determine if key embryologic markers (ex. 
abnormal gestational sac diameters or crown rump lengths) measured during early ultrasounds 
are indicative of early pregnancy loss.  The biologic timing of “loss”, that is the time at which a 
pregnancy that has arrested and is no longer developing, is not the same as the clinical 
recognition or experienced (i.e. symptomatic) timing of loss. Many pregnancies may arrest days 
or weeks prior to clinical recognition.  
Abnormal development, including slower growth in the first-trimester may be indicative 
of a failed pregnancy.
10-15
  Past research indicates that shorter than expected gestational sac 
diameters
14
  or fetal pole lengths 
13
 may be associated with increased risk of pregnancy loss. 
Additionally, crown rump length (CRL) of these fetuses was smaller than expected based on 
gestational age. Some evidence suggests that fetuses that eventually miscarried had on average 
smaller CRL than those that did not.
13
 Embryos that were relatively slow growing in the first-
trimester were at a greater risk for pregnancy loss.
10
 Other factors like missing fetal yolk sac and 
slow fetal heart rate have also been associated with risk of miscarriage.
15
 One study found that 
60% of fetuses with slow heart rate (< 90 beats per minute) at <7 weeks gestation ended in 
miscarriage (n=188 of 310 pregnancies).
12
  Another study found that 94% of embryos with small 
gestational sac (defined as difference between mean gestational sac diameter and  CRL < 5mm) 
resulted in pregnancy loss regardless of normal fetal heart rate (n=15 of 16 pregnancies).
11
  
Maternal factors are also known to influence first-trimester growth. A study by Bottomley et al. 
11 
 
found that the rate of increase in CRL was greater in fetuses of Black versus White women and 
increased with advancing maternal age.
16
  
In 2011 Jeve et al. conducted a systematic review to assess the accuracy of first-trimester 
ultrasound for diagnosis of early embryonic demise. They reported sensitivity and specificity of 
key fetal markers including fetal heart rate, gestational sac and yolk sac among women who 
experience miscarriage.
17
 Among eight identified articles for review, an empty gestational sac 
with mean diameter ≥ 25 mm and absent yolk sac with mean gestational sac diameter ≥ 20mm 
were the thresholds with the highest and most precise estimates of specificity for diagnosing 
early embryonic demise (specificity 1.0, 95% CI 0.93, 1.0 for both).
17
 They conclude there is 
scarce high-quality prospective data on which to base guidelines for the accurate diagnosis of 
early pregnancy loss. However no detailed search criteria for the review were provided and 
rationale for why 97% of the studies (n=697 of 720 studies searched) did not meet eligibility 
criteria was lacking. Furthermore all studies that were included (n=8 studies) dated prior to 
1992. 
Changes in ultrasound technology since the early nineties have resulted in more precise 
imaging and more advanced assessment of fetal viability. The transvaginal ultrasound provides 
the most accurate information in early pregnancy, given that the gestational sac and fetal pole 
are still developing at this point and a vaginal ultrasound can get closer to the developing 
pregnancy and provide a more precise measurement and therefore an improved assessment of 
viability.
18,19
 Finally, the review by Jeve et al., failed to differentiate women who were 
symptomatic of miscarriage (i.e. bleeding, cramps) compared to women who were 
asymptomatic.
17
 Women who are symptomatic of miscarriage may present a different etiology 
than women who are asymptomatic and undergoing a first-trimester ultrasound, since bleeding 
12 
 
is a predictor that strengthens the diagnostic test properties. This could be one explanation for 
the heterogeneity seen across studies.  
Race and miscarriage risk  
 Maternal factors are known to influence first-trimester growth, including race.
16,17
 
Studies incorporating race into multivariable models of miscarriage risk have not specifically 
focused on evaluating the presence or magnitude of disparity. One study reported race as a 
confounder when assessing putative risk factors associated with miscarriage, suggesting that 
Blacks have twice the risk of miscarriage compared with other racial groups,
20
 and others report 
no association between race and miscarriage risk.
21-23
  A summary of results addressing race and 
miscarriage risk can be found in Table 2-1.  
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Table 2-1. Studies addressing race and miscarriage risk 
Author 
Study type 
Location  
Study 
Period Population 
Definition 
of Loss 
No. of 
Losses Race No. (%)  
Effect 
estimate 
(95% CI) 
Confounders in 
model  
Risch et 
al., 1988
22
 
 
Case-control,  
United States 
and Canada  
1974-
1981 
Matched 
controls from 
a study on 
either 
cervical, 
ovarian or 
colorectal 
cancer 
registries 
Not defined  805  Whites 
Non-
Whites 
Not provided RR=1.0 
RR=0.8 
(0.52-1.23) 
None  
Goldhaber 
et al., 
1991
21
 
 
Prospective,  
California,  
United States  
1981-
1982 
Single HMO 
covered plan 
<28 weeks 
gestation  
833 Whites 
Black  
Other 
7,154 (79.0) 
   570  (6.3) 
1,331 (14.7) 
0.11
a
 
0.10
 a
 
0.12
 a
 
NA  
Zhang et 
al., 1996
20
 
 
Prospective, 
Connecticut 
Unites States 
1988-
1991 
11 private 
clinics and 2 
HMO plans 
Not defined  628  Whites 
Blacks 
and 
Others 
  2,568 (93.5) 
     178   (6.5) 
1.0 
RR=2.57 
(1.54-4.30) 
Maternal age 
(dichotomous 
>35 years) 
Wen et al., 
2001
23
 
Prospective, 
Minnesota, 
United States 
1989-
1992 
Single HMO 
covered plan 
Not defined  75 Whites 
Other 
624 (96.3) 
  24   (3.7) 
 
RR=1.0 
RR=1.1 
(0.40-3.20) 
None 
Mukherjee 
et al. 
2013
2
 
  
Prospective 
Southeastern 
Unites States 
2000-
2012 
Clinic and 
community 
based 
recruitment  
<20 weeks 
gestation   
537  Whites 
Blacks 
3,138 (77.1) 
   932 (22.9) 
1.0 
HR=1.57 
(1.27-1.93) 
Maternal age 
(continuous), 
alcohol use 
No=number; CI= confidence interval; HR=hazard ratio; RR=relative risk; NA=not applicable
 a
Estimated incidence within cohort RR and 
95% CI not available. 
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While there is limited research on racial disparities in risk of miscarriage, other adverse 
pregnancy outcomes, including spontaneous preterm birth and fetal growth restriction have been 
shown to differ significantly by race and may have their origins in event as early as placentation. 
Studies have shown that the overrepresentation of preterm births in non-Hispanic Black women 
is observed independently of conventional maternal medical and socioeconomic factors captured 
in epidemiologic research and that complex causal pathways may link the social construct of race 
to the biological outcome of preterm birth.
24-26
 Furthermore, the study of miscarriage requires 
careful assessment of gestational time at study entry because women who enter a study later will 
have less opportunity for a miscarriage to be observed than women who enter very early in 
pregnancy. A recent review found only four prior studies that collected adequate data to estimate 
miscarriage risk by week of gestation from early in pregnancy, and none evaluated these 
differences by race.
27
  
Our study within the RFTS cohort found that the overall risk of miscarriage remains 
elevated for Blacks compared to Whites (aHR= 1.57, 95% CI 1.27, 1.93). Our primary finding 
indicated Black women have a nearly two-fold higher risk of miscarriage compared with white 
women during gestational weeks 10–20 (loss ≥ 10 weeks, aHR= 1.93, 95% CI 1.48, 2.51), while 
there was no apparent difference in the risk of earlier miscarriage ( loss < 10 weeks aHR=1.15, 
95% CI 0.82, 1.62).
2
 There is a higher risk of loss early in pregnancy that declines with 
increasing gestational age. The finding of increased risk for Blacks during weeks 10–20 is less 
vulnerable to bias because most women have recognized their pregnancy by the tenth week of 
gestation. We used ultrasound examination data to evaluate fetal viability among study 
participants and to assess developmental stage prior to pregnancy loss. Ultrasound information 
was available for the majority of women who experienced a loss in our cohort, and we observed 
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similar patterns of early embryological arrest in Blacks and Whites. This also suggests that the 
increased risk of later loss among Black women may reflect events during fetal development 
after initial organogenesis is complete (rather than early embryologic insults).   
Heterogeneity in miscarriage risk  
One approach to coping with etiologic heterogeneity in miscarriage is to consider 
miscarriages of different gestational ages as different outcomes.
28
 Silver and colleagues 
suggest that early pregnancy losses as losses prior to ten weeks gestation, and fetal deaths 
as losses occurring between 10 and 20 weeks gestation. The suggested nomenclature is 
based on developmental periods in gestation which may share similar pathophysiology to 
other adverse birth outcomes including preterm birth and stillbirth along the pregnancy 
spectrum. Since many of these pregnancy outcomes are known to differ by race, by 
addressing the potential heterogeneity in outcomes such as miscarriage, researchers may 
be better equipped to identify putative risk factors and frame plausible biological causal 
pathways that may bar by race and influence early fetal well-being.
2
 A causal framework 
assessing both biologic and behavioral factors for race and risk of miscarriage can be 
found below (Figure 2-2). Factors include both modifiable and non-modifiable risk 
factors. The factors assessed in this causal framework can be used to establish 
measureable associations between independent variables, race and the risk of miscarriage. 
Isolating specific variables within study framework and investigating these causal 
relationships through statistical analysis can give further insight into risk factors 
associated with miscarriage and the relationships between these factors. The greater the 
heterogeneity in risk, the more likely it is that we can discover causal factors associated 
with that risk by separating etiologic distinct outcomes that may otherwise appear similar.  
16 
 
Figure 2-2. Causal model for race and miscarriage risk 
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Classifying types of miscarriage  
The existing classification of pregnancy loss ignores both developmental biology and 
clinical manifestation. This is problematic for grouping women who may have different 
pathophysiology and thus different recurrence risk as the same condition. This further limits 
research and confounds epidemiologic data collection and assessment for reproductive outcomes. 
A potentially more useful way to catalog pregnancy loss may be by developmental periods in 
gestation.
28
 Early pregnancy losses are losses that occur before ten completed weeks of gestation. 
They can be further classified as peri-implatational losses, which are losses before five weeks 
gestation with no gestational sac visible on ultrasound; pre-embryonic losses occurring between 
five and six weeks gestation, in which gestational sac, yolk sac or both may be visible on 
ultrasound but no visible embryo and; embryonic losses occurring between six and ten weeks 
gestation in which an embryo is visible with CRL < 10mm with no fetal heart tones (Table 2-2). 
Fetal deaths can be classified as losses occurring between 10 and 20 weeks gestation with a CRL 
measuring at least 30 mm. Recurrent miscarriage is defined as three or more pregnancies that end 
in loss, and occurs in about 1% of women who miscarry. A summary of common reproductive 
and ultrasound terminology can be found in the Appendix.  
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Table 2-2. Defining pregnancy loss by gestational age and ultrasound (modified from Silver et 
al.) 
Type of Loss Definition  Gestational 
weeks 
Ultrasound characteristics 
Early Pregnancy Loss Loss prior to 10 
weeks gestation  
 
< 10  
         Peri-implatational loss Loss before 5 weeks 
gestation  
 
< 5  No gestational sac 
         Pre-embryonic loss Loss between 5 and 
6 weeks gestation  
5 to <6 Gestational sac or yolk sac or 
both, no visible embryo 
 
         Embryonic loss Loss between 6 and 
10 weeks gestation  
6 to <10 Embryo with CRL<10mm and 
no FHR 
 
Fetal Death  Loss between 10 and 
20 weeks gestation  
10 to <20 Either 1. Passage of a 
conceptus with CRL ≥30mm 
2. dead conceptus in utero with 
CRL ≥30mm or  
3. loss of a conceptus after 
documented FHR at or beyond 
10 weeks of gestation  
         Early fetal death Loss between 10 and 
16 weeks gestation  
 
10 to <16  
         Late fetal death  Loss between 16 and 
20 weeks gestation  
 
16 to <20   
Recurrent miscarriage  Three or more 
pregnancies that end 
in loss 
< 20 three or 
more times 
NA 
CRL=crown-rump length; FHR=fetal heart rate; NA=not applicable  
Importance of estimating gestational age 
Accurate knowledge of gestational age is arguably the most important piece of 
information for pregnancy management. The estimation of pregnancy dates is important, not 
only for the expectant mother but also when considering therapy and interpreting diagnostic 
tests. Gestational age (GA) can be determined using the first day of the mother's last period and 
can also be referred to as the menstrual age. Comparatively, the true fetal age is the conceptional 
age (CA), which refers to the pregnancy length from the time of conception. A study by Savitz et 
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al. found that using  LMP alone is subject to systematic tendency to overestimate the duration of 
gestation when compared to ultrasound based gestational age, by  assigning a gestation 2.8 days 
longer on average than with ultrasound scanning and predict delivery among term birth less 
accurately.
29
 Having an accurate GA is crucial for different clinical aspects, such as the timing of 
chorionic villous sampling in the 1
st
 trimester, genetic amniocentesis in the 2
nd
 trimester, dating 
of the fetus, and determination of fetal size.
30
 Precise GA may also be important when evaluating 
a potential miscarriage, since timing of miscarriage occurrence may result in differences in 
clinical management decisions, such as expectant care, medical or surgical interventions. 
Clinical approaches to estimate gestational age 
The traditional ways to estimate GA include: known coital history, accurate menstrual 
history with a known LMP date, thorough clinical examination, ultrasonography and serial beta-
hCG levels. Dating by ultrasound is more accurate than by assessing menstrual dates alone. 
Using LMP alone to estimate GA assumes that conception occurs on day 14 of a 28 day 
menstrual cycle, when in fact ovulation varies greatly both from cycle to cycle and between 
individuals.
31
 Many women are uncertain of their exact cycle dates
32
, and even if the menstrual 
history is known to be correct, individual variations for the time of ovulation can alter the length 
of the cycle.
18
 Up to 30% of women may be uncertain of their LMP dates or have irregular 
cycles.
31,33
  And even among women who are certain of their LMP dates, the discrepancy 
between menstrual age and ultrasound GA can be as high as 45% among pregnancies that are 
induced post-term (>294 days), probably due to the variability in length of the follicular phase 
the menstrual cycle.
34
  Furthermore, a number of clinical signs, such as uterine size and 
quickening (i.e. perceived fetal movement by the patient)  may be helpful but are unreliable in 
solely determining GA.
35
 Therefore there has been a strong move towards scanning all obstetric 
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patients as a way to verify GA. Table 2-3  is a summary of the early studies used to estimate 
gestational age using ultrasongraphy technology. These seminal studies provide the framework 
used to estimate gestational age.  
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Table 2-3. Summary of previous studies estimating gestational age 
 
Author Year Location 
No. of 
Subjects 
 GA at 
Scan  
(days)  IVF 
Ultrasound 
Type CRL? Other
a
 Equation to estimate GA 
Robinson
36
 1975 Scotland 334 44-98 No TA Yes  t=8.052(CRL)
1/2
+23.73 
Drumm
37
 1976 Ireland 253 47-101 No TA Yes  
t=((0.374+((0.374)
2
+4x0.012
(CRL)
1/2
))/(2 X 0.012)                                          
t=15.583+(242.84+((83.333x
CRL))
1/2
)
b
 
Nelson
38
 1981 
North 
Carolina, 
USA 83 
Not 
provided
c
 No TA Yes  t=51.0008+0.6(CRL) 
Pedersen
39
 1982 Denmark 105 49-98 No TA Yes  
t=6.40-
0.266(CRL)+0.0116(CRL)
2
 
Hadlock 
40
 1984 Texas, USA 361 84-294 No TA  Yes 
t=10.85+0.060(HC)(FL)+0.6
700(BPD)+0.1680(AC) 
MacGregor
41
 1987 
Chicago, 
USA 72 49-93 Yes TA Yes  
t=45.96+8.49(CRL)-
0.2223(CRL)
2
 
Vollebergh
42
 1989 Netherlands 47 42-91 Yes TA Yes  t=7.23(CRL)
1/2
+31.7 
Tezuka
43
 1991 Japan 143 35-56 No TV  Yes t=(54.64+FHR)/3.850 
 
Klustermann
44
 1992 Italy 183 42-108 No TV Yes  
t=-3.98-
0.308(CRL)+0.0117(CRL)2 
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Author Year Location 
No. of 
Subjects 
 GA at 
Scan  
(days)  IVF 
Ultrasound 
Type CRL? Other
a
 Equation to estimate GA 
 
 
 
Hadlock
45
 1992 Texas, USA 416 35-138 No TV, TA Yes  
t=exp[1.685+0.316(CRL)-
0.049(CRL)
2
+0.004(CRL)
3
-
0.0001(CRL)
 4
] x7 
Daya
46
 1993 Canada 94 43-99 Yes TV, TA Yes  
t=40.447+1.125(CRL)+0.005
8(CRL)
2
 
Goldstein
47
 1994 
New York, 
USA 143 44-67 No TV  Yes t=L+42 
Wisser
48
 1994 Germany 160 35-98 Yes TV  Yes 
t=35.72+1.082(L)
1/2
+1.472L-
0.09749L
3/2
 
Joshi
30
 2009 Nepal 123 49-98 No TA Yes  t=8.26+0.08(CRL) 
IVF=in vitro fertilization; GA=gestational age where t refers to the estimated gestational age (in days); TA=transabdominal; 
TV=transvaginal; CRL=crown-rump length; L=longest embryonic length; 
a
Other may include: HC=head circumference; AC=abdominal 
circumference; FL=femur length BPD=fetal biparietal diameter or FHR=fetal heart rate. 
b
transformed formula based on Nelson
38
 
c
scans 
were conducted 1 to 2 weeks after first visit. 
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Early studies estimating gestational age from crown-rump length  
The first-trimester is the period during which the most accurate assessment of GA is 
possible. During this period, growth rate is most rapid and consistent and variation in size 
between fetuses of the same age is at its smallest. Crown-rump length (CRL), which is the length 
of a human embryo from the top of the head (crown) to the bottom of the buttocks (rump), often 
can be determined using ultrasonography images. The first report of ultrasound measurement of 
the fetal CRL was done by Robinson and Fleming, where they found that measuring the CRL, 
which can be done as early as the 7
th
 week, can be used as an accurate determination of GA.
36
 
Using fetal CRL measurements as a way to determine gestational age, Robinson and Fleming 
reported normal values for CRL growth from 6-14 weeks.
36
 These values were derived from 334 
measurements and a weight nonlinear analysis was performed. A “point estimate” of the GA was 
given by the equation: 
t = 8.052 x CRL
1/2
 + 27.73 
 where t refers to the time as gestational age in number of days. The accuracy of using 
CRL to determine GA is ± 4.7 days with only a single measurement and  ± 2.7 days with three 
independent measures.
36
 Based upon this, it is evident that the CRL determined sonography in 
the first-trimester provides an accurate estimation of GA for measures of early embryologic 
development during early pregnancy. In another study, Drumm found that for any given CRL, it 
was within a range of three days of the GA, as determined by menstruation history.
37
 This was 
among a population of singleton births among women with known LMP dates, a menstrual cycle 
between 26 and 31 days, no uterine bleeding prior to ultrasound and no evidence of maternal 
conditions such as diabetes mellitus, renal disease or hypertension that may affect fetal growth. 
24 
 
The normal curves provided by Drumm et al. vary from Robinson et al. by no more than 2mm at 
any stage throughout the first-trimester.
37
 It was found that the most precise estimate of fetal age 
was during a GA of 10-11 weeks, which was equivalent to CRL measurements of 31-40mm.
39
  
Potential measurement errors in crown-rump length assessment  
Many studies have shown that the CRL is the most consistent measurement for 
determining gestational age in early development.
36,37,45,46
 Prior to 10 weeks, the small CRL 
dimensions are more susceptible to measurement and operator inaccuracies.
42
  There are two 
types of errors: random and systematic. Random includes errors of operator judgment and the 
measurement process from the ultrasound. When the embryo is first visualized on ultrasound, the 
measurement is based upon the “greatest length” since it is fairly straight and there is no 
curvature to the image.
49
 As the fetus continues to develop, it assumes a C-shaped structure, and 
further unfolding of the head and regression of the tail allows accurate measurement at about 18 
mm.
49
 Most clinicians do not allow for fetal flexion and instead just take the longest direct 
distance from the crown of the head to the fetal rump. Early measurement of CRL can be more 
difficult, since measurement error is proportionally greater in small rather than large CRL values, 
leading to underestimation of CRL, which subsequently leads to an underestimation of GA.
42
  
In another study, CRL from menstrually-derived pregnancies underestimated the true GA 
when compared to ovulation-timed pregnancies.
41
 The discrepancy in timing was 3.2-3.5 days, 
which corresponded to 5.0-5.7% underestimate in gestational age
41
 when compared to studies by 
Robinson and Flemming
36
 or Drumm et al.
37
 These findings demonstrate that menstrual histories 
are not always accurate when determining GA, suggesting that among populations which use 
assisted reproductive technologies to conceive, ovulation dates should be used instead.
41
 It is 
important to carefully examine CRL in patients who conceived through IVF, since issues of 
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recurrent pregnancy loss can be seen if early fetal growth retardation is observed prior to fetal 
death. Among populations using IVF, an alternate equation for CRL and GA has been developed 
in which the date of conception is known.
46
  
Variations in crown-rump length measurements    
A  study focusing on the Nepalese population observed that CRL measurements were a 
reliable method for estimating GA, and corresponded to the Robinson nomogram up to 9 weeks 
GA. It was noted that there were slight differences between weeks 10-12, which might have been 
due to ethnic differences of fetal development.
30
 There have also been some variations noted in 
CRL, where the measurement is smaller than expected. Examples of factors associated with 
smaller CRL values include female fetuses, a fetus in early diabetic pregnancy and fetuses in 
threatened abortions.
39
 The difference in sizes between the sexes had a genetic rather than a 
hormonal mechanism. It is possible that if there exists a discrepancy between the CRL 
measurement and the menstrual age, it may be indicative of a threatened abortion or maternal 
diabetes.
39
 This discrepancy between CRL and menstrual age may have some prognostic value in 
identifying at risk fetuses.  Differences between nomograms used to estimate GA based on CRL 
can be noted because of differences in sample size, selected population, advancements in 
ultrasound technology, and ethnic population variation.
30
  
Crown-rump length measurement in threatened miscarriages    
In a study focusing on threatened abortions (n=255), it was found that the CRL of fetuses 
were smaller than expected based upon their menstrual age.
13
 Of the 8 fetal losses in this series 
(7 abortions and 1 intrauterine death) all except for one had a CRL measurement below the mean 
for their calculated GA.
13
  This phenomenon suggests that there was early fetal growth delay, 
which can be considered a marker of impending loss in threatened abortions. Additionally in this 
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study, Mantoni and Pederson found that in those who had been bleeding for more than three 
days, the increased discrepancy in size was a further two days. 
13
 However, it should be noted 
that second and third-trimester growth rates were all normal.  
Alternative fetal measurements to estimate gestational age  
Alternative fetal measurements have been proposed as measurement parameters for 
ultrasound assessment of GA.
38,40
 After 11 weeks, the variation of fetal flexion makes accurate 
CRL measurement more difficult. Therefore the real limitation of CRL is that towards the end of 
the first-trimester, the fetus tends to assume a curled position, rendering the CRL measurement 
more unreliable. During late first-trimester and in the later stages of pregnancy, using other 
parameters such as biparietal diameters results in more accuracy. Biparietal diameter (BPD) is 
the measurement of the fetal head from one parietal eminence to the other. The optimum time to 
determine BPD is between 18-26 weeks and there is no significant difference whether the BPD is 
obtained using B-mode ultrasound equipment or real-time ultrasound.
38
 However it is important 
to keep in mind that overall CRL is a more accurate method of predicting delivery date when 
compared to BPD in the first-trimester.
38
  
Other alternative fetal measurement includes head circumference, abdominal 
circumference and femur length. The fetal trunk circumference is measured at a point just caudal 
to the cardiac pulsation. It is also important to note that the femur length is more difficult to 
visualize and thus to measure in the early weeks, with a practical cutoff at 12-13 weeks gestation. 
One study examined GA prediction using multiple fetal ultrasonographic measurements 
(biparietal diameter, head circumference, abdominal circumference and femur length) in a 
racially mixed population.
50
 The use of multiple parameters to estimate fetal age proved to be 
more accurate than the use of any single measure during a later gestational window (84-294 
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days) but may not necessarily apply to early first-trimester.  
Other common fetal measurements to estimate gestational age include fetal heart rate and 
mean sac diameter. During the first-trimester, fetal heart rates vary with gestational age (refer to 
Table 2-4). Estimated fetal heart rate before six weeks gestation is between 100-115 beats per 
minute (BPM). After which, FHR increases rapidly (ex. at eight weeks gestation: 144-159 BPM; 
nine weeks gestation 137-144 BPM).
51
 A summary of estimated MSD and FHR by gestational 
week can be found in Table 2-4.  
Table 2-4. Expected first-trimester ultrasound characteristics by gestational week 
Gestational age 
[weeks] 
Mean sac diameter (MSD)
a
  
[mm ± SD] 
Mean Fetal heart rate (FHR)
b
   
[bpm ± 1 SD] 
5-5.95 3.0 ± 0.8 101.2 ± 8.7 
6-6.95 3.0 ± 0.7 124.5 ± 12.1 
7-7.95 4.0 ± 0.9 128.0 ± 11.7 
8-8.95 4.7 ± 0.6 144.3 ± 19.5 
9-9.95 5.2 ± 0.6 138.7 ± 12.4 
10-10.95 5.9 ± 0.6 136.9 ± 10.9 
11-11.95 5.4 ± 0.9 139.8 ± 18.9 
12-12.95 4.4 ± 0.6 137.3 ± 12.9 
bpm=beats per minute; mm=millimeters; SD=standard deviation; modified from 
a
Jauniaux et al. 
(1991)
52
 and 
b
Hertzberg et al. (1988)
51
  
Changes in ultrasound technology to estimate gestational age  
Transabdominal ultrasound scanning for early pregnancy was the accepted method until 
the mid-1980s. Transabdominal ultrasound rarely permits anatomic description of internal organs 
in the early embryo, and a full urinary bladder displaces the pelvic organs away from the probe. 
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Transabdominal ultrasound imaging can also be difficult in obese patients. The challenge within 
this patient population is that in pathologic pregnancies, a transabdominal ultrasound often is not 
enough. Transvaginal sonography (TVUS) can help fill in the gaps and provide relevant 
information not otherwise shown by a transabdominal ultrasound.  
Transvaginal vs. transabdominal ultrasounds 
Additionally transvaginal ultrasounds allow for a better understanding of embryonic 
anatomic stages.
47
 When compared to Robinson’s study, Goldstein and colleagues found that 
CRL measurement was approximately 2 to 3 mm shorter for equal values of GA when using 
endovaginal ultrasonography.
47
 Robinson’s study was published prior to the sonographic 
description of the yolk sac and his early embryonic measurements may have inadvertently 
included a portion of the yolk sac in its reporting. With use of transvaginal ultrasound the 
distinction between yolk sac and adjacent embryonic structures is more readily observable. 
Furthermore endovaginal ultrasounds allow for sufficient magnification to see anatomic detail 
including cardiac activity that may not be as readily visible in transabdominal ultrasounds.  
Goldstein and colleagues used information from endovagianl ultrasounds to establish a 
nomogram for GA by measuring an embryo prior to the development of a “crown” or “rump”. 47 
Other ways to use the transvaginal ultrasound examination would be to inspect the embryonic 
structure and measure the greatest embryonic length. Accordingly, the estimation of GA 
48
(t) 
according to measurement of embryonic length (L) was found to be:  
t = 35.72 + 1.082L
1/2
 + 1.472L – 0.09749L3/2   
Another study employed the use of transvaginal sonography to establish reference ranges 
according to cephalic, abdominal and limb measurements.
44
 The mean values derived in the 
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study was nearly identical to those previously obtained by Robinson and Fleming using the 
transabdominal static scanning.
44
 With the rapid growth of a fetus during the first-trimester, fetal 
measurement during this period provides an accurate assessment of gestational age and 
development. Kustermann and colleagues highlight the importance of both systematic and 
instrumental errors that are inherent to the equipment that is used in measurement. Despite this, 
the rapid growth rate of the fetus allows errors of several millimeters to be of minor clinical 
significance.  
Rationale for transvaginal ultrasounds in assessing miscarriage risk  
There have been progressive changes in ultrasound technology though the introduction of 
transvaginal probes which are better able to assess gestational age in early first-trimester.
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Furthermore, accurate embryologic and gestational dating to determine fetal viability prior to 
loss is essential if we want to better understand the causes of early pregnancy loss. There is 
scarcity of high-quality, prospective data on which to base guidelines for the accurate diagnosis 
of early pregnancy demise.
27
 Studies of miscarriage risk are limited by early enrollment of 
pregnant women, the small number of miscarriage  cases observed, inclusion of symptomatic 
together with asymptomatic women, and variable reference standards for confirming diagnosis of 
early pregnancy demise. An appropriately powered study using current ultrasound technology 
(i.e. a transvaginal approach) and an explicit reference standard for pregnancy success or loss 
may be required before setting future standards for the accurate diagnosis of early embryonic 
demise. A consensus about an appropriate methodological approach to assess gestational age 
prior to arrest should be reached before evaluating exposure to risk factors during early 
pregnancy.
15
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Exposures and miscarriage risk  
Research that gives insight to the biologic mechanisms of exposures operating during 
early pregnancy is useful, especially since this time period in pregnancy is not well understood. 
Despite also the fact that miscarriage is a common adverse pregnancy outcome that frequently 
occurs during this time period. However, a primary challenge in reproductive epidemiologic 
research is the accurate and early exposure assessment during early pregnancy. By more 
precisely identifying which insults have occurred prior to pregnancy loss and assessing 
exposures that occur after developmental arrest but before the onset of clinical symptoms we 
have more optimal method to assess miscarriage risk by not misattributing exposure time.  
Knowledge about risk factors influencing early pregnancy period is sparse and often 
times contradictory. This may be because the risk of early-pregnancy exposures on pregnancy 
loss remains unclear due to the challenges associated with prospectively recruiting women very 
early in pregnancy. It may also be due to the heterogeneity in classifying different types of loss 
which may have very different etiologies, given that 40% of losses arrest earlier when assessed 
by early first-trimester ultrasound.   
In specific aim 2 I investigate if proper classification of gestational age at arrest 
influences estimates of common putative risk factors (ex. smoking and prenatal vitamin use) 
associated with miscarriage. I assess both self-reported smoking and vitamin use in first-
trimester with risk of miscarriage in my analyses. These risk factors were chosen because they 
have been associated with first-trimester miscarriage risk in some studies and have been 
established to influence fetal well-being and may be episodic during early pregnancy. One is a 
protective factor (i.e. vitamin use) and one is a risk factor (i.e. smoking) associated with 
miscarriage. By assessing a better methodological approach to classify timing of gestational 
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arrest prior to loss we can determine the extent of potential overestimation of certain factors that 
may lead to biased estimates for factors associated with early pregnancy loss.  
Smoking   
Tobacco use remains one of the most commonly abused substances among pregnant 
women. Of women who smoke, 60% stop as soon as they find out they are pregnant. 
53
 Based on 
results from the National Natality Survey, smoking prevalence among US pregnant women was 
approximately 12%. 
53
  Some studies found an increase in risk of miscarriage among smokers,
54-
61
 while others have reported no association or only a weak relationship.
8,62-64
 Two studies 
reported a clear dose-response relationship between smoking and spontaneous abortion.
54,55
  In 
their study population, Armstrong and colleagues estimated that cigarette smoking accounted for 
11% of all miscarriages and could explain up to 40% of losses among women smoking 20 or 
more cigarettes per day.
54
 Ness and colleagues reported the risk of loss related to smoking habits 
is probably underestimated when using self-report (RR~1.4) compared to biomarker detection of 
cotinine levels from hair samples (RR~1.9).
65
 However, because smoking is generally not 
associated with fetal anomaly, it is suspected that the smoking-related risk of loss may occur 
predominantly among miscarriages with normal fetal karyotype (i.e., a fetus with normal 
chromosomes).
53
  
The association between early miscarriage and smoking has been inconsistent.
54-56,62,63,65-
68
  The inconsistencies may in part be dues to limitation in sample size, inadequate control for 
confounders, and differences in recall bias of smoking status among subjects. A synopsis of the 
major studies published since 1975 that have reported risk ratios between smoking and 
miscarriage are summarized in Table 2-5.  
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In summary, although many studies have found a positive modest association between 
maternal cigarette smoking and risk of miscarriage, dose-response associations have been 
reported only by some studies, and other studies have reported no association between smoking 
and risk of pregnancy loss. The mechanisms underlying the possible association between 
smoking and risk of miscarriage may involve toxic effects of nicotine, carbon monoxide and 
other constituents of tobacco smoke.
53
 In reproductive epidemiology, the timing of these 
exposures may be distinct or cumulative in their overall risk for loss. The contradictory findings 
may be further confounded by the heterogeneity in the type of loss assessed (e.g. early pregnancy 
loss vs. fetal death). A better assessment in the timing of loss is warranted so that we can 
understand biologically meaningful causal associations between smoking and miscarriage risk.   
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Table 2-5. Studies on miscarriage risk and smoking  
 
Author, 
Study type,  
Location 
Population 
Study 
period 
Smoking status 
Relative risk 
(95% CI) 
Adjustment 
factors 
Kline et al. 
1977
56
 
Case-control 
United States 
 
574 losses < 28 
weeks gestation , 
320 births            
1974-
1976 
Nonsmokers  
Smokers              
1.0 
1.80 (1.30-2.50) 
Age at last menses, 
history of abortion 
and live births 
Ericson and 
Källén 1986
66
 
Case-control 
Sweden 
 
219 losses, 1,032 
births without 
major 
malformation   
1980-
1981 
Nonsmokers  
Smokers                        
1.0 
1.00 (0.60-1.50) 
Video screen use, 
stress 
Sandahl 
1989
62
 
Case-control 
Sweden 
610 losses, 1,337 
births          
1980-
1985 
Nonsmokers  
Smokers     
    Any smoking 
    > 10 cigaretts/day   
        
1.0 
 
0.90 (0.80-1.00) 
0.90 (0.70-1.00)  
Maternal age parity 
Armstrong et 
al. 1992
54
 
Cohort 
Canada 
10, 191 losses, 
47,146 pregnant 
women  
1982-
1984 
Nonsmokers               
Smokers 
     1-9 cigarettes/day 
     10-19 cigarettes/day 
      ≥ 20 cigarettes/day 
1.0 
1.10 (1.00-1.20) 
1.20 (1.10-1.30) 
1.70 (1.60-1.80) 
Maternal age, 
education, 
ethnicity, 
employment during 
pregnancy 
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Author, 
Study type,  
Location 
Population 
Study 
period 
Smoking status 
Relative risk 
(95% CI) 
Adjustment 
factors 
Windham et 
al. 1992
63
 
Case-control 
United States 
626 losses < 20 
weeks' gestation  
1,300 births              
1986-
1987 
Nonsmokers               
Smokers  
    1-10 cigarettes/day  
     > 10 cigarettes/day 
1.0 
0.90 (0.70-1.20)  
1.10 (0.80-1.60) 
Maternal age, 
previous fetal loss, 
marital status, 
insurance, alcohol 
intake, intake of 
bottled water 
      
Dominguez-
Rojas et al. 
1994
55
 
Cohort 
Spain 
169 losses, 711 
women with > 1 
pregnancy        
1989-
1991 
Nonsmokers               
Smokers  
    1-10 cigarettes/day  
    >11 cigarettes/day 
1.0 
1.00 (0.60-1.50)  
3.40 (1.70-6.90) 
Maternal age, age 
at menarche, 
previous 
spontaneous 
abortion, marital 
status 
      
Chatenoud et 
al. 1998
67
 
Case-control 
Italy 
782 losses < 12 
weeks' gestation 
1,543 births                                  
1990-
1997 
Nonsmokers               
Former smokers  
     Smokers before    
pregnancy 
        Smokers before and 
during pregnancy 
1.0 
0.90 (0.70-1.20)  
0.70 (0.50-1.00)  
1.30 (1.00-1.60) 
Maternal age, 
education, marital 
status, history of 
spontaneous 
abortion or 
miscarriage, 
nausea, alcohol or 
coffee intake in 
first trimester 
      
Ness et al. 
1999
65
 
Case-control 
United States 
400 losses <22 
weeks’ gestation  
570 births  
1995-
1997 
Nonsmokers               
Former smokers  
Current smokers 
1.0 
0.90 (0.60-1.30)  
1.40 (1.00-1.90) 
None 
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Author, 
Study type,  
Location 
Population 
Study 
period 
Smoking status 
Relative risk 
(95% CI) 
Adjustment 
factors 
Windham et 
al. 1999
68
 
Cohort 
United States 
499 losses, 5,342 
pregnant women                         
1990-
1991
Nonsmokers     
Smokers  
    1-4 cigarettes/day  
    5 cigarettes/day 
 
           
1.0 
 
0.90 (0.60-1.50)  
1.30 (0.90-1.90) 
Maternal age, prior 
fetal loss, alcohol 
intake, caffeine 
intake, gestational 
age at interview 
Maconochie 
et al. 2007
8
 
Population-
based  
Case-control 
England 
603 losses < 13 
weeks' gestation               
6,116 births > 13 
weeks gestation                                
2000-
2001 
Nonsmoker 
Smokers  
    < 5 cigarettes/day  
5-10 cigarettes/day 
    11-20 cigarettes/day 
    >20 cigarettes/day 
1.0 
 
0.68 (0.43–1.07)a 
1.03 (0.71–1.50)a 
1.13 (0.88–1.44)a 
1.19 (0.86–1.66)a 
Year of conception, 
maternal age, 
previous 
miscarriage and 
previous live birth. 
CI=confidence interval; 
a
adjusted odds ratio 
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Vitamins   
Multi-vitamin supplementation is commonly recommended for all women who are 
pregnant or planning a pregnancy. Prenatal vitamin supplementation during early pregnancy is 
related to lower risk of neural tube defects and is associated with decreased risk of adverse 
pregnancy outcomes including preterm birth, pre-eclampsia and low-birth weight.
69-71
 A 
summary of studies that have investigated the relationship between vitamin exposure, including 
folic acid supplementation and risk for miscarriage can be found in  Table 2-6.. Investigators 
have reported both increased and decreased risk of miscarriage associated with vitamin use 
during early pregnancy.
8,61,72-76
 A Cochrane review assessing nearly 100,000 pregnancies from 
28 clinical trials found no significant differences between women taking any vitamins compared 
with controls for total fetal loss (relative risk (RR) 1.04, 95% confidence interval (CI) 0.95, 1.14) 
or early or late miscarriage (RR 1.09, 95% CI 0.95, 1.25).
75
 In another study, taking vitamins 
reduced the odds of miscarriage by 50% (OR=0.46, 95% CI 0.38, 0.55),
8
 the effect was most 
marked among those taking folic acid, iron or multivitamins. A study within the RFTS 
population, vitamin use was prospectively reported by 95% of study participants.
73
  Odds of 
miscarriage was  60% lower for women exposed to vitamin supplementation during early 
pregnancy compared to those who were not (adjusted odds ratio= 0.43, 95% CI 0.30,0.60).
73
 
Differences observed in effect estimates across studies may be a result of exposure 
ascertainment, including biomarker detection through plasma levels, exposure definitions, and 
model adjustments. Vitamin use may be a proxy measure of other health-conscious behaviors 
associated with pregnancy health such as alcohol intake and physical activity during 
pregnancy.
73
 The importance of vitamin supplementation may also be related to other lifestyle 
and behavioral factors including pregnancy intendedness. A woman who is intending a 
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pregnancy may be more health conscious which may include positive behaviors towards the 
intended pregnancy, such as taking vitamin supplementation. Conversely, a woman who has an 
unintended or unwanted pregnancy may not be as likely to take positive health measures, like 
vitamin supplementation.  
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 Table 2-6. Studies on miscarriage risk and vitamin use 
Author, 
Study type,  
Location Population Study period Vitamin use 
Odds Ratio      
(95% confidence 
interval) 
Adjustment 
factors 
Hook and 
Czeizet 
1997
74
 
Randomized 
control trial 
Hungary 
363 losses  
2,787 births  
1984-1992 No Folate acid supplement 
Folate acid supplement 
1.0 
1.16 (1.01-1.3)
a,b
 
None 
      
Windham et 
al. 2000
76
 
Cohort 
United States 
499 losses,  
4,645 
pregnancies       
1990-1991 No Folate acid supplement 
Folate acid supplement 
1.0 
1.14 (0.96-1.35)
a,b
 
None 
      
Gindler et al. 
2001
72
 
Population-
based  
Case-control 
China 
2,155 losses, 
23,806 births 
1993-1995 No Folate acid supplement 
Folate acid supplement 
1.0 
0.97 (0.84-1.12)
a
 
education 
      
George et al. 
2006
61
 
Case-control 
Sweden 
562 losses, 
1,037 births         
1996-1998 No Folic acid supplement 
Folic acid supplement 
Plasma folate (nmol/L) 
       ≤4.9  
       5.0–8.9  
       9.0–13.9  
       ≥14.0   
1.0 
3.10 (1.4-6.60)
b
 
 
0.80 (0.4-1.90) 
1.0 
2.30 (1.10-4.60) 
2.20 (1.00- 4.90) 
maternal age, 
previous 
pregnancy history, 
induced abortions, 
myoma, time to 
conceive, marital 
status, smoking, 
caffeine and 
alcohol intake 
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Author, 
Study type,  
Location Population Study period Vitamin use 
Odds Ratio      
(95% confidence 
interval) 
Adjustment 
factors 
Maconochie 
et al. 2007
8
 
Population-
based 
Case-control 
England 
603 losses < 
13 weeks' 
gestation               
6,116 births > 
13 weeks                              
2000-2001 No Vitamins 
Any Vitamins 
     Folic acid 
     Iron 
     Zinc 
     Vitamin C 
     Other multivitamin 
     Other vitamins 
1.0 
0.46 (0.38–0.55) 
0.46 (0.37–0.56) 
0.25 (0.16–0.37) 
0.50 (0.20–1.23) 
0.55 (0.30–1.01) 
0.59 (0.39–0.88) 
0.52 (0.27–0.97) 
Year of 
conception, 
maternal age, 
previous 
miscarriage and 
previous live birth. 
   
 
      
Hasan et al. 
2009
73
  
Cohort 
United States 
524 losses, 
3,659 
pregnancies 
>20 weeks' 
gestation             
2000-2008 No Vitamins 
Vitamin use 
1.0 
0.43 (0.30-0.60) 
maternal age, 
gravidity, 
progesterone use 
in early 
pregnancy, 
smoking, 
race/ethnicity, 
education, marital 
status, and study 
site 
      
Rumbold et 
al. 2011
75
 
Meta-analysis 
28 clinical 
trials, with 
11,723 losses 
and 98,267 
pregnancies  
Cochrane 
Pregnancy and 
Childbirth Group 
Trial 2010 
No Vitamins 
Vitamin use 
1.0 
1.04 (0.95-1.14)
a,c
 
 
a 
Risk ratio; 
b
Unadjusted estimates 
c
Meta-analysis estimates
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CHAPTER III  
METHODS 
Methods overview  
In order to better understand timing and disparities in miscarriage risk I use data from 
Right from the Start, ,a large prospective pregnancy cohort. In this section. I describe in more 
detail the cohort, data collection methods and proposed statistical analysis for each of my 
specific aims. Below is a summary table that describes an overview of the purpose of each 
specific aim, lists the exposure and outcome of interest to be studied, which portion of the study 
population used, including total number of subjects and overview of proposed statistical analyses 
(Table 3-7).  
Briefly, in specific aim 1 I establish an alternate method to estimate gestational age using 
early ultrasound data in order to have a better outcome measurement of gestational arrest prior to 
miscarriage. I use a sub-cohort of women who experienced miscarriage and have ultrasound data 
available. In specific aim 2 I assess this new method within the full cohort by comparing models 
that use self-reported LMP to estimate gestational age with models that use the new 
measurement for gestational age at  arrest. I assess overall bias in these models by comparing 
risk estimates for common putative factors associated with miscarriage risk. Finally in aim 3 I 
further describe differences in gestational age at arrest between Blacks and Whites within this 
cohort, including women with intended pregnancies.  
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Table 3-7. Overview of specific aims, study population, and statistical analyses 
Specific Aim Purpose Exposure  Outcome 
RFTS Study 
Population  Analyses  
Aim 1 Establish and describe 
GAAD, GAAD gap 
N/A Miscarriage  Sub-cohort: Women 
with  miscarriage and 
Ultrasounds only 
(n=504) 
 Descriptive statistics 
(Chi-square, t-test) 
 Sensitivity analysesa  
Aim 2 Compare models with 
different estimates for 
gestational age              
[i.e. GAAD vs. LMP] 
Smoking or 
vitamin use 
Miscarriage  Full cohort: Women 
with term birth or 
miscarriage (n=5,513) 
 Cox PH models      
(overall and patterns of 
use) 
 Bootstrap analyses 
(overall use) 
Aim 3 Race(Black/White) and 
GAAD gap, model 
comparison 
Race*pregnanc
y intention 
interaction with 
Smoking or  
vitamin use 
Miscarriage  Sub-cohort:  
Women(Black/White) 
with miscarriage and 
Ultrasounds only 
(n=447) 
and 
Full-cohort: 
 Women (Black/White) 
with term birth or 
miscarriage (n=4,903) 
 Descriptive statistics 
(Chi-square, t-test) 
 Cox PH models          
(overall and patterns of 
use) 
 Bootstrap analyses 
(overall use) 
 
RFTS=Right from the Start; GAAD=gestational age at arrest of development; LMP=last menstrual period; N/A=not applicable; 
PH=proportional hazard models. 
a
Sensitivity analyses include women with pregnancy losses before or after first-trimester interviews; 
women with early(<10 weeks) vs. late loss(≥10weeks); nulliparous women only; women who pre-enrolled; women without prior 
history of loss; women who had losses >3 days of study enrollment.
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RFTS Study population 
Right from the Start (RFTS) is an ongoing prospective community-based pregnancy 
cohort study that began enrollment in 2000. Over time, the study has included three phases 
(RFTS 1, 2, and 3). Women, either pregnant or planning a pregnancy, enrolled from nine areas in 
three states (North Carolina, Texas and Tennessee). Participants were between 18 and 45 years 
of age, spoke English or Spanish, intended to carry the pregnancy to term and had not used 
assisted reproductive technologies to conceive.
3
 The study was designed to recruit women from a 
variety of clinic and community-based settings.
3
 
Women who were not yet pregnant but trying to conceive could pre-enroll before 
pregnancy and were followed until a positive pregnancy test. To avoid over-enrollment of sub-
fertile women, non-pregnant participants in the study must have been attempting to get pregnant 
for fewer than six months (RFTS 1 and 2) or fewer than three months (RFTS 3). Women were 
eligible for up to 12 months of pre-enrollment. Women entered the study before 12 completed 
weeks of gestation (RFTS 1), before nine completed weeks of gestation (RFTS 2), or only prior 
to pregnancy (RFTS 3). Informed, written consent was obtained from each study participant in 
compliance with institutional review board procedures. A summary of RFTS eligibility and 
research activities by study phase can be found in Table 3-8. 
  
43 
 
Table 3-8. Right from the Start study phase and eligibility criteria  
RFTS Study features and activities RFTS 1 RFTS 2 RFTS 3 
Active period of enrollment 12/200-07/04 08/04-11/08 05/06-01/12 
Number of participants 2,481 3,034 590 
Pre-pregnant participants 232 843 589 
Web and phone based daily diary No  No  Yes 
Enrollment age 18-45 years Yes Yes Yes 
States TX, NC, TN NC, TN TN 
Reproductive technology to conceive No No No 
Informed consent Yes Yes Yes 
Language: English or Spanish Yes Yes Yes 
Attempting to get pregnant < 6 months < 6 months < 3 months 
Gestational age at enrollment < 12 weeks < 9 weeks Pre-enrolled 
Median age of ultrasound (weeks)? 9.29 7.29 6.86 
Median age of ultrasound if miscarriage 
occurred (weeks)? 
8.86 7.14 6.86 
TX=Texas; NC=North Carolina; TN=Tennessee  
Women who had their LMP before May 5, 2012 were included in this dataset (n=6,105). 
Participants had an early-pregnancy ultrasound for assessment of embryologic viability, 
documentation of stage of development, and confirmation of gestational dating. Research 
ultrasounds were conducted at a time in gestation in which all normal pregnancies would be 
expected to have a fetal pole and heart rate identifiable. The transvaginal ultrasound (TVUS) 
used in RFTS provides the most accurate information in early pregnancy, given that the early 
developing gestational sac and fetal pole are still developing at this point and a vaginal 
ultrasound can get closer to the developing pregnancy and provide a more accurate assessment of 
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gestational dating.
19
 Participants completed a baseline interview at the time of enrollment and 
comprehensive computer assisted telephone interview in the first-trimester. In the interview, 
information collected included reproductive and medical history, socio-demographic 
characteristics, and health behaviors around the time of conception or during pregnancy. 
Participants who experienced pregnancy loss before the scheduled interview were interviewed as 
soon as possible after miscarriage. Pregnancy outcomes were self-reported by study participants 
and verified by medical records. A timeline of RFTS study activities can be found in Figure 3-3. 
Figure 3-3. Timeline of Right from the Start activities and estimating GAAD 
 
Exclusions 
Women were allowed to enroll more than once in RFTS. To allow for independent 
observations, subsequent pregnancies are excluded for women who enrolled more than once 
(n=333). Furthermore, women who had induced abortions (n=17), and women who had 
ectopic/molar pregnancies (n=11) were also excluded.  Women with these rare birth outcomes 
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may have a different etiology than women who miscarry and therefore they were excluded from 
our analysis. Women whose pregnancy outcome was not known at the time of analysis were also 
excluded (n=231, 3.8%). We compared women who experience a miscarriage(<20 weeks 
gestation) with women who have term pregnancy(≥20 weeks gestation). We documented 
miscarriage in 697 women (12.6%) during the study period. Pregnancy was verified by 
ultrasound or repeat pregnancy tests. Participants who had birth outcomes at a gestational age 
later than 20 weeks served as a comparison group. The comparison group (n=4,816) consisted of 
women who had live births (n=4,787) or stillbirths (n=29).  
Estimating gestational age from ultrasound  
Research ultrasounds were conducted at a time in gestation (> 5 
4
7
 weeks after LMP) in 
which normal pregnancies would be expected to have a fetal pole and heart rate. Traditionally 
gestational age is based on a women’s self-reported LMP, referred to here as the estimated 
gestational age (EGA). Accuracy of self-reported LMP dating in this cohort is excellent within 
+/- 1 day compared to ultrasound estimates (0.8 days longer than ultrasound estimates).
77
 
However, since developing pregnancies can end days or weeks before clinical onset of symptoms 
for miscarriage, we estimate gestational age based on characteristics at the time of ultrasound for 
all women within our cohort.  Women were classified based on developmental stage at loss (i.e. 
gestational age at time of arrested development). This new estimation for gestational age variable 
is referred to as GAAD (Table 3-9).  
Characterizing developmental stage at ultrasound  
Initially we characterized the developmental stage at ultrasound in the following way based on 
the following characteristics, women who have normal fetal development, women who have 
abnormal fetal development and women who have anembryonic development at time of first-
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trimester transvaginal ultrasound (Table 3-9). Women who are considered to have normal fetal 
development include women with a fetal pole and normal FHR at ultrasound. Women who are 
considered to have abnormal fetal development included women with a visible fetal pole and 
either abnormal or no FHR visible on ultrasound. Women who are considered to have 
anembryonic development include women with an empty uterus, gestational sac only, or 
gestational and yolk sac visible on ultrasound but no fetal pole or FHR visible. 
Table 3-9. Estimating gestational age at arrest (GAAD) in Right from the Start 
Ultrasound 
Developmental Stage
a
 (n) 
Ultrasound 
characteristics (n) 
Estimating GAAD variable (days) 
Loss before Ultrasound 
(188) 
n/a Initially exclude all losses before ultrasound, 
subsequent sensitivity analysis 
Fetal Pole (312)   
 Normal FHR (180)** Gestational age based on formula A  + 
Midpoint from ultrasound date to date of loss 
 Abnormal FHR (32) Gestational age based on formula A + 
Midpoint from ultrasound date to date of loss 
 No FHR (100) Gestational age based on formula A + 
Midpoint from ultrasound date to date of loss 
Anembryonic gestation  
(160) 
  
 Gestational sac only 
(83) 
Gestational age based on formula B 
 Gestational and yolk 
sac (77) 
Gestational age based on formula B 
Empty uterus (37)  If ≤ 4.5 weeks: Self-reported LMP to date of 
ultrasound  
If > 4.5weeks: Assign 4.5 weeks (32 days) for 
all women  
a
Developmental stage among women who experienced miscarriage only (n=697). GAAD= 
gestational age at arrested development; FHR=fetal heart rate; Formula (A)
45
: 
t=exp[1.685+0.316(CRL)-0.049(CRL)
2
+0.004(CRL)
3
-0.0001(CRL)
4
]x7;  Formula (B)
47
: t=L+42 
where t refers to estimated gestational age in number of days and L refers to measurement of 
length of the mean gestational sac diameter. 
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Estimating GAAD and the GAAD gap in RFTS 
Estimating gestational age at arrest based on ultrasound information within this cohort 
was done in the following way: For women who had a loss before their transvaginal ultrasound 
GAAD cannot be calculated. I conducted a complete case analysis removing these women from 
our analysis. For women with anembryonic gestation, the GAAD was the gestational age at time 
of arrested development using the criteria outlined in Table 3-9. For women with anembryonic 
development in which gestational sac or gestational and yolk sac are visible GAAD was 
estimated based on the formula by Goldstein and colleagues.
47
 A special case of anembryonic 
gestation is women with empty uterus. For women with an empty uterus in which neither the 
yolk sac or gestational sac are visible, GAAD is the EGA based on self-reported LMP to the date 
of the ultrasound if less than 4.5 weeks (i.e. 32 days). If greater than 4.5 weeks, I assigned 32 
days gestation for these women (Table 3-9). This designation is based on early developmental 
structures visible on ultrasound. In a normal pregnancy, the first structure visible on TVUS is a 
gestational sac by week 5 (Table 2-2), For anembryonic gestation of empty uterus, no gestational 
sac is visible on ultrasound, and therefore a conservative estimate 4.5 weeks (i.e. 32 days) 
gestation is assigned. 
For women with normal or abnormal ultrasounds I estimated gestational age based on a 
nomogram for CRL plus the midpoint from date of ultrasound to date of clinical loss. We have 
information on embryologic development from a single time point from their first-trimester 
TVUS. For women with normal or abnormal fetal development who subsequently go on to 
miscarry, we know the date of loss happened sometime between the date of ultrasound and the 
reported date of loss. Embryologic development may have stopped at any time between the date 
of ultrasound and when they reported a loss. Since we do not have daily ultrasounds for these 
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women to determine the exact date their development stopped, I estimated GAAD based on the 
formula assessing CRL by Hadlock and colleagues
45
 plus the midpoint from ultrasound date to 
the date of loss. Since we do not know the exact date that development stopped for women with 
normal and abnormal ultrasounds from a single ultrasound measurement, we simplifed by 
choosing the midpoint between date of ultrasound and date of reported loss for these women. 
Based on the data available from early first-trimester ultrasounds, we used the following 
formulas to estimate GAAD in days gestation (Hadlock et al.
45
 (Equation 1) and Goldstein et 
al.
47
 (Equation 2)): 
Equation 1: t=exp[1.685+0.316(CRL)-0.049(CRL)
2
+0.004(CRL)
3
-0.0001(CRL)
4
]x7
 
Equation 2: t=L+42 
where t refers to the gestational age in number of days and L the measurement of length of the 
mean gestational sac diameter in millimeters (mm). Many studies have shown that the CRL is the 
most consistent measurement for determining gestational age in early development.
36,37,45,46
 
However, if a woman is missing a CRL measurement from their first-trimester ultrasound, I 
estimated GAAD based on formula B and the longest embryonic length. The Hadlock formula 
estimates gestational age in weeks gestation and with CRL measured in centimeters (cm). The 
Hadlock formula was multiplied by 7 in order to estimate GAAD in days gestation.  
I also determined the GAAD gap for each woman. The GAAD gap is defined as the 
difference in days gestation between self-reported LMP date of loss and the newly estimated 
GAAD based on Table 3-9.  
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Rationale for chosen nomograms 
The formulas to estimate GAAD were chosen based on the two largest prior studies 
conducted in the United States to estimate gestational age from ultrasound characteristics (Table 
2-3). Both studies used a single early first-trimester transvaginal ultrasound visit to estimate 
gestaional age  within a study population that had not used in vitro fertilization in order to 
conceive. Ultrasound measurements were made among singleton births in women with no 
diseases known to adversely affect fetal growth(e.g. diabetes mellitus) (Hadlock et al.
45
 n=416; 
Goldstein et al.
47
 n=143).  Both studies consisted of subjects with a known history of LMP. 
Furthermore, study ultrasounds were performed by physicians and or registered sonographers.  
Additionally, these formulas allow us to estimate GAAD for women in our cohort as a 
continuous variable in days gestation. Instead of grouping all women by ultrasound characteristic 
and assigning the appropriate gestational week based on development, (for example, assigning 5
4
7
 
weeks gestation for all women with a gestational and yolk sac only visible on ultrasound) our 
estimates for days gestation was a continuous variable.  Categorizing a continuous variable can 
result in loss of information and the statistical power to detect an association between a predictor 
variable and an outcome.
78
 It would also conceal any non-linearity in the relation between the 
variable and outcome. Furthermore, it underestimate the extent of variation in an outcome 
between groups, such as the risk of miscarriage. There may be considerable variability in risk of 
miscarriage within each group by developmental stage at ultrasound (e.g. among normals and 
abnormals). For these reasons, the above nomograms are well suited to estimate GAAD within 
the RFTS study population.  
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Specific aim 1: Determining GAAD gap, exploratory analysis  
For specific aim 1 investigate the variation and distribution of the GAAD gap for RFTS 
women who have ultrasound data.  I defined the GAAD gap as the difference in days gestation 
between estimated gestational age based on self-reported LMP and estimated gestational age 
based on developmental stage at arrest (i.e. GAAD gap= (self-reported LMP – GAAD)). I expect 
GAAD gap to be positive for most women in this cohort. This would indicate that self-reported 
LMP is greater than newly estimated GAAD, which would mean that for most women 
pregnancies had arrested earlier than when they self-reported a clinical loss. If the GAAD gap 
was negative, it would indicate that these women may have been unaware of their LMP at time 
of ultrasound.  
I describe and report the distribution of the GAAD gap by developmental stage at 
ultrasound within the cohort. I conduct initial exploratory and descriptive analyses to assess the 
GAAD gap (e.g. mean, median and mode of GAAD gap). I assess GAAD gap differences by 
assessing both predictors for longer than median vs. shorter than median GAAD gap within our 
cohort. I test associations with predictors of miscarriage risk such as first-trimester bleeding
79
 as 
well as established factors in the literature associated with pregnancy loss (e.g. age, parity, 
pregnancy intention, prior history of loss). I use non-parametric methods to assess the GAAD 
gap when comparing groups. Non-parametric tests imply that there is no assumption of a specific 
distribution for the population. I used the Mann-Whitney U-test to compare sample medians. 
Mann-Whitney U-test assumes a non-normal distribution in the GAAD gap, which is especially 
important if data is skewed. The p-value for a two-tailed test has a null hypothesis that assumes 
the medians are equal between groups.     
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Specific aim 1: Hypothesis 
In specific aim #1 I hypothesized that the GAAD gap was greater than 10 days within this 
cohort. That is among women with a pregnancy loss who have ultrasound information, the 
number of days between self-reported LMP and GAAD will be greater than 10 days.  
Sensitivity analyses for Specific aim 1: 
I conducted the following sensitivity analyses to specific aim 1 to assess the robustness of 
estimating GAAD within this cohort.  
Women with prior or recurrent miscarriage history  
Prior miscarriage history is a strong predictor for future miscarriage, however we did not 
use prior miscarriage history as a potential cofounder in our analysis since it may be an 
intermediate covariate for future risk.  Adjusting for prior  loss could lead to biased estimates for 
the risk of smoking on miscarriage due to residual confounding in our model (i.e. since we would 
be conditioning on a collider pathway).
80,81
 I did a sensitivity analysis removing women who 
have ever experienced a miscarriage or who have ever experienced recurrent miscarriage (i.e. 3 
or more prior losses) in order to determine if GAAD gap changes appreciably. Recurrent 
miscarriage in our cohort was defined either, as at least 3 prior pregnancy losses or as 2 prior 
losses and current birth outcome as a miscarriage.  
Miscarriage pre and post-interview 
 In order to determine if recall bias is present within our study I assessed GAAD gap 
based on time of the first-trimester interview.  Women who experience loss prior to the interview 
may be more unsure of their LMP than women who experience loss after the interview. For a 
majority of women in our study, the ascertainment of behavioral factors during pregnancy 
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including smoking status and vitamin use was collected after the loss (n=445, 68.2%).
2
 Overall, 
the mean interval between loss and first-trimester interview was less than 3.5 weeks (24.8 
(standard deviation, 17.5) days), and does not differ significantly by race. Furthermore, questions 
on exposure status in the FTI clearly asked about behaviors during that pregnancy and not after 
the loss occurred. Therefore I believe that recall bias was minimal in our cohort. I report overall 
analysis and analyses stratified pre and post interview to determine if our results change 
appreciably.  
Miscarriage within 3 days of enrollment     
The hazard for miscarriage tends to be higher in prospective cohorts for the first few days 
of study enrollment. Elimination of the first three days of follow-up (which means excluding 
from study losses that happened in these three days) seems to eliminate this form of bias.
21
 
Women who experience a loss within three days of enrollment may already be experiencing a 
threatened miscarriage, especially if associated with heavy bleeding. I did a sensitivity analysis 
removing women who experienced a pregnancy loss within three days of study enrollment 
(n=49, 7.0%) to determine if our results change.  
Specific aim 2: Comparing GAAD models with LMP models 
For specific aim 2 I investigate if incorporating proper classification of gestational age at 
arrest influences estimates of common putative factors associated with pregnancy loss. The study 
strength of the RFTS study is that we capture a wide variety of pregnancy-related health 
behaviors in early first trimester in our first-trimester interview. I assess both a protective factor 
(e.g. vitamin use) as well as risk factor (e.g. smoking) associated with miscarriage. These factors 
were chosen as examples to test the new GAAD method and assess the impact of bias on our 
estimates for miscarriage risk. The analyses were useful to determine if GAAD can explain in 
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part some of the differences reported in the literature for miscarriage risk associated with either 
smoking or vitamin use. Misclassifying time at loss in studies of miscarriage can lead to biased 
estimates of the effect of that exposure on pregnancy loss.  
Specific aim 2: Hypotheses  
Using time to event analyses, I compare models that use GAAD with models that use 
traditional self-reported LMP for gestational age. I determine the extent of potential bias in our 
reported estimates for risk of miscarriage associated with either smoking or vitamin use in the 
first-trimester.  When comparing LMP models to GAAD models for smoking exposure, I 
hypothesize that models that use the classified GAAD will attenuate the risk associated with 
miscarriage compared to models that use LMP for gestational age. For vitamin use, a protective 
factor, I also hypothesize that GAAD models will attenuate the association with miscarriage 
compared to models that use LMP.  A separate DAG for each exposure was assessed to 
determine potential confounders. 
Rationale for Cox Models 
 Descriptive summary statistics on maternal characteristics during pregnancy between 
women who experience miscarriage and women who did not experience miscarriage were 
compared using log-rank test for equality for survival functions. Cox regression were used to 
estimate hazard ratios (HR) for the effect of each exposure on risk of miscarriage. Models were 
left truncated to include gestational age at enrollment. Miscarriage studies that recruit pregnant 
women are left truncated because women enter the study at different gestational ages and an 
unknown proportion of the source population experiences losses prior to enrollment.
82
 In RFTS 
participants are followed from the time of enrollment in the study and contribute to the analysis 
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until an outcome or loss to follow-up occurs. Thus, Cox models address actual time “at risk” and 
“in view” for each woman by accounting for variable gestational age at study entry.  
Cox models were used to screen candidate confounders. Cox model is preferred over the 
logistic model when survival time information is available and data requires censoring. The Cox 
model uses more information (i.e. the survival times) than logistic regression models, which 
considers a binary outcome and ignores survival times, censoring and truncation. 
83
 Additionally, 
simulation studies suggest that bias in the odds ratio exceed 20% when average gestational age at 
entry for the exposed versus the unexposed differs by 10 days or more, which has been observed 
when assessing various socioeconomic factors, such as education and ethnicity in miscarriage 
risk. Cox regression can correct for left truncation and is no more difficult to perform than 
logistic regression.
82
 Therefore Cox models with left truncation to include gestational age at 
enrollment were preferred over logistic models in our analyses. 
Cox models were used to compare overall risk for miscarriage as well as early (<10 
weeks gestation) versus late miscarriage (≥ 10 weeks gestation). All analyses were conducted 
using Stata SE/12 software (StataCorp LP, College Station, TX). 
Exposures 
In specific aim 2 I investigate if proper classification of gestational age at arrested 
development influences the estimates of common putative risk factors associated with 
miscarriage. I assess the following exposures, smoking and vitamin use and their association 
with risk for miscarriage in our RFTS cohort. I assessed these risk factors with miscarriage risk 
by comparing models with improved classification of gestational age at arrest development with 
traditional models that use self-reported LMP to estimate gestational age.  
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Smoking 
Smoking exposure during early pregnancy is a self-reported measure obtained during the 
first-trimester interview. Briefly, smoking status was assessed based on the following items from 
the first-trimester interview: 
1. While you were pregnant this most recent time, did you smoke cigarettes regularly, I 
mean one or more cigarettes every day? 
2. Have you ever smoked cigarettes regularly, and by regularly I mean one or more 
cigarettes every day for at least a month? 
3. When did you stop smoking? (Month, Day, Year) 
4. Before you stopped, how many cigarettes did you usually smoke a day? 
5. In the past 4 months, has your smoking changed in any way? 
6. When did your smoking change? (Month, Day, Year) 
Smoking status was assessed in the following way: Women were classified as unexposed 
if indicated they have never smoked. If women indicate that they currently smoke during their 
pregnancy they were classified as exposed in pregnancy.  For women who quit smoking within 
four months prior to the interview, (meaning exposures in the pregnancy and/or periconception 
window) or women who quit ≥ four months from interview were classified as exposed pre-
pregnant (i.e. former smokers). 
Vitamin use   
Vitamin exposure in RFTS was assessed in a similar way to the study by Hassan and 
colleagues.
73
 Vitamin use is a self-reported measure during the FTI. Briefly, vitamin use was 
assessed based on the following items from the first-trimester interview:  
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1. Do you now take prescription or nonprescription prenatal vitamins? 
2. In the past four months, did you take prescription or nonprescription prenatal vitamins? 
3. Did you start taking prescription or nonprescription prenatal vitamins more than four  
months ago? 
4. Do you now take multivitamins other than prenatal vitamins? 
5. In the past four months, did you take multivitamins other than prenatal vitamins? 
6. Did you start taking multivitamins other than prenatal vitamins more than four months 
ago? 
Women who reported any use of prenatal or multivitamin use during pregnancy was considered 
among the exposed group. All others were considered unexposed.  
Outcome  
In our cohort, pregnancy was verified by ultrasound examination or repeat pregnancy 
tests. Miscarriage was defined as loss of a recognized pregnancy prior to 20 completed weeks of 
gestation. Outcomes are self-reported and verified by medical records. Miscarriage events are 
self-reported in both the pregnancy outcome form as well as the first-trimester interview. If dates 
for self-reported miscarriage do not match, medical records were abstracted for those records. 
Participants who had a birth outcome at a gestational age later than 20 weeks served as the 
comparison group. Because of the etiologic heterogeneity in miscarriage
28
 we considered 
subsequent sensitivity analyses by grouping miscarriages of different gestational ages as 
different outcomes. Based on conceptualization by Silver and colleagues we defined early 
pregnancy losses as losses occurring up to 10 weeks gestation, and the median in our data, and 
fetal death as losses occurring between 10 and 20 weeks gestation.
28
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Confounders 
Potential confounders examined from baseline and the first-trimester interviews included 
factors known to be associated with both spontaneous abortion and the exposure of choice have 
been chosen a priori based on current literature using directed acyclic graphs (DAG). DAGs are 
causal diagrams that incorporate qualitative, a priori subject matter knowledge because statistical 
criteria are insufficient to characterize either confounding or selection bias, I have also used 
causal diagrams to incorporate qualitative a priori subject matter knowledge.
84
 Figure 3-4 is a 
DAG diagram for risk of miscarriage with smoking as a risk factor. A similar DAG diagram for 
risk of miscarriage with vitamin exposure was also be assessed Figure 3-5. A summary of other 
covariates of interest can be found in Table 3-10.  
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Figure 3-4. Directed acyclic graph of smoking exposure and miscarriage risk
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Figure 3-5. Directed acyclic graph of vitamin use and miscarriage risk 
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I report categorical breakdowns for maternal age and body mass index (continuous, and 
categories[ BMI <19.8; 19.8 to ≤26.0 [referent]; 26.1 to ≤ 29.0; > 29 kg/m2])  based on 
meaningful clinical cut-points for ease of interpretability in our summary of descriptive statistics.  
However, only maternal age (years, continuous and categories) was assessed as a potential 
confounder in our analyses based on the DAG.  Age was assessed initially as a continuous 
variable in our multivariate modeling.  Dichotomizing a continuous predictor variables may 
result in biased estimation, in Cox proportional hazard regression
78,85,86
 it may result in inflation 
of the type-I error of the risk factor.
78,87
 I tested the linearity assumption of the relationship 
between continuous variables and the log-hazard of miscarriage risk. The linear relationship will 
be assessed by the use of restricted cubic splines. A Wald chi-square test will be used to 
determine if a linear relationship between continuous predictors and the log-hazard of 
miscarriage exists. If linearity assumptions were not met, quadratic terms for continuous 
variables were used in our modeling and reported adjusted hazard ratios. 
Other demographic factors assessed as cofounders in analysis included household income 
(≤$40,000; $40,001 to $80,000; >$80,000 [referent]), maternal education (≤ high school; some 
college; ≥ 4 years college [referent]), marital status (married/living as married [referent]; other).  
In addition I assessed potential confounders related to maternal reproductive history and health 
behaviors during pregnancy, namely parity (yes/no), previous preterm birth (yes/no), previous 
induced abortion (yes/no), diabetes status (yes/no), pregnancy intention (yes/no), prenatal 
vitamin use (yes/no), alcohol use (unexposed(referent), exposed in pregnancy, exposed pre-
pregnant) and smoking status (unexposed (referent), exposed in pregnancy, exposed pre-
pregnant) (Table 3-10). The variables that are assessed as confounders were chosen a priori 
based on my DAG. These were variables that were believed to be (1) associated with the 
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outcome (time to miscarriage) among unexposed women (i.e. non-smokers and non-vitamin 
users); (2) associated with the exposure within the entire source population and; (3) not within 
the causal pathway between exposure and miscarriage risk. Confounders were assessed one at a 
time.  For the association between smoking and miscarriage risk the following variables were 
assessed as potential confounders based on my DAG, age, race, maternal education, marital 
status, household income, parity, alcohol use and pregnancy intention (Figure 3-4). For the 
association between vitamin use and miscarriage risk the following variables were assessed as 
potential confounders based on my DAG, age, race, maternal education, marital status, 
household income, parity, smoking, alcohol use and pregnancy intention (Figure 3-5). 
Confounding was  defined as a 10% change from the crude hazard ratio (HR) for miscarriage 
risk between those exposed  to smoking in the first-trimester compared to unexposed(referent), 
or between those exposed to vitamin use (referent) compared to those unexposed to vitamin use. 
Confounding was assessed using Cox proportional hazard models with gestational age estimated 
based on self-reported LMP for either exposure and miscarriage risk. If a 10% change is 
observed from the crude hazard ratio, the variable was retained in the final models. Final model 
adjustments for smoking and vitamin use, and overall model assessment are discussed in Chapter 
5.  
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Table 3-10. Covariates for analysis 
Socioeconomic Status  Maternal 
behaviors 
Maternal characteristics Current 
pregnancy  
Prior obstetric outcomes 
Race 
 Non-Hispanic White 
 Non-Hispanic Black 
 Hispanic 
 Other 
Household income 
 ≤$40,000 
 $40,001–$80,000 
 >$80,000 
 Missing 
Maternal education 
 High school or less 
 Some college 
 College (≥4 years) 
 Missing 
Marital status 
 Married, living as 
married, single 
 Other 
 Missing 
Smoking 
 Never 
 Current  
 Former 
Alcohol Use 
 Never 
 Current  
 Former 
Body mass index (kg/m
2
) 
(continuous) 
Body mass index 
 Underweight (<18.5) 
 Normal weight (18.5–24.9) 
 Overweight (25.0–29.9) 
 Obese (≥30.0) 
Body mass index, (restricted cubic 
splines) 
Maternal age, years (continuous) 
Maternal age, years 
 <20 
 20–24 
 25–29 
 30–34 
 ≥35 
Maternal age, years  (restricted 
cubic splines) 
Parity 
 Nulliparous 
 Primaparous (1) 
 2+ prior pregnancies  
History of diabetes 
 No 
 Yes 
Prenatal vitamin 
use 
 No 
 Yes 
Fibroids 
 No 
 Yes 
Pregnancy Intention  
 No 
 Yes 
Previous miscarriage 
 No 
 Yes 
Recurrent Miscarriage (3 
or more losses) 
     No 
     Yes 
Previous induced abortion 
 No 
 Yes 
Prior preterm birth  
 No 
 Yes 
Prior stillbirth 
 No 
 Yes 
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Pregnancy intention 
I am also interested in considering pregnancy intention as a potential confounder for risk 
of miscarriage. Unwanted or unintended pregnancies may be associated with modifiable 
behavioral factors in early first-trimester such as smoking or vitamin use. For example, women 
may be less likely to smoke, or more likely to use vitamins for intended pregnancies compared to 
unintended pregnancies. Furthermore the influence of pregnancy intention is known to differ by 
race for outcomes such as preterm birth, low birth weight and small for gestational age,
4-6
 and 
may be reasonable to assume that it may differ for miscarriage outcomes as well. Additionally, 
women who are not planning a pregnancy may be less sure of their LMP dates. Therefore I 
hypothesize that I would expect the GAAD gap to be greater for women not planning a 
pregnancy (i.e. an unintended pregnancy) compared to women with planned pregnancies(i.e. 
intended pregnancy). 
Pregnancy intention will be coded based on previous work reported in the National 
Family Growth Survey (NFGS) for unplanned pregnancies.
88
 Questions in RFTS first-trimester 
interview regarding pregnancy intention were based on criteria of the NFGS. Pregnancy 
intention was coded as a yes/no variable for these analyses. Unintended pregnancies include both 
mistimed and unwanted pregnancies. Intended pregnancies include pregnancies that were 
planned. Pregnancy intention is based on the following questions from the first-trimester 
interview: FTG7(contraception and planning at time of conception) or FTE4(a)(contraception 
use (yes/no)) as well as FTG13(pregnancy timing) or FTG12(wanted pregnancy? (yes/no)). The 
full set of these questions and their respective responses can be found in the appendices. Women 
who did not answer, refused to answer or listed did not know to any of the above questions in the 
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FTI were not be assessed for pregnancy intention based on the criteria listed below (n=633).  A 
summary of how pregnancy intention was coded can be found in Table 3-11.   
Briefly, a pregnancy was considered intended if any of the following criteria are true: 
Ftg7=1 and Ftg13=Either later, right time, or didn’t care when or,  
Fte4(a)=no contraception and  Ftg13=Either later, right time, or didn’t care when  
An unintended pregnancy was coded as mistimed if any of the following criteria are true: 
Ftg7=2 and Ftg13=too soon or,  
Ftg7=3 and Ftg13=too soon or,  
Fte4(a)=no contraception and Ftg13=too soon or,  
Fte4(a)=yes contraception and Ftg13=too soon and Ftg12=yes (wanted baby in future)  
And finally an unintended pregnancy was coded as unwanted if any of the following criteria are 
met: 
Ftg7=4 and Ftg12=no (did not want baby in future) or,  
Fte4(a)=yes contraception and Ftg12= no (did not want baby in future).  
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Table 3-11. Coding pregnancy intention in Right from the Start 
RFTS       
Variable name 
FTG7 FTE4(a) FTG13 FTG12 
Variable Description Contraception and planning Contraception use 
(yes/no) 
Pregnancy timing Wanted pregnancy 
(yes/no) 
Variable Question  Which of the following best 
describes your situation 
around the time you got 
pregnant? 
 
What are all the birth 
control methods you used 
in the 12 months before 
you got pregnant? 
Did you get pregnant this most 
recent time, sooner than you 
wanted, later than you wanted, or 
at about the right time? 
 
At the time you got 
pregnant this most 
recent time, did 
you want to have 
another baby at 
some time in your 
life? 
Pregnancy Intention (Yes) 
 1=stopped using 
contraception because you 
wanted to get pregnant  
 
 Either Later, right time or didn’t 
care when  
 
  No contraception  Either Later, right time or didn’t 
care when 
 
Pregnancy Intention (No) 
 Mistimed 2= not using contraception 
and were not really trying to 
get pregnant  
 
 Too soon  
 3= got pregnant during a 
change or gap in using 
contraception and you were 
not trying to get pregnant 
 Too soon  
  No contraception  Too soon  
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RFTS       
Variable name 
FTG7 FTE4(a) FTG13 FTG12 
Variable Description Contraception and planning Contraception use 
(yes/no) 
Pregnancy timing Wanted pregnancy 
(yes/no) 
  Yes (any type) Too soon Yes  
Unwanted 4= got pregnant while using 
contraception every time 
and you were not trying to 
get pregnant 
 
-- -- No 
  Yes (any type)  No  
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Bootstrapping to compare models (GAAD vs. LMP) for miscarriage risk  
In specific aim 2 I report and compare hazard estimates for both methods (e.g. GAAD vs. 
self-reported LMP) with common early pregnancy exposures associated with miscarriage (i.e. 
smoking and vitamin use). For each exposure I use bootstrap methods to estimate the ratio of 
effect sizes and 95% confidence interval between either model (i.e. GAAD model vs. LMP 
model). I defined the bias ratio as the adjusted hazard ratio of LMP model divided by the 
adjusted hazard ratio of GAAD model (i.e. bias ratio= 
adjusted HR ratio of LMP model
adjusted HR ratio of GAAD model
).  
Bootstrapping approaches use resampled data to make adjustments for statistical biases as 
well as random error.
89
 Furthermore it can be used as a way to assess internal study validity. To 
bootstrap the sampling distribution of the specific effects within a model and to assess bias, a 
sample of size n cases with replacement from the original sample is used. In other words, a given 
case can be selected as part of a bootstrap sample not at all, once, twice, or even multiple times 
in resampled data.
90
 The bootstrap approach is used mainly for the estimation of parameters and 
their variability in a given model and can be applied to Cox regression analyses.
91
  I used 1,000 
bootstrap replications with our data, since this has been shown to improve model stability and 
precision of estimates.
91,92
  
Power calculations for chosen exposures    
Smoking 
For this analysis I have determined that 697 women had miscarriages, and 4,816 
comparison subjects had term pregnancies.  The incidence of pregnancy loss among never 
smokers is 12.5%.  With 80% power and alpha=0.05, I am able to detect true hazard risk of 1.24 
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in smokers compared to  never smokers. Figure 3-6 shows power and detectable hazard ratio for 
miscarriage risk in smokers compared to never smokers within RFTS. 
Figure 3-6. Power and detectable hazard ratio for miscarriage risk in smokers compared to never 
smokers in Right from the Start 
 
   
Vitamin use 
For our vitamin analysis we have determined that 205 women reported not using vitamins 
in the first trimester and nearly ninety seven percent of women reported using vitamins 
(n=5,033). The incidence of miscarriage among unexposed women is 12.5%. The median 
survival time among controls was 39.7 gestational weeks from LMP (i.e. women who did have 
vitamin exposure). With 80% power and a type I error probability of 0.05, I am able to detect 
true hazard ratios of failure (i.e. miscarriage) for vitamin exposed subjects relative to vitamin 
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unexposed subjects of 0.55.  The Type I error probability associated with this test of the null 
hypothesis is that the vitamin exposed and vitamin unexposed survival curves are equal. Power 
analyses were conducted using Cox proportional hazard power calculator in Stata (StataCorp LP, 
College Station, Texas).  
Sensitivity analyses for specific aim 2:  
I conducted the following sensitivity analyses for specific aim 2 in order to assess the 
robustness of our results. 
Estimating GAAD for women with loss prior to ultrasound  
Initially in aim 1 I did a complete case analysis: women with a loss prior to ultrasound 
were excluded. I did a subsequent sub-analyses in which I estimate GAAD for women who have 
a loss prior to their ultrasound and compare results to the complete case scenario. I estimate 
GAAD for these women by assigning estimated gestational age based on self-reported LMP for 
all women with losses prior to ultrasound. I report the hazard estimates for risk of miscarriage 
associated with either smoking or vitamin use and compare results to complete case scenario.   
Specific aim 3: Comparing GAAD gap by race and if risk of loss associated with common 
early pregnancy exposures are modified by race 
For specific aim 3 I assess if the GAAD gap differs by race. I further assess Cox 
proportional hazard models to determine if risk of loss for common factors (i.e. smoking and 
vitamin use) associated with miscarriage risk is modified by race. I compare models that use 
GAAD with models that use traditional self-reported LMP to estimate gestational age for each 
exposure. If effect modification by race is found, I report stratified estimates in both models and 
determine the extent of potential bias in our reported estimates. 
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Race is a self-reported measure obtained during baseline interview at enrollment. For the 
purpose of this analysis race were grouped into the following categories non-Hispanic white 
(referred to throughout as “White”) and non-Hispanic black (referred to throughout as “Black”). 
Women with missing information for race or who declined to self-identify their race were 
excluded from this analysis (n=9). Women who self-identified as Hispanic regardless of White or 
Black racial self-identification (n=361) or as other races(n=240), which include Native 
Americans and Asians, were also be excluded. Interaction terms were generated by strata of each 
exposure status and either Black or White race. Interactions were assessed on the multiplicative 
scale, using the likelihood ratio test to compare two nested regression models: the “full” model, 
containing the main effects and the interaction term, and the reduced model, containing only the 
main effects. If the likelihood ratio test has a p,0.10, the interaction term was retained in the final 
model.  
Race and pregnancy intention interaction  
In specific aim 2 I investigate the risk of miscarriage associated with either first-trimester 
smoking or vitamin use. Because pregnancy intendedness varies by race 
4-6
 in the U.S. general 
population and may influence behavior factors such as smoking and vitamin use I include an 
interaction for race and pregnancy intendedness in our models.  The interaction term was 
generated as the multiplication of the pregnancy intendedness (Yes or No) times race (Black or 
White). Interactions were assessed using the likelihood ratio test to compare two nested 
regression models: the “full” model, containing the main effects and the interaction term, and the 
reduced model, containing only the main effects. If the likelihood ratio test has p<0.10, the 
interaction term was retained in our final adjusted models.  
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Specific aim 3: Hypothesis  
For specific aim 3 I hypothesize that the GAAD gap will be greater in Black women 
compared to White women. Because Black women experience later losses, and since they are 
more likely to enroll later than White women in RFTS,
2
 they are further along in pregnancy and 
less likely to have gestational arrest at time of ultrasound. Furthermore in time to event analyses 
I hypothesize that within our cohort putative risk factors associated with miscarriage risk will 
not be modified by race. Finally, for our secondary analyses I hypothesize that Black women will 
have more unintended pregnancies compared to White women in this cohort, that the GAAD gap 
will be greater for unintended pregnancies than intended pregnancies among Black and White 
women and that that interaction between race and pregnancy intention will be significant in our 
models. 
Handling missing data and correlated data in analysis  
All variables were checked to determine missingness. If missing data was found, 
ultrasound records were reviewed to assure whether data entered into the dataset were indeed 
missing. Only five women with miscarriages and ultrasound data had missing CRL or MSD 
measurements. For data from the first-trimester interview, if data were determined to be missing, 
I assessed how the missing observations were coded in the dataset. If the missing data was coded 
as a number, it was set to “.” using Stata. If data are coded as 997 “Refused” or 998 “Don’t 
know” the values were set to missing. No assumptions was made about the gestational age of 
individuals who were not available during a specific period of time. Correlations between 
variables were assessed with Spearman’s or Pearson’s correlation coefficients, where 
appropriate. Covariates with a correlation higher than 70% were not included simultaneously in a 
multivariate model, to avoid instability of regression coefficients and inflation of standard errors.  
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Potential considerations in analysis 
I have outlined potential considerations and alternative approaches that could be used for 
this analysis below.   
Early ultrasounds for abnormal development  
Because of early first-trimester ultrasounds, RFTS may identify women who have a loss 
earlier than when they would have experienced that loss had they not enrolled in this study. This 
may be particularly important for women who have abnormal ultrasounds, and subsequently go 
on to miscarry. The mean gestational age at loss is slightly earlier for women who have abnormal 
or anembryonic gestation compared to women with normal appearing ultrasounds within our 
cohort, although with similar confidence bounds.
2
 These women may be more likely to be 
conscious of a potentially failed pregnancy before the miscarriage is clinically symptomatic. This 
bias is less likely for women who have anembryonic gestations because developmentally their 
pregnancies had already arrested regardless of an early first-trimester ultrasound. Furthermore, 
prior to the 10 weeks gestation, the small CRL dimensions are more susceptible to measurement 
and operator inaccuracies.
42
 There is the potential for these early pregnancies to be identified as 
abnormal due to the measurement process on ultrasound. To account for this potential bias for 
women with abnormal ultrasounds, GAAD estimates have incorporated developmental stage at 
ultrasound plus variability based on midpoint between ultrasound and reported date of loss in 
specific aim 1.  
Early ultrasounds after reported date of loss  
Furthermore, there is a small subset of women who had an ultrasound done after their 
reported date of loss (n=19). These women might be in the process of a threatened miscarriage at 
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the time of ultrasound in which the full conceptus had not evacuated the uterus and 
heterogeneous tissues such as the gestational sac may distort the endometrial echo on 
ultrasound.
93
 I first determined the date of pregnancy loss based on medical abstraction for these 
women. If the date of loss based on medical records is in fact before their ultrasound date, I did a 
sensitivity analysis removing these women to determine if risk estimates for miscarriage change 
appreciably in specific aims 1 and 2. Both the overall analyses and analyses with women who 
have date of loss before ultrasound are reported.  
Follicular phase length for scans ≥45 days from self-reported LMP 
Another potential limitation in determining timing of loss is the uncertainty in pregnancy 
dating. After the occurrence of a positive pregnancy test, time of conception is traditionally dated 
as two weeks after the LMP. However, dating may be imprecise due to differences in follicular 
phase length and time between menses and ovulation.
29
  I can do a sensitivity analysis restricting 
women who are scanned ≥45 days from self-reported LMP, a time in which fetal viability should 
be present by ultrasound detection for all women to determine if risk estimates for miscarriage 
change appreciably for specific aim 2. Both the overall analyses and analyses with only women 
with scans ≥45 days from self-reported LMP were reported for specific aim 1.  
Differences in fetal growth by race for chosen nomograms  
The nomograms chosen to estimate GAAD were based on results from populations very 
early in pregnancy. The racial distributions for these populations are not provided in these 
studies. 
45,47
  Early first-trimester fetal growth varies by race, however these differences are very 
small. Blacks have a greater increase in CRL compared to Whites, equivalent to an extra increase 
in CRL of 0.019 mm per day of gestation.
16
 This increase overall accounts for 0.81 mm 
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difference in CRL at six weeks gestation compared to White women.
16
 Since differences in fetal 
growth very early in pregnancy are minute, these do not necessarily result in clinically 
meaningful differences. Therefore I do not believe that the racial distribution of the populations 
used for our chosen nomgrams will significantly alter the conclusions of this analysis.  
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CHAPTER IV  
ESTIMATING THE GAP BETWEEN TIME OF GESTATIONAL ARREST AND 
CLINICAL SYMPTOMS OF MISCARRIAGE  
 
Abstract 
Approximately 15% of recognized pregnancies end in miscarriage before 20 weeks. 
Conventionally, gestational age at loss is estimated from the first day of a woman’s last 
menstrual period (LMP) until self-reported loss based on symptoms or care is sought. However, 
embryologic development may stop days to weeks prior to onset of clinical symptoms of 
miscarriage. Women from the southeastern United States (North Carolina, Texas and Tennessee) 
were enrolled from 2000-2012 in Right from the Start, a prospective community-based 
pregnancy cohort. RFTS conducts standardized early first-trimester transvaginal ultrasounds, as 
well as detailed interviews for all participants. Developmental stage of arrest prior to loss was 
estimated from ultrasound and used to calculate the mean gap between embryologic arrest and 
clinical loss. Ultrasounds, conducted between 40 and 95 days gestation from LMP, were 
available for nearly three-quarters of women who experienced miscarriage (n=509, 73.0%). 
Mean gestational age at clinical loss based on LMP was 71.7±22.2 days. Gestational arrest prior 
to miscarriage was observed in 38.7% of losses (n=197). Estimated mean gestational age at arrest 
of development (GAAD) was 58.1±16.1 days. The mean GAAD gap was nearly three weeks 
(GAAD gap 19.3±15.0days).  The mean gap between LMP and estimated gestational age at 
arrest did not differ by race or pregnancy intention. Basing timing of miscarriage from LMP to 
clinical recognition of loss ignores the developmental state of the embryo prior to the loss in 
cases in which the pregnancy arrested earlier. In models that estimate risk of time-varying 
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exposures in early pregnancy, this gap has the potential to bias effect estimates by over-
estimating or mis-assigning exposure time.  
Running Head: Gestational arrest prior to miscarriage 
Key Words: Miscarriage, gestational arrest, ultrasound, reproductive epidemiology, prospective 
cohort 
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Introduction 
Approximately 10 to 15% of clinically recognized pregnancies end in miscarriage, 
defined as a pregnancy loss before completion of 20 weeks of gestation.
1,8,94,95
 More than 30% of 
all conceptions may end in loss when taking into account unrecognized pregnancies. 
1
 
Conventionally, pregnancy is dated from the first day of a woman’s last reported menstrual 
period (LMP) and time from LMP is referred to as gestational age. In studies of miscarriage, 
LMP is often used to estimate gestational age at loss; however, embryologic development may 
stop days to weeks prior to the onset of clinical recognition of miscarriage. Basing timing of 
miscarriage on the time from LMP to the clinical recognition of loss alone ignores the 
developmental state of the embryo prior to the loss. This is potentially problematic if a 
pregnancy had, as is clinically known to be common, in fact arrested earlier.
2,93,96-101
  
Prior work from our group indicates nearly forty percent of losses in this cohort have 
anembryonic gestation or abnormal development of the embryo as assessed by absent fetal heart 
rate or fetal pole development inconsistent with dates.
2
 Ultrasound can be used to estimate when 
development stopped prior to clinically recognized miscarriage. In reproductive epidemiology, 
misattributing exposure time may in fact result in overestimation of certain risk factors and lead 
to biased estimation of the effect of exposures associated with miscarriage.   
A better understanding of the patterns in timing of loss and the differences between 
ultrasound developmental stage at arrest and clinical onset of symptoms for miscarriage are 
important for epidemiologic studies. We aim to describe the variation and distribution in the 
number of days between ultrasound estimated developmental stage at arrest and clinical onset of 
symptoms of miscarriage among women who experience a pregnancy loss within a prospective 
pregnancy cohort.    
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Materials and Methods 
Study population and data collection 
Right from the Start (RFTS) is a prospective community-based pregnancy cohort study 
that began enrollment in 2000. Women, either pregnant or planning a pregnancy, enrolled from 
metropolitan and suburban areas in south-eastern United States in three states (Texas, Tennessee 
and North Carolina). The study sites included Galveston, Texas; Chattanooga, Knoxville, 
Memphis and Nashville, Tennessee and the Greater Triangle region of North Carolina(including 
Raleigh, Durham and Chapel Hill). Participants were between 18 and 45 years of age, spoke 
English or Spanish, intended to carry the pregnancy to term, and had not used assisted 
reproductive technologies to conceive. 
3,73,79
 Over time, the study has included three phases 
(RFTS 1, 2, and 3). 
Women who were not yet pregnant but trying to conceive could pre-enroll before 
pregnancy and were followed until a positive pregnancy test. To avoid over-enrollment of sub-
fertile women, pre-enrolled women in the study must have been attempting to get pregnant for 
fewer than six months (RFTS 1 and 2) or fewer than three months (RFTS 3). Women were 
provided pregnancy test kits for up to 12 months of pre-enrollment. Women formally enrolled in 
the study before 12 completed weeks of gestation (RFTS 1), before nine completed weeks of 
gestation (RFTS 2), or at time of positive pregnancy test after pre-enrollment prior to pregnancy 
(RFTS 3). 
79
 Informed, written consent was obtained from each study participant in compliance 
with institutional review board procedures.  
 Women who had their LMP before May 5, 2012 were included in this dataset (n=6,105). 
Participants had an early-pregnancy ultrasound for assessment of embryologic viability, 
documentation of stage of development, and confirmation of gestational dating for ongoing 
79 
 
pregnancies. Accuracy of self-reported LMP dating in this cohort is excellent, with a mean 
difference of less than one day, and has been previously described. 
77
 Research ultrasounds were 
conducted at a time in gestation (> 5 4/7 weeks after LMP) in which normal pregnancies would 
be expected to have a fetal pole and heart rate identifiable. Participants completed a baseline 
interview at the time of enrollment and comprehensive computer assisted telephone interview in 
the first-trimester. Information collected from the interview included reproductive and medical 
history, socio-demographic characteristics, and health behaviors around the time of conception 
or during pregnancy. Participants who experienced pregnancy loss before the scheduled 
interview were interviewed as soon as possible after the loss. 
Pregnancy outcomes were self-reported by study participants and verified by medical 
records. Exclusions from the analysis include women who enrolled during more than one 
pregnancy (n=333, only the first pregnancy was included), women who had induced abortions 
(n=17), women who had a missing pregnancy outcome status at the time of analysis (n=231), and 
women who had ectopic/molar pregnancies (n=11).  
Variable definitions GAAD 
Miscarriage was defined as loss of a recognized pregnancy prior to 20 completed weeks 
of gestation using LMP dating. Pregnancy was verified by ultrasound or repeat pregnancy test. 
We documented 697 miscarriages during the study period. Of the women who experienced loss 
nearly one-third experienced their loss prior to ultrasound (n=188).  
Women with ultrasounds were classified based on developmental stage at loss (i.e. 
gestational age at time of arrested development). This new estimation for gestational age at arrest 
of development is referred to as GAAD. GAAD was estimated using prespecified established 
nomograms
45,47
 to estimate gestational age using key characteristics from ultrasound (Table 1). 
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Developmental stage at ultrasound was initially categorized based on the following 
characteristics, normal fetal development, abnormal fetal development, and anembryonic 
development at time of first-trimester transvaginal ultrasound (Table 4-12).   
Women considered to have normal fetal development included those with a fetal pole and 
normal fetal heart rate (FHR) at ultrasound. Women considered to have abnormal fetal 
development included women with a visible fetal pole and either abnormal or no FHR visible on 
ultrasound. Women who are considered to have anembryonic development include women with 
an empty uterus (and no subsequent diagnosis of ectopic gestation), gestational sac only, or 
gestational and yolk sac visible on ultrasound but no fetal pole or FHR visible. 
Estimating GAAD within RFTS was done in the following way: GAAD was not 
calculated for women who had a loss before their transvaginal ultrasound. Women with 
anembryonic gestation had a GAAD equal to the gestational age at time of arrested development 
using the criteria outlined in Table 1. The earliest structure in development that can be visualized 
on transvaginal ultrasound is the gestational sac between 4.5 to 5 weeks from LMP. Among 
women with anembryonic development in which gestational sac or gestational and yolk sac are 
visible, GAAD was estimated based on the formula by Goldstein and colleagues. 
47
 A special 
case of anembryonic gestation is women with empty uterus. Among women with an empty 
uterus in which neither the yolk sac or gestational sac are visible, GAAD was assigned based on 
the estimated gestational age based on self-reported LMP to the date of the ultrasound if less than 
4.5 weeks (i.e. 32 days). If greater than 4.5 weeks, 32 days gestation for these women was 
assigned.  
For women who had normal or abnormal fetal development on ultrasound in which a 
fetal pole could be visualized we estimated GAAD based on a nomogram for CRL by Hadlock 
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and colleagues 
45
 plus the midpoint from date of ultrasound to date of loss. Since we do not know 
the exact date that embryologic development stopped for women with normal and abnormal 
ultrasounds from a single ultrasound measurement, we simplified estimating GAAD by choosing 
the midpoint between date of ultrasound and date of reported loss for these women. 
Based on the data available from early first-trimester ultrasounds, we used the following 
formulas to estimate GAAD in days gestation for women in this cohort (Hadlock et al. 
45
 
(Formula A) and Goldstein et al. 
47
 (Formula B)): 
A. t=exp[1.685+0.316(CRL)-0.049(CRL)
2
+0.004(CRL)
3
-0.0001(CRL)
4
]x7
 
B. t=L+42 
where t refers to the gestational age in number of days and L the measurement of length of the 
mean gestational sac diameter (MSD) in millimeters (mm). Many studies have shown that the 
crown-rump length (CRL) is the most consistent measurement for determining gestational age in 
early development.
36,37,45,46
 The Hadlock formula estimates gestational age in weeks gestation 
and with CRL measured in centimeters (cm). The Hadlock formula was multiplied by seven in 
order to estimate GAAD in days gestation. GAAD was rounded up to the nearest whole integer 
in days gestation. Women who had ultrasounds but were missing either CRL or MSD 
measurements were excluded when estimating GAAD (n=4). We were able to estimate GAAD 
for 504 women who experienced a loss and had ultrasound measurements. We also determined 
the GAAD gap for these women. The GAAD gap was defined as the difference in days gestation 
between self-reported LMP date of loss and the newly estimated GAAD. A study subject flow 
chart for specific aim 1 can be found in Figure 4-7.  
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Statistical analysis 
We report the overall distribution of estimated gestational age based on LMP and GAAD 
based on developmental state of the embryo for women who experienced loss and had 
ultrasounds in RFTS. In order to better understand characteristics of GAAD, we conducted initial 
exploratory and descriptive analyses to assess the GAAD gap. Chi-square testing was used to 
compare categorical variables. For categories with fewer than five individuals, Fisher’s exact test 
was used. Continuous variables were compared using t-test. Gestations were further categorized 
based on the median GAAD gap within this cohort (median GAAD gap 19 days). We tested 
GAAD gap for associations with other established predictors of miscarriage risk (e.g. age, parity, 
pregnancy intention, prior history of loss) to determine if these factors differ among those 
women with longer than median (> 19 days) vs. shorter than median GAAD gap (≤ 19 days). 
Both overall results and results with GAAD gap dichotomized at the median are presented. We 
used a sign-rank test to compare the observed versus hypothesized GAAD gap of 10 days. 
We also conducted sensitivity analyses to determine the robustness of our GAAD 
distribution within this cohort. These include the following scenarios: 1. To address potential 
recall bias, we stratified our analysis by whether participants completed their interviews before 
or after their loss, 2. to investigate timing of loss based on key embryologic development, we 
dichotomized loss at 10 weeks, the median gestational age at time of loss based on LMP for our 
cohort. We grouped losses into early loss (prior to 10 weeks gestation) and late loss (≥ 10 weeks 
gestation). We further restricted women who had ultrasounds conducted ≥45 days from LMP, a 
time in which fetal viability determined by fetal pole and visible heart rate should be present, 3. 
to eliminate the potential for prior pregnancy outcomes to have an influence on the quality of 
reporting we restricted our analysis to women in their first pregnancies, with intended 
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pregnancies and women who were not pregnant prior to enrollment, 4. to address potential for 
recurring reasons for loss, we also restricted our analysis to exclude those women with prior loss, 
recurrent loss (3 or more reported losses), and with a loss within 3 days of study enrollment. 
Analyses were conducted using Stata SE/12.1 software (StataCorp LP, College Station, TX).  
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Results 
Six-hundred ninety-seven miscarriages were documented. Ultrasound data was available 
for nearly three-quarters of women with a pregnancy loss (n=509, 73.0%). Among women who 
experienced a pregnancy loss key participant characteristics did not differ significantly by 
ultrasound status (Table 4-13.). Compared to women with ultrasounds, women without 
ultrasounds were more likely to be slightly older, have a lower BMI (< 30kg/m
2
), income > 
$80,000, have a college degree, White, be married, be parous (> 1+), no prior loss and to abstain 
from tobacco products. Additionally, women without ultrasounds were less likely than women 
with ultrasounds to be pregnant at time of enrollment and have a prior history of pregnancy loss. 
Mean gestational age at enrollment was similar among women with ultrasounds (6.5 weeks) and 
those without ultrasounds (6.6 weeks) (Table 4-13). 
The mean gestational age at loss based on LMP for women without ultrasounds was 58.6 
(±18.3) days (Table 4-14). Mean gestational age at clinical loss based on LMP was 71.7 (±22.2) 
days. Anembryonic gestation was observed in 38.7% of losses (n=197). Estimated mean GAAD 
was 58.1 (±16.1) days among women who had losses with ultrasound data available (Table 4-
14). The median difference between GAAD and a clinically symptomatic loss based on LMP 
was 19 days(Table 4-14). The median midpoint between ultrasound and symptomatic loss for 
women with fetal poles was smallest among women with no heart rate (median midpoint no 
heart rate, abnormal heart rate, normal heart rate: 4, 7 and 14 days respectively) (results not 
shown). The observed GAAD gap differed significantly from the hypothesized GAAD gap of 10 
days (sign rank test p-value=0.0000). 
When dichotomized by the median GAAD gap within this cohort (i.e. 19 days) key 
participant characteristics did not differ significantly between those with longer vs,  shorter than 
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median GAAD gap (Table 4-15). Women with a longer than median GAAD gap (> 19 days) 
however were more likely to enroll in Texas, have a slightly later gestational age at time of study 
enrollment, and less likely to report having recurrent miscarriage (3 or more losses) than women 
with shorter than median GAAD gap (≤ 19 days). (Table 4-15). Furthermore only twenty seven 
women had a GAAD gap tht fell within 3 days of their self-reported LMP (5.4%), suggesting 
most losses have observable delays in development. Of the 504 women with estimated GAAD, 
39 did not complete the first-trimester interview [FTI] (7.7%), and 308 completed the interview 
after their loss (61.1%). In order to further evaluate the distribution of GAAD and the GAAD 
gap within this cohort, we conducted several sensitivity tests (Table 5). These included 
restriction by timing of loss, consideration of time of interview in relation to loss, restricting by 
parity, pregnancy intention, prior history of loss and loss within 3 days of enrollment. Across 
scenarios, the median estimates for GAAD varied from 49 to 65 days, and median GAAD gap 
varied between 11 and 23 days (Table 4-16). 
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Discussion 
We used ultrasound data to evaluate fetal viability among study participants and assess 
developmental stage prior to pregnancy loss.  We demonstrate that the mean GAAD gap between 
LMP and estimated gestational age at arrested development for women with miscarriage in this 
cohort is nearly three weeks (mean GAAD gap 19.3 ± 15.0days, median 19 days). Gestational 
arrest is observed in a majority of pregnancy losses and misclassifying timing of loss by as much 
as three weeks may result in biased risk estimates for the effect of early pregnancy exposures 
associated with loss. This is potentially problematic in studies of reproductive epidemiology in 
which data is often sparse and contradictory for factors influencing early pregnancy. Because of 
early first-trimester ultrasounds, RFTS likely identifies women will have a loss earlier than when 
developmental arrest would have been identified had they not enrolled in this study. The mean 
gestational age at clinical loss is slightly earlier for women who have abnormal or anembryonic 
gestation compared to women with normal appearing ultrasounds within our cohort, although 
with similar confidence bounds.
2
 Women with abnormal ultrasounds may be more likely to be 
conscious of a potentially failed pregnancy before the miscarriage occurs. This bias is less likely 
for women who have anembryonic gestations because developmentally their pregnancies had 
already arrested regardless of an early first-trimester ultrasound. Furthermore, prior to 10 weeks 
gestation, the small CRL dimensions are more susceptible to measurement and operator 
inaccuracies, though such error is typically measured in days.
42
 Nonetheless this introduces the 
potential for these early pregnancies to be identified as abnormal due to the ultrasound 
measurement process alone.  
One potential limitation within this cohort is that gestational age was estimated based on 
measurements from a single ultrasound visit. However by taking cross-sectional ultrasound 
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information we have the ability to estimate probable developmental state prior to miscarriage and 
have a better developmental outcome measurement for loss than self-report. The formulas to 
estimate GAAD were chosen based on the two largest prior studies conducted in the United 
States to estimate gestational age from ultrasound characteristics. Both studies used a single early 
first-trimester transvaginal ultrasound visit to estimate GA within a study population that had not 
used in vitro fertilization in order to conceive. 
45,47
 Study ultrasounds used to develop the 
established nomograms were performed by physicians and or registered sonographers. 
Ultrasound measurements were made among singleton births in women with no diseases known 
to adversely affect fetal growth (e.g. diabetes mellitus) and consisted of subjects with a known 
LMP. Additionally, the formulas to estimate GAAD for women in our cohort remain a 
continuous variable in days gestation. Our work suggests it is possible for researchers to more 
accurately identify the timing of insults prior to pregnancy loss and to set aside exposures that 
occur after developmental arrest but before the onset of symptoms such as bleeding. This would 
prevent misattribution of exposure time.  
Timing of miscarriage, as is typical in the literature, was defined in our study based on 
participant self-report, either based on the day of dilatation and evacuation or the day of heaviest 
bleeding for each woman. As in all studies without sequential ultrasound or high sensitivity 
human chorionic gonadotropin levels, we are unable to know the exact time of embryonic demise 
for participants who subsequently miscarry. For simplicity in this application we estimated 
GAAD from a previously developed nomogram and chose the mid-point between ultrasound 
date and date of loss for women with normal or abnormal ultrasounds.  An ideal study would 
have repeated ultrasound measures on each subject with a known time of initiation until date of 
loss was clinically detectable. However, factors including cost and participant burden make such 
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studies difficult and unlikely to be conducted. Future studies that determine developmental state 
and measures developmental progress variables at one time point could use our analysis 
approach to assess exposure-time misclassification and influence on miscarriage risk for risk 
factors associated with pregnancy loss. 
Another potential limitation of our approach is the generalizability of our findings may be 
limited by the enrollment of subjects. In order to elaborate differences in the timing of 
miscarriage we used ultrasound data from a diverse prospective community-based cohort, 
however we cannot exactly define the population base of women that was theoretically eligible 
to be in the study within these communities. RFTS emphasizes community-based recruitment 
among women who are planning a pregnancy and is likely less biased than recruitment from 
populations like academic medical centers. However, women who choose to enroll in a study of 
early pregnancy health may be different than the general population of women trying to get 
pregnant, potentially contributing to selection bias into the study. Participants in RFTS tend to be 
better educated, more health conscious with lifestyle factors related to pregnancy planning and 
have access to care that may restrict generalizablity.
73
  
Analyses of clinical populations often overestimate the larger population occurrence of 
adverse birth outcomes because they potentially include women who may be at higher risk 
initially for adverse birth outcomes in addition to those women who can seek out prenatal 
care.
73,79
 RFTS captures a greater proportion of actual pregnancy losses compared to clinic-based 
recruitment by enrolling women prior to the typical onset of prenatal care and by enrolling a 
proportion of women as they begin to plan conceptions.
3
 Women do not alter prenatal care 
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choices to enroll, and therefore it is unlikely that enrollment procedures and study activities 
influenced outcomes within this population.  
We conducted several sensitivity analyses in which to assess GAAD estimation within 
this cohort. Our overall results remain robust. Previous history of loss is an established predictor 
for future miscarriage.
1,8,57,102
 We did a simple sensitivity analysis, removing women who had 
ever had a prior miscarriage (n=122) from the analysis. Estimates for GAAD did not change 
appreciably when these women were removed (median GAAD 54 days, median GAAD gap 19 
days). One potential limitation in determining timing of loss is the uncertainty in pregnancy 
dating. After the occurrence of a positive pregnancy test, time of conception is traditionally dated 
as two weeks after the LMP. However, dating may be imprecise due to differences in follicular 
phase length and time between menses and ovulation.
29
 Sensitivity analysis restricting women 
who are scanned ≥45 days from self-reported LMP, a time in which fetal viability should be 
present by ultrasound detection for all women did not change GAAD distribution appreciably 
(median GAAD 56 days, median GAAD gap 19 days). Finally we assessed if predictors of 
miscarriage differed significantly by median length of GAAD gap for women in this cohort. 
When we stratified by median GAAD gap (i.e. ≤19 days vs. >19 days) our results did not change 
appreciably (Table 4-15). Since distribution of the GAAD gap has not been the focus of prior 
research, we hypothesized that women with smaller GAAD gaps may indicate a subset of 
women who are more confident in their LMP dating, and by proxy other pregnancy-related 
behaviors may differ than women with larger GAAD gaps. However only a small subset of 
women (n=27) had a GAAD gap that fell within 3 days of their self-reported LMP and no 
notable differences in demographic characteristics were observed when these women were 
removed from analysis (data not shown).  
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Early fetal growth is important both in epidemiologic studies and clinical settings when 
related to reproductive outcomes such as miscarriage. Development may stop days to weeks 
prior to the onset of clinical recognition of miscarriage. This research proposes a novel method 
for assessment of gestational arrest prior to loss. We are not aware of prior studies that have 
addressed timing of loss in the context of gestational arrest using early first-trimester ultrasound 
information. Research that gives insight to the mechanisms operating during early pregnancy is 
useful, especially since this time period in pregnancy is not well understood. The timing of 
embryologic of fetal insult can help to differentiate distinct mechanisms of loss.
89,103
 For 
example, chromosomal abnormalities have been observed in at least half of all pregnancy losses 
occurring in the first trimester, but represent a higher fraction of early losses than of later 
losses.
57
 Basing pregnancy loss on the time from LMP to clinical recognition of loss ignores the 
developmental state of the fetus prior to the loss. Nearly 40% of pregnancy losses have arrest in 
gestational development when assessed by early first-trimester ultrasound.
2
 This results in 
inappropriate overestimation of exposure time for common risk factors in early pregnancy. A 
better understanding of embryologic and fetal development in relation to miscarriage timing is 
important in epidemiologic studies when studying factors in early-pregnancy that may cause or 
prevent pregnancy loss by their presence in specific windows of embryologic development. 
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Table 4-12. Estimating Gestational Arrest at Development (GAAD) for women with miscarriage 
within Right from the Start, 2000-2012 
 
  
Ultrasound 
Developmental Stage  
Ultrasound Characteristics No. of 
losses  
Estimating gestational age at 
arrested development (GAAD)  
Loss before ultrasound N/A 188 Cannot be estimated  
Anembryonic gestation     
 Empty Uterus 37 ≤ 4.5 weeks: Self-reported 
LMP to date of ultrasound 
> 4.5 weeks: assign 32 days 
gestation  
    
 Gestational sac only  83 Gestational age based on mean 
gestational sac diameter
47
  
    
 Gestational and yolk sac 77 Gestational age based on mean 
gestational sac diameter
47
 
Fetal pole present    
 No fetal heart rate 100 Gestational age based on crown 
rump length
45
 + midpoint from 
date of ultrasound to date of 
loss  
    
 Abnormal fetal heart rate  32 Gestational age based on crown 
rump length
45
 + midpoint from 
date of ultrasound to date of 
loss 
    
 Normal fetal heart rate 180 Gestational age based on crown 
rump length
45
 + midpoint from 
date of ultrasound to date of 
loss 
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Table 4-13. Characteristics of participants who experienced miscarriage within Right from the 
Start, 2000-2012 
 
Miscarriage among RFTS Study Participants
 
With Ultrasounds 
N=509 (73.0%) 
Without Ultrasound 
N=188 (27.0%) 
Mean (SD) No. % Mean (SD) No. % 
Maternal age, years 30.6 (5.8)   30.6(5.5)   
Maternal age, years       
 <20  17 3.3  3 1.6 
 20–24  65 12.8  21 11.2 
 25–29  134 26.3  51 27.1 
 30–34  163 32.0  70 37.2 
 ≥35  130 25.5  43 22.9 
 Missing  0   0  
Body mass indexa 26.4 (6.6)   25.3(5.5)   
Body mass index       
 Underweight (<18.5)  13 2.6  5 2.9 
 Normal weight (18.5–24.9)  247 49.2  97 56.1 
 Overweight (25.0–29.9)  127 25.3  37 21.4 
 Obese (≥30.0)  115 22.9  34 19.7 
 Missing  7   15  
Household income       
 ≤$40,000  130 28.5  48 26.8 
 $40,001–$80,000  164 36.0  57 31.8 
 >$80,000  162 35.5  74 41.3 
 Missing  51   9  
Maternal education       
 High school or less  86 16.9  26 13.8 
 Some college  89 17.5  28 14.9 
 College (≥4 years)  333 65.6  134 71.3 
 Missing  1   0  
Marital status       
 Married, living as married, single  443 87.0  170 90.4 
 Other  66 13.0  18 9.6 
 Missing  0   0  
Race       
 Non-Hispanic White  348 68.4  140 74.5 
 Non-Hispanic Black  104 20.4  32 17.0 
 Hispanic  32 6.3  10 5.3 
 Other  25 4.9  6 3.2 
 Missing  0   0  
Pregnancy Intention       
 No  108 26.5  36 25.2 
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Miscarriage among RFTS Study Participants
 
With Ultrasounds 
N=509 (73.0%) 
Without Ultrasound 
N=188 (27.0%) 
Mean (SD) No. % Mean (SD) No. % 
 Yes  299 73.5  107 74.8 
    Missing  102   45  
Gestational age at enrollment, 
weeks 
6.5 (1.6) 6.3
b
  6.6 (2.0) 6.2
b
  
Pregnant at time of recruitment       
 No  158 31.0  68 36.2 
 Yes  351 69.0  120 63.8 
 Missing  0   0  
Parity       
 Nulliparous  210 45.5  77 42.1 
 1  162 35.1  74 40.4 
 ≥2  90 19.5  32 17.5 
 Missing  47   5  
Previous miscarriage       
 No  340 73.6  129 70.5 
 Yes  122 26.4  54 29.5 
 Missing  47   5  
Recurrent Miscarriage(3 or more)
c
       
     No  86 70.5  44 81.5 
     Yes  36 29.5  10 18.5 
     Missing  0   0  
Previous induced abortion       
 No  380 82.3  158 86.3 
 Yes  82 17.7  25 16.7 
 Missing  47   5  
Diabetes       
 No  448 95.5  175 96.7 
 Type 1  1 0.2  1 0.6 
 Type 2  4 0.9  1 0.6 
 Gestational diabetes       
  Nulliparous  1 0.2  0 0.0 
  1  5 1.1  0 0.0 
  ≥2  8 1.7  3 1.7 
  Missing  42   8  
Hypertension       
 No  312 95.4  122 91.0 
 Yes  15 4.6  12 9.0 
 Missing  182   54  
Nausea       
 No  156 33.3  69 38.1 
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Miscarriage among RFTS Study Participants
 
With Ultrasounds 
N=509 (73.0%) 
Without Ultrasound 
N=188 (27.0%) 
Mean (SD) No. % Mean (SD) No. % 
 Yes  313 66.7  112 61.9 
 Missing  40   7  
Site       
    North Carolina  294 57.8  111 59.0 
    Tennessee  178 35.0  63 33.5 
    Texas  37 7.3  14 7.5 
Prenatal vitamin use       
 No  71 15.1  28 15.6 
 Yes  398 84.9  151 84.4 
 Missing  40   9  
Smoking       
 Never  342 73.1  137 75.7 
 Current   23 4.9  4 2.2 
 Former  103 22.0  40 22.1 
    Missing  41   7  
Alcohol Use       
 Never  57 12.2  17 9.4 
 Current   82 17.5  46 25.6 
 Former  330 70.4  117 65.0 
    Missing  40   8  
Abbreviations: SD, standard deviation; No., number. 
a
 Body mass index: weight (kg)/height (m)
2
. 
b 
Median for gestational age at enrollment. 
c
 Only among women who experienced a prior miscarriage 122 with ultrasound and 54 without 
ultrasound  
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Table 4-14. Estimating gestational age in pregnancies with miscarriage based on ultrasound characteristics for self-reported LMP and 
GAAD within Right from the Start, 2000-2012 
LMP=Last menstrual period; GAAD=gestational age at arrest of development; SD=standard deviation; N/A=not applicable    
Ultrasound 
Developmental Stage Ultrasound Characteristics 
RFTS Study Participants with Miscarriage 
LMP (days) GAAD (days) GAAD gap (days) 
Mean (SD) Median Mean (SD) Median Mean (SD) Median  
Loss before Ultrasound N/A 58.6 (18.3) 57 N/A N/A N/A N/A 
Anembryonic gestation         
 Empty Uterus 60.9 (21.4) 55 32.4 (2.3) 32 28.5 (22.3) 23 
 Gestational sac only  69.3 (15.3) 69 55.8 (11.0) 52 14.3 (15.5) 13 
 Gestational and yolk sac 70.0 (16.7) 69 55.8 (10.6) 53 15.2 (18.4) 13 
Fetal Pole        
 No fetal heart rate 74.0 (11.5) 73 53.2 (8.5) 51 21.8 (9.9) 22 
 Abnormal fetal heart rate  72.8 (14.4) 72.5 52.9 (6.8) 52 20.9 (9.3) 18.5 
 Normal fetal heart rate 88.0 (25.7) 84 69.3 (17.4) 65 19.7 (13.4) 19 
Overall  71.7 (22.2) 70 58.1 (16.1) 55.5 19.3 (15.0) 19 
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Table 4-15. Characteristics of participants by median gestational age at arrest of development 
(GAAD) gap in Right from the Start, 2000-2012 
 
RFTS Study Participants with Miscarriage
 
GAAD gap >19 days 
N=246 
GAAD gap ≤ 19 days 
N=258 
Mean (SD) No. % Mean (SD) No. % 
Maternal age, years 30.3 (5.9)   30.8 (5.8)   
Maternal age, years       
 <20  10 4.1  7 2.7 
 20–24  37 15.0  28 10.9 
 25–29  60 24.4  72 27.9 
 30–34  79 32.1  82 31.8 
 ≥35  60 24.4  69 26.7 
 Missing  0   0  
Body mass indexa 27.2 (7.3)   25.7 (5.7)   
Body mass index       
 Underweight (<18.5)  4 1.7  9 3.5 
 Normal weight (18.5–
24.9) 
 114 47.1  129 50.6 
 Overweight (25.0–29.9)  59 24.4  68 26.7 
 Obese (≥30.0)  65 26.9  49 19.2 
 Missing  4   3  
Household income       
 ≤$40,000  64 28.4  65 28.8 
 $40,001–$80,000  81 36.0  51 35.8 
 >$80,000  80 35.6  80 35.4 
 Missing  21   32  
Maternal education       
 High school or less  46 18.7  39 15.2 
 Some college  43 17.5  46 17.9 
 College (≥4 years)  157 63.8  172 66.9 
 Missing  0   1  
Marital status       
 Married, living as married, 
single 
 212 86.2  227 88.0 
 Other  34 13.8  31 12.0 
 Missing  0   0  
Race       
 Non-Hispanic White  163 66.3  181 70.2 
 Non-Hispanic Black  56 22.8  47 18.2 
 Hispanic  14 5.7  18 7.0 
 Other  13 5.3  12 4.6 
 Missing  0   0  
Pregnancy Intention       
 No  61 28.8  49 22.8 
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RFTS Study Participants with Miscarriage
 
GAAD gap >19 days 
N=246 
GAAD gap ≤ 19 days 
N=258 
Mean (SD) No. % Mean (SD) No. % 
 Yes  151 71.2  166 77.2 
    Missing  34   43  
Gestational age at 
enrollment, weeks 
6.8 (1.7) 6.6
b 
 6.2 (1.5) 6.0
b 
 
Pregnant at time of 
recruitment 
 
 
    
 No  69 28.0  85 33.0 
 Yes  177 72.0  173 67.0 
 Missing  0   0  
Parity       
 Nulliparous  98 44.1  107 45.5 
 1  79 35.6  83 35.3 
 ≥2  45 20.3  45 19.2 
 Missing  24   23  
Previous miscarriage       
 No  166 74.8  169 71.9 
 Yes  56 25.2  66 28.1 
 Missing  24   23  
Recurrent Miscarriage(3 or 
more)
c
 
      
     No  46 82.1  40 60.6 
     Yes  10 17.9  26 39.4 
     Missing  0   0  
Previous induced abortion       
 No  184 82.9  191 81.3 
 Yes  38 17.1  44 18.7 
 Missing  24   23  
Diabetes       
 No  218 94.8  225 96.2 
 Type 1  1 0.4  0 0.0 
 Type 2  2 0.9  2 0.9 
 Gestational diabetes       
  Nulliparous  1 0.4  0 0.0 
  1  0 0.0  5 2.1 
  ≥2  6 2.6  2 0.9 
  Missing  16   24  
Hypertension       
     No  143 94.7  165 95.9 
     Yes  8 5.3  7 4.1 
     Missing  95   86  
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RFTS Study Participants with Miscarriage
 
GAAD gap >19 days 
N=246 
GAAD gap ≤ 19 days 
N=258 
Mean (SD) No. % Mean (SD) No. % 
Fibroids 
     No  214 87.0   221 85.7 
     Yes  32 13.0  37 14.3 
     Missing  0   0  
Age of menarche, years       
 ≤ 10  19 8.3  17 7.3 
 11–13  151 65.9  165 70.8 
 >13  59 25.8  51 21.9 
    Missing  17   25  
Nausea       
 No  69 30.0  87 37.2 
 Yes  161 70.0  147 62.8 
 Missing  16   24  
Bleeding       
 No  106 46.1  103 44.0 
 Yes  124 53.9  131 56.0 
 Missing  16   24  
Site       
    North Carolina  132 53.7  161 62.4 
    Tennessee  89 36.2  85 33.0 
    Texas  25 10.1  12 4.6 
Prenatal vitamin use       
 No  37 16.1  32 13.7 
 Yes  193 83.9  202 86.3 
 Missing  16   24  
Smoking       
 Never  168 73.0  169 72.5 
 Current   12 5.2  11 4.7 
 Former  50 21.7  53 22.8 
    Missing  16   25  
Alcohol Use       
 Never  29 12.6  27 11.5 
 Current   34 14.8  46 19.7 
 Former  167 72.6  161 68.8 
    Missing  16   24  
Abbreviations: SD, standard deviation; No., number. 
a
 Body mass index: weight (kg)/height 
(m)
2
. 
b 
Median gestational age at enrollment.
c
 Only among women who had prior miscarriage  
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Table 4-16. Further analyses and restrictions to evaluate gestational age at arrest of development (GAAD) in Right from the Start, 
2000–2012  
 RFTS Study Participants with Miscarriage 
   GAAD (days) GAAD gap (days) 
 No. of 
Losses 
% of 
Loss Mean (SD) Median Mean (SD) Median 
Time of Miscarriage       
   No Interview available 39 7.7 56.5 (21.4) 51 20.8 (21.4) 17 
   Interviewed before loss 157 31.2 67.4 (19.6) 65 23.5 (17.4) 23 
   Interviewed after loss 308 61.1 53.7 (10.6) 52 16.9 (12.0) 17 
   Early loss (<10 weeks) from LMP 201 39.9 48.4 (8.6) 49 10.6 (9.8) 11 
   Late loss (≥10 weeks) from LMP 303 60.1 64.7 (16.7) 62 25.0 (15.2) 23 
Restrictions       
   Nulliparous women only 205 40.7 57.1 (16.0) 55 20.0 (14.3) 19 
    Women with intended pregnancies only  295 58.5 55.8 (12.9) 53 18.8 (12.2) 19 
   Women not  pregnant at time of enrollment    154 30.6 54.2 (14.0) 52 16.6 (13.6) 17.5 
   Ultrasound scan ≥ 45 days  from LMP 446 88.5 58.5(15.8) 56 19.8(14.0) 19 
Exclusions       
   Women with prior loss 122 24.2 56.9 (15.8) 54 19.6 (15.1) 19 
   Women with recurrent loss (3 or more losses)
a
 36 7.1 58.0 (16.4) 56 19.6 (15.2) 19 
   Women with a loss within 3 days of enrollment 11 2.2 58.5 (16.1) 56 19.5(15.0) 19 
Abbreviations: SD, standard deviation; No., number.
 a
Includes women with 3 or more prior losses (n=13) as well as women with 2 
prior losses with current outcome also a miscarriage (n=23).  
100 
 
 
Figure 4-7. Aim 1: Study subject inclusion criteria 
 
 
 
 
 
 
 
 
Total number of subjects in dataset with LMP 
before May 5, 2012   
n=6,105 
First Pregnancies Only 
n=5,772 
Term pregnancies and pregnancy loss 
n=5,513 
 
Exclude Multiple Enrollees (n=333) 
Exclude other or unknown pregnancy outcomes (n=259) 
 Induced Abortion (n=17) 
 Ectopic/Molar/Other pregnancy outcome (n=11) 
 Missing pregnancy outcome status (n=231) 
 
Exclude pregnancy outcomes ≥ 20 weeks gestation 
(n=4,816) 
 Live births  (n=4,787) 
 Stillbirths (n=29)  
Pregnancy loss only (< 20 weeks gestation) 
n=697  
 
Pregnancy loss with ultrasound  
n=509 
 
Pregnancy loss with ultrasound in which 
GAAD can be estimated  
n=504 
 
Exclude pregnancy losses which occurred 
prior to ultrasound (n=188)  
Missing ultrasound measurements  
No mean sac diameter or crown-rump length (n=5) 
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CHAPTER V  
COMPARING MODELS FOR TIMING OF MISCARRIAGE USING COMMON 
EARLY PREGNANCY EXPOSURES 
 
Abstract  
In miscarriage studies (pregnancy loss at <20 weeks), gestational age at time of loss is 
estimated from using the first day of a woman’s last menstrual period (LMP) to the onset of 
symptoms. Conventionally embryologic development may stop weeks prior to onset of clinical 
symptoms. In models that estimate risk of time-varying exposures in early pregnancy, this gap 
between arrest of development and symptoms has the potential to bias effect estimates by over-
estimating exposure time. To determine if failing to account for this gap influences effect 
estimates, we chose to assess both a risk and protective factor associated with miscarriage. 
Women were enrolled in Right from the Start (RFTS), a prospective pregnancy cohort, from 
2000-2012. Participants completed study ultrasounds as well as detailed first-trimester 
interviews.  We compared models that estimated gestational age based on self-reported LMP and 
models that incorporated gestational age at time of arrested development (GAAD). We used 
bootstrap methods to determine the magnitude of potential bias for both models. There were 697 
observed miscarriages among 5,513 women. The risk of miscarriage was reduced among those 
who took vitamins for either models (adjusted hazard ratio (aHR) 0.41 95% confidence interval 
(CI) [0.30, 0.55] LMP model; aHR=0.43 95% CI [0.27, 0.69] GAAD model). Smoking during 
pregnancy was not associated with miscarriage (current smokers compared to never smokers 
aHR=0.93 95% CI [0.61, 1.41] LMP model; aHR=1.09 95% CI [0.64, 1.88] GAAD model). The 
bias ratio using bootstrap analysis was significant for smoking use (current smokers ratio=0.85, 
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95% CI [0.75, 0.94]) but not vitamin use (ratio=0.93, 95% CI [0.86, 1.02]). Misattributing 
exposure-time that results from arrest of development can bias risk estimates in studies of 
miscarriage.  
Running head: LMP vs. GAAD Model comparison and magnitude of bias 
Key Words: Miscarriage, gestational arrest, reproductive epidemiology, prospective cohort, 
early pregnancy exposures, misclassified exposure-time, bias  
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Introduction  
Approximately 10 to 15% of clinically recognized pregnancies end in miscarriage, a 
pregnancy loss before completion of 20 weeks of gestation. 
1,8,94
  However, the existing 
classification of pregnancy loss ignores the developmental biology of a pregnancy loss, and 
focuses solely on clinical manifestation of a pregnancy loss. This is problematic for grouping 
women who may have different pathophysiology and thus different recurrence risk as the same 
condition. It further limits research and confounds epidemiologic data collection and assessment 
for reproductive outcomes. A potentially more useful way to classify pregnancy loss may be by 
developmental periods in gestation.
28
 By more precisely identifying which insults have occurred 
prior to pregnancy loss and assessing exposures that occur after developmental arrest but before 
the onset of clinical symptoms researcher’s will have more optimal method to assess miscarriage 
risk by not misattributing exposure time. Our group has demonstrated that the mean gap between 
an arrested pregnancy and the clinical manifestation of that loss in a diverse prospective 
community-based pregnancy cohort is on average approximately 19 days (or 2.7 weeks) but can 
range anywhere between 11 and 23 days (work in preparation, Mukherjee et. al).  Our work 
suggests it is possible for researchers to more accurately identify the timing of insults prior to 
pregnancy loss and to set aside exposures that occur after developmental arrest but before the 
onset of symptoms such as bleeding.  
By assessing a better methodological approach to classify timing of gestational arrest 
prior to loss we can determine the extent of potential overestimation of certain factors that may 
lead to biased estimates for their association with early pregnancy loss. Knowledge about risk 
factors influencing early pregnancy period is sparse and often  contradictory. This may be due to 
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the heterogeneity in classifying different types of loss which may have very different etiologies, 
given that up to 40% of losses arrest earlier than onset of clinical symptoms when assessed by 
early first-trimester ultrasound.
2
   
We wanted to study if the gap in timing of loss influences effect estimates for exposures 
associated with loss. Tobacco use remains one of the most commonly abused substances among 
pregnant women. Based on results from the National Natality Survey, smoking prevalence 
among US pregnant women was approximately 12%,
53
 and of women who smoke, 60% stop as 
soon as they find out they are pregnant. 
53
 The association between early miscarriage and 
smoking has been inconsistent.
54-56,62,63,65-68
  Some studies found an increase in risk of 
miscarriage among smokers,
54-61
 while others have reported no association or only a weak 
relationship.
8,62-64
 The inconsistencies may in part be dues to limitation in sample size, 
inadequate control for confounders, and differences in recall bias of smoking status among 
subjects. Alternatively, multi-vitamin supplementation is commonly recommended for all 
women who are pregnant or planning a pregnancy. Prenatal vitamin supplementation during 
early pregnancy is related to lower risk of neural tube defects and is associated with decreased 
risk of adverse pregnancy outcomes including preterm birth, pre-eclampsia and low-birth 
weight,
69-71
 however the magnitude of association with miscarriage risk has remained 
imprecise.
8,61,72-76
  
In reproductive epidemiology, the timing of exposures like these examples may be 
distinct or cumulative in their overall risk for loss and the contradictory findings may be further 
confounded by the heterogeneity in the type of loss assessed (i.e. early pregnancy loss vs. fetal 
death). A better assessment in the timing of loss that takes into account developmental stage at 
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arrest is warranted so that we can understand biologically meaningful causal associations 
between these candidate factors and miscarriage risk. We chose exposures that have been 
established in the literature as factors that influence fetal well-being, may be episodic during 
early pregnancy, and may either cause (e.g. smoking) or prevent (e.g. vitamin use) first-trimester  
miscarriage risk. We aim to compare models that take into account gestational age at arrest of 
development with those that use self-reported LMP and determine the magnitude of bias present 
in the latter estimates.  
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Materials and Methods 
Study population and data collection 
Right from the Start is an ongoing prospective community-based pregnancy cohort 
study that began enrollment in 2000. Over time, the study has included 3 phases 
designated “RFTS 1,” “RFTS 2,” and “RFTS 3.” Women, either pregnant or planning a 
pregnancy, enrolled from 9 areas in 3 states (North Carolina, Texas, and Tennessee). 
Participants were between 18 and 45 years of age, spoke English or Spanish, intended to 
carry the pregnancy to term, and had not used assisted reproductive technologies to 
conceive.
3,73,79
  The study was designed to recruit women from a variety of clinic- and 
community-based settings and has been described in detail elsewhere.
3
  Informed, written 
consent was obtained from each study participant in compliance with institutional review 
board procedures and approvals. 
Women who had their last menstrual period before May 5, 2012, were included in 
this data set (n=6,105). Participants had an early pregnancy ultrasound examination for 
assessment of embryological viability, documentation of stage of development, and 
confirmation of gestational dating. The accuracy of self-reported last menstrual period 
dating in this cohort is excellent and has been described.
77
 Research ultrasound 
examinations were conducted at a time in gestation (>5 4/7 weeks from the LMP) in 
which normal pregnancies would be expected to have a fetal pole and heart rate. 
Participants completed a baseline interview at the time of enrollment and a 
comprehensive computer-assisted telephone interview in the first trimester. In the 
interview, information collected included reproductive and medical history, 
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sociodemographic characteristics, and health behaviors around the time of conception or 
during pregnancy. Participants who experienced pregnancy loss before the scheduled 
interview were interviewed as soon as possible after the loss. 
Pregnancy outcomes were self-reported and verified by medical records. Exclusions 
from the analysis include women who enrolled during more than one pregnancy (n=333, 
only the first pregnancy was included), women who had induced abortions (n=17), 
women who had a missing pregnancy status at the time of analysis (n=231), and women 
who had ectopic/molar pregnancies (n=11). 
Variable definitions 
The primary exposures of interest in this analysis are smoking and vitamin use. 
Exposure status is a self-reported measure acquired during the first-trimester interview. 
For this analysis, smoking was grouped into the following categories: never smokers 
(referent), current smokers, and former smokers (within 4 months prior to the interview, 
meaning exposures in the pregnancy and/or periconception window, or ≥4 months from 
interview). Information about the frequency of use was also obtained. Questions were 
asked separately for prenatal vitamins and multivitamins (see Appendix); in order to 
remain consistent with previously published work within this cohort both categories of 
supplements were combined because of potential misclassification by participants. Both 
types of supplements were referred to simply as ‘‘vitamins.’’ Participants were asked 
whether they were currently taking vitamins or, in the case of a miscarriage, whether they 
had taken vitamins during pregnancy. Information about the frequency and timing of 
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vitamin use in an average week was also obtained. Participants who reported any use of 
vitamins during pregnancy were considered exposed.  
Miscarriage was defined as loss of a recognized pregnancy prior to 20 completed 
weeks of gestation from LMP. We documented miscarriage in 697 women (12.6%) 
during the study period. Pregnancy was verified by ultrasound examination. Participants 
who had birth outcomes at a gestational age later than 20 weeks served as a comparison 
group. The comparison group (n=4,816) consisted of women who had livebirths 
(n=4,787) or stillbirths (n=29).  Figure 5-8 summarizes subject inclusion for specific aim 
2.  
Statistical analysis 
Confounders 
Potential confounders examined from baseline and the first-trimester interviews 
included factors recognized to be associated with both miscarriage and the exposure of 
choice. Candidate confounders related to sociodemographic factors included age (years); 
household income (≤$40,000, $40,001–$80,000, >$80,000 (referent)); maternal 
education (high school or less, some college, 4 or more years of college (referent)); 
marital status (married/living as married (referent), other); and maternal race (non-
Hispanic White (referred to throughout as “White”) (referent), non-Hispanic Black 
(referred to throughout as “Black”), Hispanic regardless of white or black racial self-
identification, and other races which include Native Americans and Asians). In addition, 
we assessed potential confounders related to maternal reproductive history and health 
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behaviors during pregnancy, namely, parity (yes/no), previous induced abortion (yes/no), 
diabetes status (yes/no), prenatal vitamin use (yes/no), alcohol use (never, current, 
former, within 4 months prior to the interview (meaning exposures in the pregnancy 
and/or periconception window) or ≥4 months from interview), smoking status (never, 
current, former), and study site (Galveston, Texas; Raleigh and Research Triangle Park, 
North Carolina (referent); and Chattanooga, Knoxville, Memphis and Nashville, 
Tennessee). We did not consider prior history of miscarriage as a confounder in our data 
because we would be potentially overadjusting when a factor that caused a previous 
miscarriage may also be a causal factor in the current pregnancy.
80
 
Timing of pregnancy loss and regression analysis  
Cox regression was used to estimate hazard ratios for the association between either 
smoking or vitamin use and risk of miscarriage. Participants were followed from the time 
of enrollment in the study and contributed to analysis until an outcome or loss to follow-
up occurred. Cox models accounted for variable gestational age at study entry and were 
used to screen candidate confounders. Confounding was defined as a greater than 10% 
change from the crude hazard ratio for miscarriage risk for current or former smokers 
compared to never smokers (referent) or those exposed to vitamin use (referent) 
compared to those unexposed to vitamin use.  If a 10% change was observed from the 
crude hazard ratio, the variable was retained in the final models.  
Gestational age at the time of loss was calculated from the first day of the LMP for the 
index pregnancy to the end of that gestation. In addition, we used ultrasound examination 
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findings by grouping losses into developmental stage documented on ultrasound examination 
prior to pregnancy loss and estimated a gestational age at arrested development (GAAD). 
Separate Cox models were used to compare overall risk for miscarriage with early pregnancy 
exposures using gestational age based on either self-reported LMP (i.e. LMP models) or 
estimated GAAD (i.e. GAAD models). LMP models include all women with losses, including 
women without ultrasounds. GAAD models include women with losses and ultrasound 
information. We restricted the analysis to those with complete covariate information. Final 
hazard models for smoking exposure included adjustment for maternal age and alcohol use and 
for vitamin use included adjustment for age only. To optimize fit, maternal age was specified by 
the inclusion of linear and quadratic terms in the model.  
Bias ratio and bootstrap analysis 
Finally in order to assess the potential magnitude of bias in our risk estimates for 
miscarriage risk we used bootstrap analysis to estimate the ratio of effect sizes between models. 
Bootstrapping approaches use resampled data to make adjustments for statistical biases as well 
as random error. The bias ratio was defined as the ratio between the two models (i.e. bias ratio= 
adjusted HR ratio of LMP model
adjusted HR ratio of GAAD model
) for either exposure and miscarriage risk. We conducted a 1000 
bootstrap replications to estimate the bias ratio and 95% confidence interval between models. All 
analyses were conducted using Stata SE/12.1 software (StataCorp LP, College Station, Texas). 
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Results 
 Nearly 13% of women experienced a miscarriage in this cohort (n=697, 12.6%). 
Ultrasound data was available for most women who had term births (n=4,694, 97.5%). Of 
women who reported a pregnancy loss, 73% had ultrasound data (n=509).  Most key participant 
characteristics did not differ significantly by pregnancy outcome (Table 1).  However, women 
who had miscarriages tended to be slightly older, have a higher household income (>$80,000), 
have a prior history of miscarriage and indicated having used alcohol compared to women who 
had term births (Table 1). Mean gestational age at the time of enrollment was earlier for women 
with miscarriage (6.5 weeks) compared to women who had term births (7.0 weeks) (Table 5-17). 
Twenty-seven percent of the women in our cohort were recruited prior to pregnancy (n=1,468) 
(Table 5-17).   
 Self-reported smoking and amount of smoking (i.e. number of cigarettes per day) did not 
differ significantly by pregnancy outcome (Table 5-18). The majority of women in our cohort 
reported being never smokers (n=3,863; 70.1%).  Women who had miscarriages were less likely 
to report early first-trimester vitamin use (n=601; 92.8%) compared to women who had term 
births (n=4,432; 96.6%) (Table 5-18). The majority of women who indicated exposure to 
vitamins during the first-trimester reported taking them five or more times per week (n=4,523; 
89.9%).   There were less than five percent missing values among self-reported early pregnancy 
exposure status from the first-trimester interview (missing smoking status n=260, 4.7%; missing 
vitamin use n=275, 4.9%) (Table 5-18).  
Risk of miscarriage was significantly reduced with exposure to early pregnancy vitamin 
use when adjusted for maternal age in either LMP or GAAD based models (adjusted hazard ratio 
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(aHR) = 0.41 95%, confidence interval (CI) [0.30, 0.55] LMP model; aHR=0.43, 95% CI [0.27, 
0.69] GAAD model) (Table 5-19). When we assessed frequency of vitamin exposure during 
early first-trimester the risk of miscarriage was still significantly reduced (Table 5-19). This 
protective effect was most evident among women who reported taking vitamins less than five 
times per week compared to women who did not report any vitamin use during early pregnancy 
(aHR=0.28, 95% CI [0.18, 0.43] LMP model; aHR=0.28 95% CI [0.15, 0.52] GAAD model) 
(Table 5-19).   
Adjusted for maternal age and alcohol use, smoking during early pregnancy was not 
associated with miscarriage risk in either models in this cohort (current smokers compared to 
never smokers aHR=0.93, 95% CI [0.61, 1.41] LMP model; aHR=1.09, 95% CI [0.64, 1.88] 
GAAD model; former smokers compared to never smokers aHR=0.88, 95% CI [0.73, 1.07] LMP 
model; aHR=0.93, 95% CI [0.72, 1.20] GAAD model) (Table 5-19). When assessing frequency 
of smoking associated with miscarriage, though no significant effect was observed, the number 
of cigarettes per day among current smokers compared to never smokers occurred in opposite 
directions for the GAAD model compared to the LMP model (< 10 cigarettes per day compared 
to never smokers aHR=0.88, 95% CI [0.52, 1.51] LMP model; aHR=1.03, 95% CI [0.53, 2.00] 
GAAD model; (≥ 10 cigarettes per day compared to never smokers aHR=0.93, 95% CI [0.49, 
1.77] LMP model; aHR=1.07, 95% CI [0.43, 2.66] GAAD model) (Table 5-19).  The amount of 
smoking among former smokers compared to never smokers was similar in both LMP and 
GAAD models (Table 5-19).     
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We conducted bootstrap analysis of our two models using a thousand replications to 
compare the ratio of effect sizes (i.e. bias ratio= 
adjusted HR ratio of LMP model
adjusted HR ratio of GAAD model
 ). For early 
pregnancy smoking, the bias ratio comparing the two models was 15% for current smokers and 
5% for former smokers (current smokers ratio=0.85, 95% CI [0.75, 0.94]; former smokers 
ratio=0.95, 95% CI[0.92, 0.97]) (Table 5-20). The bias ratio was not significant for early 
pregnancy vitamin use in this cohort (ratio=0.93, 95% CI [0.86, 1.02]) (Table 5-20). Similar 
results were observed for consistency of early-pregnancy exposure (Table 5-20). This suggests 
that misclassification in timing of loss influences risk estimates for exposures associated with 
loss. It further implies that strong effects associated with loss may be less variable and prone to 
bias  when gestational arrest prior to loss is properly classified.  
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Discussion 
Our analysis demonstrates that proper classification of gestational age at arrest may bias 
the risk estimates of miscarriage associated with early-pregnancy smoking when compared to 
models that use gestational age estimated by self-reported LMP alone. Models that use self-
reported LMP to estimate gestational age differ by as much as 15% for current smokers and 5% 
of former smokers when compared to models that use GAAD to estimate gestational age. 
Although, a similar magnitude of bias was observed with early pregnancy vitamin use (7%), the 
small number of women reporting no vitamin use may have affected precision estimates, but still 
likely indicates some evidence of bias present. These results suggest early-pregnancy exposures 
associated with miscarriage risk are influenced by proper classification of gestational arrest prior 
to loss.  
We demonstrate that misclassifying time at loss in studies of miscarriage results in biased 
risk estimates.  Embryologic development may stop weeks prior to the onset of clinical 
symptoms or diagnostic recognition of miscarriage.
2,93,96-101
 We used ultrasound data to evaluate 
fetal viability among study participants and assess developmental stage prior to pregnancy loss. 
Because of early first-trimester ultrasounds, RFTS likely identifies women who will have a 
pregnancy loss earlier than when developmental arrest would have been identified had they not 
enrolled in this study. We are able to identify gestational arrest prior to clinically recognized loss 
in nearly 40% of all losses. Our aim was to assess a better methodological approach to classify 
timing of gestational arrest prior to loss in order to determine the extent of potential 
overestimation of putative factors that may lead to biased estimates for their association with 
early pregnancy loss.  
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The early-pregnancy exposures that were chosen were a means to assess this new 
methodological approach within a diverse prospective pregnancy cohort.  These factors have 
been associated with first-trimester miscarriage in the literature, have been established to 
influence fetal well being and may be episodic during early pregnancy. We wanted to compare 
this new approach to what is traditionally used in miscarriage studies to estimate gestational age, 
namely self-reported LMP. Bias was assessed with bootstrap analysis. Bootstrap methods were 
used to estimate and compare effect size between models with different outcome measurement 
(i.e. that is miscarriage outcome based on GAAD vs. miscarriage outcome based on LMP) and to 
assess the robustness of our findings. Bootstrapping allows for resampling within the data and 
can be used as a way to assess internal study validity. Bootstrapping approaches use resampled 
data to make adjustments for statistical biases as well as random error, 
89
 are used to estimate  
parameters and their variability in a given model and can be applied to Cox regression 
analyses.
91
   
One potential limitation within this cohort is that gestational age was estimated based on 
measurements from a single ultrasound. However by taking cross-sectional ultrasound 
information we have the ability to estimate probable developmental state prior to miscarriage and 
have a better developmental outcome measurement for loss than self-reported LMP. Another 
limitation may include collection of data in first-trimester interview in relation to pregnancy loss. 
Of the women who had miscarriages, 5% did not complete the first-trimester interview (n=38) 
and for approximately 64% of women (n=445), ascertainment of behavioral factors during 
pregnancy including alcohol consumption, smoking, and vitamin use, was collected after the 
loss. Among women who experienced a loss prior to their interview, the mean interval between 
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loss and first-trimester interview was less than 3.5 weeks (24.8 sd (17.5) days), and the questions 
in the interview were clearly asking about behaviors during their recent pregnancy. In addition, 
less than five percent of data was missing for these women, suggesting that RFTS does a 
thorough assessment of collecting data for many early-pregnancy behaviors and characteristics.   
The primary strength of our study is our ability to follow a large diverse sample of 
women recruited from the community prospectively through their pregnancies, many of whom 
were enrolled prior to pregnancy.
3
 In addition, we were able to evaluate numerous potential 
confounders and analyze the data with hazard models that account for variation in gestational age 
at study entry. A study of miscarriage requires careful assessment of gestational time at study 
entry because women who enter a study later will have less opportunity for a miscarriage to be 
observed than women who enter very early in pregnancy. Furthermore, RFTS avoids over 
selection of women who may be subtly symptomatic or at high risk by advertising as a study 
about pregnancy health. Women do not alter prenatal care choices to enroll, and therefore it is 
unlikely that enrollment procedures and study activities influenced behaviors or outcomes within 
this population. 
Research that gives insight to the biologic mechanisms of exposures operating during 
early pregnancy is useful, especially since this time period in pregnancy is not well understood. 
A primary challenge in reproductive epidemiologic research is the accurate and early exposure 
assessment during early pregnancy. An analysis that takes into account gestational arrest prior to 
clinical loss would prevent misattribution of exposure time in epidemiologic studies of early-
pregnancy exposures and miscarriage risk. Estimates of miscarriage risk very early in pregnancy 
are in the time period most vulnerable to this bias, so further studies with early ascertainment of 
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pregnancy and careful longitudinal follow-up are needed. Next steps in this type of analysis 
could include assessing the influence of time-varying exposures such as over-the counter 
medication use,
104
 or anti-depressant use in early first-trimester
105-107
 both of which have been 
associated with increased miscarriage risk. By more accurately identifying which insults have 
occurred prior to pregnancy loss and assessing exposures that occur after developmental arrest 
but before the onset of bleeding we will have more optimal method to assess miscarriage risk by 
not misattributing exposure time.  
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Table 5-17. Comparing common characteristics by pregnancy outcome among Right from the 
Start, 2000–2012  
 
RFTS Study Participants
 
Miscarriage  
N=697 (12.6%) 
Term Births  
N=4,816 (87.4%) 
Mean (SD) No. % Mean (SD) No. % 
Maternal age, years 30.6 (5.7)   28.7 (5.0)   
Maternal age, years       
 <20  20 2.9  166 3.5 
 20–24  86 12.3  789 16.4 
 25–29  185 26.5  1,713 35.6 
 30–34  233 33.4  1,540 32.0 
 ≥35  173 24.8  605 12.6 
 Missing  0   3  
Body mass indexa 26.1 (6.4)   25.8 (6.2)   
Body mass index       
 Underweight (<18.5)  18 2.7  121 2.6 
 Normal weight (18.5–24.9)  344 51.0  2,552 53.9 
 Overweight (25.0–29.9)  164 24.3  1,121 23.7 
 Obese (≥30.0)  149 22.1  938 19.8 
 Missing  22   84  
Household income       
 ≤$40,000  178 28.0  1,376 30.9 
 $40,001–$80,000  221 34.8  1,693 38.0 
 >$80,000  236 37.2  1,385 31.1 
 Missing  60   343  
Maternal education       
 High school or less  112 16.1  850 17.7 
 Some college  117 16.8  872 18.1 
 College (≥4 years)  467 67.1  3,094 64.2 
 Missing  1   0  
Marital status       
 Married, living as married, single  613 88.0  4,286 89.0 
 Other  84 12.0  530 11.0 
 Missing  0   0  
Race       
 Non-Hispanic White  488 70.0  3,409 70.9 
 Non-Hispanic Black  136 19.5  870 18.1 
 Hispanic  42 6.0  3.19 6.6 
 Other  31 4.5  209 4.4 
 Missing  0   9  
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RFTS Study Participants
 
Miscarriage  
N=697 (12.6%) 
Term Births  
N=4,816 (87.4%) 
Mean (SD) No. % Mean (SD) No. % 
 
Pregnancy Intention 
 No  144 26.2  1,151 29.5 
 Yes  406 73.8  2,751 70.5 
    Missing  537   96  
Gestational age at enrollment, 
weeks 
6.5 (1.7)   7.0 (2.0)   
Pregnant at time of recruitment       
 No  226 32.4  1,242 25.8 
 Yes  471 67.6  3,574 74.2 
 Missing  0   0  
Parity       
 Nulliparous  287 44.5  2,196 48.2 
 1  236 36.6  1,576 34.6 
 ≥2  122 18.9  785 17.2 
 Missing  52   259  
Previous miscarriage       
 No  469 72.7  3,560 78.1 
 Yes  176 27.3  997 21.9 
 Missing  52   259  
Alcohol Use       
 Never  74 11.4  656 14.3 
 Current   128 19.7  158 3.4 
 Former  447 68.9  3,788 82.3 
    Missing  48   214  
Has study ultrasound       
 No  188 27.0  122 2.5 
 Yes  509 73.0  4,694 97.5 
 Missing  0   0  
Site       
    North Carolina  405 58.1  2,687 55.8 
    Tennessee  241 34.6  1,779 36.9 
    Texas  51 7.3  350 7.3 
Abbreviations: RFTS, “Right from the Start”; SD, standard deviation. 
a
 Body mass index: weight (kg)/height (m)
2
. 
b Median for gestational age at enrollment.  
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Table 5-18. Common early pregnancy exposures and consistency of use in Right from the Start, 
2000-2012 
 
 
Miscarriage Term Births  
N % N % 
Smoking overall
 
     
 Never  479 73.8 3,384 73.5 
 Current  27 4.2 157 3.4 
 Former 143 22.0 1,063 23.1 
    Missing 48  212  
Consistency of smoking overall      
    Non-smoker 479 73.9 3,384 73.7 
 <10 cigarettes per day  102 15.7 709 15.5 
 ≥10 cigarettes per day 67 10.3 497 10.8 
   Missing 49  226  
 Consistency of use among current 
smokers  
    
 <10 cigarettes per day  17 63.0 104 66.7 
 ≥10 cigarettes per day 10 37.0 52 33.3 
   Missing 0  1  
Consistency of use among former  
smokers 
    
 <10 cigarettes per day  85 59.9 605 57.6 
 ≥10 cigarettes per day 57 40.1 445 42.4 
    Missing 1  13  
Vitamin use overall     
 No 47 7.3 158 3.4 
 Yes  601 92.8 4,432 96.6 
    Missing 49  226  
Consistency of vitamin use
a
     
 <5 times per week  39 6.1 465 10.1 
 ≥ 5 times per week 558 86.6 3,965 86.4 
    Frequency per week unknown  4  2  
a
Only among women who indicated vitamin use 601 who had miscarriages and 4,432 who had 
term births   
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Table 5-19. Models for miscarriage risk associated with common early pregnancy exposures 
using gestational age based on self-reported LMP or GAAD among Right from the Start, 2000–
2012 
 Unadjusted       
Model: LMP 
Adjusted 
Model 1:  LMP 
Adjusted 
Model 2: GAAD 
HR 95% CI aHR 95% CI aHR 95% CI 
Smoking Overall
a 
       
 Never  1.0 Referent  1.0 Referent 1.0 Referent 
 Current  1.24 0.83, 1.86 0.93 0.61, 1.41 1.09 0.64, 1.88 
 Former 0.99 0.82, 1.19 0.88 0.73, 1.07 0.93 0.72, 1.20 
 Consistency of use 
among Current 
Smokers
a
  
      
   Non-smoker  1.0 Referent 1.0 Referent 1.0 Referent 
 <10 cigarettes per 
day  
1.12 0.67, 1.87 0.88 0.52, 1.51 1.03 0.53, 2.00 
 ≥10 cigarettes per 
day 
1.54 0.82, 2.89 0.93 0.49, 1.77 1.07 0.43, 2.66 
Consistency of use 
among Former 
Smokers
a
 
      
 Non-smoker  1.0 Referent 1.0 Referent 1.0 Referent 
 <10 cigarettes per 
day  
1.01 0.80, 1.28 0.86 0.68, 1.08 0.99 0.73, 1.34 
 ≥10 cigarettes per 
day 
0.97 0.74, 1.27 0.91 0.69, 1.20 0.84 0.57, 1.24 
Vitamin use overall
b
       
 No 1.0 Referent 1.0 Referent 1.0 Referent 
 Yes  0.43 0.32, 0.58 0.41 0.30, 0.55 0.43 0.27, 0.69 
Consistency of vitamin 
use
b
 
      
 No vitamin use  1.0 Referent 1.0 Referent 1.0 Referent 
 <5 times per week  0.29 0.19, 0.45 0.28 0.18, 0.43 0.28 0.15, 0.52 
 ≥ 5 times per week 0.44 0.33, 0.60 0.42 0.31, 0.57 0.45 0.28, 0.71 
Gestational age based on self-reported last menstrual period (LMP) or gestational age at arrest of 
development (GAAD) 
Abbreviations: LMP, last menstrual period; GAAD, gestational age at arrest of development; 
HR, unadjusted hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval. 
a
 Models for smoking, adjusted for age(quadratic) and alcohol use  
b
 Models for vitamin use, adjusted for age(quadratic) 
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Table 5-20. Bootstrap analysis bias ratio for risk of miscarriage associated with common early 
pregnancy exposures in Right from the Start, 2000–2012 
 Model comparison  
Magnitude of bias  
Bias Ratio
c 
aHR LMP model 
aHR GAAD model 
 95% CI 
Smoking
a 
   
 Current  0.85 0.75, 0.94 
 Former 0.95 0.92, 0.97 
Consistency of use among Current 
Smokers
a
  
  
 <10 cigarettes per day  0.87 0.74, 0.99 
 ≥10 cigarettes per day 0.87 0.71, 1.09 
Consistency of use among Former  
Smokers
a
 
  
 <10 cigarettes per day  0.86 0.83, 0.90 
 ≥10 cigarettes per day 1.08 1.05, 1.12 
Vitamin use
b
   
 Yes  0.93 0.86, 1.02 
Consistency of Vitamin use
b
   
 <5 times per week  1.01 0.93, 1.08 
 ≥ 5 times per week 0.94 0.87, 1.01 
Abbreviations: CI, confidence interval 
a
 Models for smoking, adjusted for age (quadratic) and alcohol use 
b
 Models for vitamin use, adjusted for age (quadratic) 
c
 Bias Ratio:
aHR LMP model 
aHR GAAD model 
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Figure 5-8. Aim 2: Study subject inclusion criteria  
 
  
Study subject flow chart: Aim 2 (LMP vs. GAAD models with early pregnancy exposures) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total number of subjects in dataset with Last 
Menstrual Period (LMP) before May 5, 2012.   
n=6,105 
First Pregnancies Only 
n=5,772 
Outcome of interest  
n=5,513 
 Term Pregnancy [≥ 20 weeks gestation] 
(n=4,816) 
o Live births(n=4,787) 
o Stillbirths (n=29) 
 Pregnancy loss [< 20 weeks gestation] 
(n=697) 
Exclude Multiple Enrollees (n=333) 
Exclude other or unknown pregnancy outcomes (n=259) 
 Induced Abortion (n=17) 
 Ectopic/Molar/Other pregnancy outcome (n=11) 
 Missing pregnancy outcome status (n=231) 
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CHAPTER VI  
RACIAL DIFFERENCES IN RISK OF MISCARRIAGE ASSOCIATED WITH 
COMMON EARLY PREGNANCY EXPOSURES 
 
Abstract 
Racial disparities for factors associated with miscarriage risk are sparse and may be influenced 
by differences in pregnancy intention and timing of loss. We examined if GAAD gap differs 
between Blacks and Whites and whether early pregnancy exposures associated with loss are 
modified by race. Women were enrolled in Right from the Start, a diverse community-based 
cohort (2000-2012). Study participants completed study ultrasounds and detailed first-trimester 
interviews. We compared models that estimated gestational age based on self-reported LMP and 
models that incorporated gestational age at time of arrested development (GAAD). We used 
bootstrap analysis to determine the magnitude of bias in our risk estimates. Over twenty percent 
of women self-identified as Black (n=1,006). There were 624 observed miscarriages among 
4,903 women. The median GAAD gap was longer for Blacks compared to Whites (median 
GAAD gap 21 days vs. 19 days, p-value=0.04). Using the LMP models unadjusted for 
confounders we did not observe effect modification by race for the relationship between smoking 
and miscarriage risk (likelihood ratio test p=0.34), but did for the relationship between vitamin 
use and miscarriage risk (likelihood ratio test p=0.06). Adjusted for confounding, the protective 
effect of vitamin use on miscarriage risk was stronger among White women than Black women 
when using the LMP method (Whites aHR=0.34, 95% CI [0.21, 0.54]; Blacks aHR=0.53, 95% 
CI [0.33, 0.84], race interaction p-value=0.18), while no substantial difference by race was 
observed with the GAAD method (Whites aHR=0.43, 95% CI [0.24, 0.76]; Blacks aHR=0.44,  
95% CI [0.26, 0.74], race interaction p-value=0.93). The magnitude of bias in our reported 
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estimates was roughly twenty percent for both races (Whites bias ratio=0.79, 95% CI [0.62, 
0.87]; Blacks bias ratio=1.19, 95% CI [1.13, 1.45]). These results suggest that the protective 
effect of vitamin use on miscarriage risk from the LMP model may be overestimated for Whites 
and underestimated for Blacks within this pregnancy cohort.  Early-pregnancy vitamin use 
associated with miscarriage risk is influenced by proper classification of gestational arrest prior 
to loss, and the magnitude and direction of bias differs by race. 
Running head: Race stratified estimates for miscarriage and magnitude of bias  
Key Words: Miscarriage, gestational arrest, race, vitamin use, pregnancy intention, bias  
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Introduction 
Miscarriage (a pregnancy loss < 20 weeks gestation) is a common clinical outcome. A 
better understanding of embryologic and fetal development in relation to timing of miscarriage, 
including differences by race, is important in epidemiologic studies when studying factors in 
early-pregnancy that may cause or prevent pregnancy loss.  In studies of miscarriage, last 
menstrual period (LMP) is often used to estimate gestational age at loss; however, embryologic 
development may stop days to weeks prior to the onset of clinical symptoms of miscarriage. 
Basing timing of miscarriage on the time from LMP to the clinical recognition of loss alone 
ignores the developmental state of the embryo prior to the loss. This is potentially problematic if 
a pregnancy had, as is clinically known to be common, in fact arrested earlier.
2,93,96-101
 
Research on racial differences in miscarriage risk are sparse and may be influenced by 
differences in pregnancy intention.  Prior work within RFTS has indicated that Blacks and 
Whites have different gestational ages at clinical loss, with Black women having greater risk for 
miscarriage between weeks 10 and 20 in gestation (aHR=1.93, 95% CI [1.48, 2.51]).
2
 In order to 
determine if the observed later losses in Blacks are due to difference in developmental stage at 
loss, we aim to assess gestational arrest prior to loss and compare the GAAD gap by race. 
Additionally, pregnancy intention varies by race 
4-6
 in the U.S. general population and may 
influence behavioral factors such as smoking and vitamin use during early pregnancy associated 
with pregnancy loss. Women with unintended pregnancies may be less certain of their LMP 
dates and may have greater variability in their GAAD estimates based on developmental stage at 
ultrasound when compared to women who are planning a pregnancy.  
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In this study, we build upon our prior work and use data from the RFTS pregnancy cohort 
to examine the racial differences in the GAAD gap and if early pregnancy exposures as it relates 
to timing of miscarriage risk are modified by race. The aims of this study are 1. to test whether 
GAAD gap differs by race or pregnancy intention; 2. to assess if timing of gestational arrest 
associated with early pregnancy exposures is modified by race by comparing models that use 
GAAD or self-reported LMP to estimate gestational age and; 3. to determine the magnitude of 
bias in our reported estimates when comparing these models.  
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Materials and Methods 
Study population and data collection 
Data was available from the Right from the Start pregnancy cohort. Women who had 
their last menstrual period before May 5, 2012, were included in this data set (n=6,105). 
Participants completed a baseline interview at the time of enrollment and a comprehensive 
computer-assisted telephone interview in the first trimester. In the interview, information 
collected included reproductive and medical history, sociodemographic characteristics, and 
health behaviors around the time of conception or during pregnancy. Participants who 
experienced pregnancy loss before the scheduled interview were interviewed as soon as possible 
after the loss. In addition, in order to enroll in the study women also consented to early first-
trimester transvaginal ultrasounds. Research ultrasound examinations were conducted at a time 
in gestation (>5 4/7 weeks from the LMP) in which normal pregnancies would be expected to 
have a fetal pole and heart rate. Study ultrasounds were conducted for assessment of 
embryological viability, documentation of stage of development, and confirmation of gestational 
dating. Additionally, pregnancy outcomes were self-reported by study participants and verified 
by medical records.  
For women who enrolled in the study for more than one pregnancy, we limited our study 
population to their first enrolled pregnancy in RFTS (n=333 subsequent pregnancies excluded). 
We further excluded women who had induced abortions (n=17), women who had a missing 
pregnancy status at the time of analysis (n=231), and women who had ectopic/molar pregnancies 
(n=11). Additionally, in order to study effect modification by race we restricted our analyses to 
women who self-identified as non-Hispanic White (referred to throughout as White) or non-
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Hispanic Black (referred to through as Black). Women with missing information for race (n=7) 
or who decline to self-identify their race (n=2) were excluded from this analysis. Women who 
self-identified as Hispanic regardless of White or Black racial self-identification or as other 
races, which include Native Americans and Asians, were also excluded from this analysis 
(n=361 and  n=240, respectively). A total of 4,903 women contributed to these analyses.  Study 
subjects included in analysis for specific aim 3 can be found in Figure 6-9.  
Outcome definitions 
Pregnancy was verified by ultrasound or repeat pregnancy test. Miscarriage was defined 
as loss of a recognized pregnancy prior to 20 completed weeks of gestation using self-reported 
LMP dating. This was referred to as the LMP method to estimate gestational age at loss. We 
documented 624 miscarriages during the study period. Of the women who experienced loss 
nearly one-third experienced their loss prior to ultrasound (n=172). Women with ultrasounds 
were classified based on developmental stage at loss (i.e. gestational age at time of arrested 
development or GAAD). GAAD was estimated using prespecified established nomograms
45,47
 to 
estimate gestational age using key characteristics from ultrasound and described in detail in Aim 
1. GAAD was estimated among losses with complete ultrasound data (four White women and 
one Black woman had ultrasounds, but were missing both mean sac diameter and crown-rump 
length measurements, and were therefore excluded from our GAAD estimates). The GAAD gap 
was defined as the difference in days gestation between self-reported LMP date of loss and the 
newly estimated GAAD.  GAAD and the GAAD gap were estimated for 344 White and 103 
Black losses.  
  
130 
 
 
Exposure definitions 
The primary exposures of interest in this analysis are smoking and vitamin use. Exposure 
status is a self-reported measure acquired during the first-trimester interview. For this analysis, 
smoking was grouped into the following categories: never smokers (referent), current smokers, 
and former smokers (within four months prior to the interview (meaning exposures in the 
pregnancy and/or periconception window) or ≥4 months from interview)). Information about the 
frequency of use was also obtained among women reporting current or former smokers. 
Questions were asked separately for prenatal vitamins and multivitamins (see Appendix). In 
order to remain consistent with previously published work within this cohort both categories of 
supplements were combined because of potential misclassification by participants. Both types of 
supplements are referred to as ‘‘vitamins.’’ Participants were asked whether they were currently 
taking vitamins or, in the case of a miscarriage, whether they had taken vitamins during 
pregnancy. Information about the frequency and timing of vitamin use in an average week was 
also obtained. Participants who reported any use of vitamins during pregnancy were considered 
exposed.  
Variable definition for pregnancy intention 
We were also interested in the potential interaction between race and pregnancy 
intention. Pregnancy intention was defined based on criteria from the National Family Growth 
Survey (NFGS) for unplanned pregnancies.
88
 Pregnancy intention was coded as a yes/no variable 
for these analyses. Intended pregnancies include pregnancies that were planned. Unintended 
pregnancies include both mistimed and unwanted pregnancies. Pregnancy intention was based on 
the following questions from the first-trimester interview: FTG7 (contraception and planning at 
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time of conception), FTE4(a)(contraception use (yes/no)), FTG13(pregnancy timing) and 
FTG12(wanted pregnancy (yes/no)). A list of pregnancy intention questions from the first-
trimester interview and their respective responses can be found in the appendices (Appendix 
3.3). Women who did not answer, refused to answer or listed did not know to any of the above 
questions in the first-trimester interview were not assessed for pregnancy intention based on the 
criteria listed below (n=552). Briefly, a pregnancy was considered intended if the woman 
stopped using contraception or had not used contraception because she wanted to become 
pregnant and the pregnancy occurred at about the right time, later or didn’t care when in her life 
(FTG13= either later, right time or didn’t care when). A pregnancy was considered mistimed if 
the woman stopped using contraception or had a gap in contraception use and she became 
pregnant too soon (FTG13=too soon) or if the woman was still using contraception and became 
pregnant too soon but wanted to have another baby eventually (FTG12= yes). A pregnancy was 
classified as unwanted if the woman became pregnant while using contraception and did not 
want to have another baby at any time in the future (FTG12=no).  A more detailed description of 
the pregnancy intention variable and its classification can be found in chapter 3 (Table 3-11). 
Among women with pregnancy losses, GAAD and the GAAD gap were estimated for 285 
intended and 96 unintended pregnancies.  
Statistical analysis 
Descriptive statistics and subsequent analyses were generated using SE/12.1 software 
(StataCorp LP, College Station, Texas). Descriptive statistics were expressed as frequencies and 
proportions for categorical variables and means and standard deviations for continuous variables, 
stratified by race. We further examined developmental stage at ultrasound by race and report the 
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overall distribution of GAAD gap by race and pregnancy intention. A Wilcoxon rank-sum test 
was used to compare the medians between groups.   
We used Cox proportional hazard survival models with variable gestational age at study 
entry to estimate the risk of miscarriage associated with early pregnancy exposures (i.e. smoking 
(current or former vs. never); and vitamin use(any vs. none)).  Participants were followed from 
the time of enrollment in the study and contributed to the analysis until an outcome of either 
miscarriage, birth or stillbirth occurred or loss to follow-up happened. Gestational age at the time 
of loss was calculated from the first day of a woman’s self-reported LMP for the index 
pregnancy to the end of that gestation (herein referred to as the LMP method to estimate 
gestational age at loss). Cox models using LMP method were used to screen for candidate 
confounders and to test for effect modification by race. For each level of the exposure status, we 
tested effect modification by race unadjusted for confounders using a likelihood ratio test using 
the LMP method. Race stratified analyses were only presented if these tests suggested 
heterogeneity present (p<0.10). Additionally, we used a likelihood ratio test to test the 
contribution of a race and pregnancy intention interaction within our model. If the likelihood 
ratio test had a p-value<0.10, the race-pregnancy intention interaction term was retained in our 
final models. Schoenfeld residuals were also tested to assess the proportionality of hazards for 
the final Cox model (results not shown). The Breslow method was used to handle ties.  
Potential confounders examined from baseline and the first-trimester interviews included 
factors known to be associated with both miscarriage and exposure of choice.  Race was not 
considered as a confounder in stratified models, but was assessed as a potential confounder in the 
non-stratified models. A change in estimate of at least 10% was used to classify a variable as a 
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confounder in non-stratified models. Similarly, in race stratified models if a 10% change in 
estimate was observed in either Blacks or Whites, the variable was considered a confounder. 
Candidate confounders for smoking and miscarriage relationship included maternal age, 
household income, maternal education, marital status, maternal race, parity, alcohol use and 
pregnancy intention. Candidate confounders for vitamin use and miscarriage relationship 
included the above factors with the addition of smoking.  If a 10% change was observed from the 
crude hazard ratio, the variable was retained in the final models. To optimize fit, maternal age 
was specified by the inclusion of linear and quadratic terms in the model. We did not consider 
prior history of miscarriage as a confounder in our data because we would be potentially 
overadjusting by including a causal factor for current risk.
80
 Analysis was restricted to those with 
complete covariate information. We used similar adjusted Cox regression models using 
gestational age estimated based on GAAD (herein referred to as the GAAD method) for overall 
risk for miscarriage with early pregnancy exposures.  
Finally in order to assess the potential magnitude of bias in our risk estimates for 
miscarriage we conducted 1000 bootstrap replications to estimate the bias ratio and 95% 
confidence interval between either model. The bias ratio was defined as the ratio between the 
two models (i.e. bias ratio= 
adjusted HR ratio of LMP model
adjusted HR ratio of GAAD model
) for either exposure and miscarriage 
risk and described previously (refer to Chapter 5).  
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Results 
Nearly 21% of participants self-identified as Black (n=1,006) (Table 6-21). Twenty-
seven percent of the women in our cohort were recruited prior to pregnancy (n=1,341) and the 
majority had ultrasound information. Compared with White women, Black women were more 
likely to be younger, to have a higher body mass index (≥30 kg/m2), to have income <$80,000, 
not to have a college degree, to be unmarried, to be parous (>1). Additionally, Blacks were more 
likely than Whites to self-report an unintended pregnancy and to have had prior history of 
adverse pregnancy outcomes, including prior history of stillbirths, preterm births and induced 
abortions. In terms of behaviors during pregnancy, Blacks were more likely to abstain from 
alcohol and tobacco products during pregnancy, but were more likely to not use vitamins 
compared to Whites. Mean gestational age at the time of enrollment was later for Blacks (7.8 
weeks) than for Whites (6.1weeks) (Table 6-21).  
There were 624 miscarriages observed. Among women with miscarriages, over seventy 
percent had ultrasound data available (Whites 71%, Blacks 76%). Ultrasound characteristics did 
not differ by race (Table 6-22). Anembryonic gestation was observed in over a third of all 
miscarriages with recorded ultrasound information (39.7% Whites, 35.6% Blacks). The median 
gestational age at loss based on self-reported LMP was nearly a week and half earlier for Whites 
than for Blacks (median LMP Whites 68 days, Blacks 79.5 days; p=0.0000), and was earlier for 
women with intended pregnancies than women with unintended pregnancies (median LMP 
intended pregnancies 69 days, unintended pregnancies 76 days; p=0.0001) (Table 6-23). The 
median estimated GAAD for women with pregnancy loss and ultrasound information was also 
earlier for Whites compared to Blacks (median GAAD Whites 54 days, Blacks 60 days; 
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p=0.0002) and for women with intended pregnancies compared to unintended pregnancies 
(median GAAD  intended pregnancies 54 days, unintended pregnancies 59 days; p=0.0023). The 
median GAAD gap was similar by race (Whites 19 days, Blacks 21 days; p=0.04) and pregnancy 
intention (intended pregnancies 18 days, unintended pregnancies 22 days; p=0.08) (Table 6-23). 
We did not find evidence of effect modification by maternal race for the association between 
smoking and risk of miscarriage (LR test race p=0.34 from LMP method). Additionally, the 
interaction term between race and pregnancy intention did not contribute substantially to the 
model for smoking and miscarriage risk (LR test race and pregnancy intention p=0.31 from LMP 
method). After assessing for potential confounders for inclusion, the final model was adjusted for 
maternal age and alcohol use. Overall results for smoking-miscarriage risk relationship, 
including assessing the magnitude of bias have been previously presented and are not reported 
here (refer to Chapter 5, Table 5-19).  Proportional hazards test suggest that proportional hazard 
assumptions for risk of miscarriage associated with smoking are not violated using either method 
(adjusted [global] model LMP method p=0.22, GAAD method p=0.09) (results not shown).  
We observed effect modification by race for the effect of vitamin use on miscarriage risk 
(LR test for race p=0.06 from LMP method), however the interaction between race and 
pregnancy intention did not contribute substantially to the model (LR test for race and pregnancy 
intention p=0.16 from LMP method) and was not included (Table 6-24). For our stratified 
models, race was not considered as a confounder. Final models for the relationship between 
vitamin use and miscarriage risk were stratified by race and adjusted for age. The protective 
effect of overall vitamin use on miscarriage risk was stronger among White women than Black 
women when using the LMP method (Whites aHR=0.34,  95% CI [0.21, 0.54]; Blacks 
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aHR=0.53, 95% CI [0.33, 0.84]), while no substantial difference by race was observed using the 
GAAD method (Whites aHR=0.43,  95% CI [0.24, 0.76]; Blacks aHR=0.44, 95% CI [0.26, 
0.74]) (Table 6-24).  
We conducted a thousand replication bootstrap analyses of our two models to compare 
the ratio of effect sizes (i.e. the bias ratio). The overall magnitude of bias was nearly twenty 
percent for both Whites and Blacks (Whites bias ratio=0.79, 95% CI [0.62, 0.87]; Blacks bias 
ratio=1.19, 95% CI [1.13, 1.45]), although it occurred in different directions (Table 6-25). 
Compared to GAAD models, which present effect estimates based on improved classification of 
gestational age at loss, the LMP model overestimated the protective effect of vitamin use on 
miscarriage risk for Whites, and underestimated the protective effect for Blacks. Similar 
magnitude of bias was demonstrated with consistency of vitamin use for women taking vitamins 
≥5 times per week (Whites bias ratio=0.78, 95% CI [0.62, 0.88]; Blacks bias ratio=1.15, 95% CI 
[1.07, 1.45]) (Table 6-25). 
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Discussion  
We have demonstrated that risk of miscarriage associated with vitamin use differs by race 
when self-reported LMP is used to estimate gestational age. However by properly classifying 
gestational age at loss, we observed no difference in the effect of vitamin use between Whites 
and Blacks. We observed no such differences in miscarriage risk by race for early pregnancy 
smoking exposure. No differences in developmental stage on ultrasound by race or influence of 
pregnancy intention by race were observed. For both Blacks and Whites, vitamin use 
significantly protects against miscarriage risk for women in this cohort using either model to 
estimate gestational age (i.e. LMP or GAAD), with the strongest effects seen in women taking 
vitamins <5 times per week. However, we further demonstrate that the magnitude of bias 
introduced in these estimates is nearly twenty percent and occur in opposite directions for Blacks 
and Whites. These results suggest that the protective effect of vitamin use on miscarriage risk 
may be overestimated for Whites and underestimated for Blacks within this prospective 
pregnancy cohort. The patterns of bias (i.e. overestimating the protective effect of vitamin use 
for Whites and underestimating the protective effect for Blacks) remain when accessing 
frequency of vitamin use. These results suggest that the effect of early-pregnancy vitamin use 
associated with miscarriage risk is influenced by proper classification of gestational arrest prior 
to loss, and that the direction of bias differs by race while the magnitude is similar.  
Of note, we found important demographic differences between participants who self-
identified as Black compared to women who self-identified as White, suggesting that the results 
shown here may partly represent a collection of lifestyle factors related to preconception access 
to care, pregnancy planning, and self-selection into our study. For example, pregnancy intention 
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is an important indicator of a woman’s readiness to bear a child, her mental and physical health, 
and her sociodemographic context.
5
 While Black women were more likely to indicate unintended 
pregnancies in our cohort compared to White women, the interaction between race and 
pregnancy intention was not significant in our models. We further illustrate that the GAAD gap 
was greater for women with unintended pregnancies compared to women with intended 
pregnancies. This suggests that women with unintended pregnancies have greater variability in 
their GAAD estimates based on developmental stage at ultrasound and may be less sure of their 
LMP dates when compared to women with intended pregnancies. Although preventing 
unintended pregnancies remains an important public health concern, understanding underlying 
contributors to unwanted and mistimed pregnancies may help explain concurrent risk factors 
associated with adverse pregnancy outcomes.
5,6
  
This study examined the overall relationship between vitamin use and miscarriage risk, 
not the effect of specific supplement components, such as folic acid.
8,61,72,74,76
 We may be 
measuring a proxy for other health-conscious or preventative behaviors that are related to 
vitamin supplementation during pregnancy.
73
 Future studies would benefit from the inclusion of 
both biologic and self-reported information on vitamin use. Finally, more consistent vitamin use 
was associated with a hazard ratio slightly closer to the null compared to less frequent use for 
both Blacks and Whites. This appears counterintuitive, but it could occur if women who are 
more vigilant about daily vitamin supplementation are at higher risk of miscarriage than women 
who are not as attentive to taking their daily vitamin. These results remain consistent with 
previously published work on vitamin use within RFTS cohort.
73
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One potential limitation within this cohort is that gestational age was estimated based on 
measurements from a single ultrasound. However by taking cross-sectional ultrasound 
information we have the ability to estimate probable developmental stage prior to miscarriage 
and have a better way to classify time at loss than self-reported LMP. Other limitations may 
include collection of data in first-trimester interview in relation to pregnancy loss. However, on 
average the interval between loss and first-trimester interview was less than 3.5 weeks, and the 
questions in the interview were clearly asking about behaviors during their recent pregnancy. 
The primary strength of our study is our ability to follow a large diverse sample of 
women recruited from the community prospectively through their pregnancies, many of whom 
were enrolled prior to pregnancy.
3
 RFTS is a community-based pregnancy cohort. Clinic-based 
studies may be demographically different from population-based studies, and may overestimate 
the occurrence of adverse outcomes.
108
 We believe our results can be informative for pregnant 
women, and women planning pregnancies in the United States.  In addition, we were able to 
evaluate potential confounders and analyze the data with hazard models that account for 
variation in gestational age at study entry. Furthermore, women do not alter prenatal care choices 
in order to enroll in RFTS, and therefore it is unlikely that enrollment procedures and study 
activities influenced behaviors or outcomes within this population. 
Although we have documented no overall effect for miscarriage risk due to smoking 
exposure by race, we show evidence for racial differences in vitamin use during pregnancy when 
self-reported LMP is used to estimate gestational age. We observed that Blacks were less likely 
to take vitamins compared with Whites, and there were significant racial differences in 
miscarriage risk due to vitamin exposure. We have demonstrated that in this cohort traditional 
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models that use self-reported LMP to estimate gestational age, race modifies that association 
between vitamin use and miscarriage risk. However no modification by race is observed when 
gestational age was estimated using GAAD for risk of miscarriage with vitamin use. We 
illustrate that misclassifying time at loss in studies of miscarriage results in biased risk estimates 
when stratified by race in direction of effect but not magnitude of effect. In other words, by 
misclassifying time at loss, we have artificially introduced effect modification by race for risk of 
miscarriage associated with vitamin use. These data may help to explain the inconsistent findings 
across studies of miscarriage risk associated with vitamin use. By properly classifying 
gestational arrest prior to loss, effect modification by race disappears for the vitamin use 
miscarriage association. Further investigation is warranted to examine if the protective effect of 
vitamin use on miscarriage risk remains consistent when assessing self-reported information on 
vitamin use with biologic assessment of vitamin supplementation. 
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Table 6-21. Characteristics by race of Right from the Start participants, 2000–2012 
 
RFTS Study Participants
 
Whites 
N=3,897 (79.5%) 
Blacks  
N=1,006 (20.5%) 
Mean (SD) No. % Mean (SD) No. % 
Maternal age, years 29.7 (4.6)   26.6 (5.7)   
Maternal age, years       
 <20  60 1.5  92 9.2 
 20–24  404 10.4  331 32.9 
 25–29  1,420 36.5  280 27.8 
 30–34  1,411 36.2  202 20.1 
 ≥35  601 15.4  101 10.0 
 Missing  1   0  
Body mass index
a
 25.0 (5.5)   29.3 (7.9)   
Body mass index       
 Underweight (<18.5)  109 2.8  19 1.9 
 Normal weight (18.5–24.9)  2,284 59.4  306 31.0 
 Overweight (25.0–29.9)  861 22.4  274 27.7 
 Obese (≥30.0)  594 15.4  389 39.4 
 Missing  49   18  
Household income       
 ≤$40,000  720 19.8  558 62.4 
 $40,001–$80,000  1,528 41.9  226 25.3 
 >$80,000  1,395 38.3  110 12.3 
 Missing  254   112  
Maternal education       
 High school or less  386 9.9  388 38.6 
 Some college  587 15.1  282 28.0 
 College (≥4 years)  2,923 75.0  336 33.4 
 Missing  1   0  
Marital status       
 Married, living as married, 
single 
 3,714 95.3  649 64.5 
 Other  183 4.7  357 35.5 
 Missing  0   0  
Pregnancy Intention       
 No  788 22.5  439 51.9 
 Yes  2,718 77.5  407 48.1 
    Missing  392   160  
Gestational age at enrollment, 
weeks 
6.6 (1.8) 6.3
b
  7.8 (2.1) 7.7
b
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RFTS Study Participants
 
Whites 
N=3,897 (79.5%) 
Blacks  
N=1,006 (20.5%) 
Mean (SD) No. % Mean (SD) No. % 
Pregnant at time of recruitment 
 No  1,217 31.2  124 12.3 
 Yes  2,680 68.8  882 87.7 
 Missing  0   0  
Parity       
 Nulliparous  1,785 48.2  423 45.3 
 1  1,328 35.9  284 30.4 
 ≥2  589 15.9  226 24.2 
 Missing  195   73  
Previous miscarriage       
 No  2,894 78.2  700 75.0 
 Yes  808 21.8  233 25.0 
 Missing  195   73  
Recurrent miscarriage
c
       
 No  725 89.7  212 91.0 
 Yes  83 10.3  21 9.0 
 Missing  0   0  
Previous preterm birth       
 No  3,430 92.7  820 87.9 
 Yes  272 7.3  113 12.1 
 Missing  195   73  
Previous stillbirth       
 No  3,670 99.1  909 97.4 
 Yes  32 0.9  24 2.6 
 Missing  195   73  
Previous induced abortion       
 No  3,273 88.4  676 72.5 
 Yes  429 11.6  257 27.5 
 Missing  195   73  
Vitamin use       
 No  61 1.7  113 11.7 
 Yes  3,639 98.4  851 88.3 
 Missing  197   42  
Smoking       
 Never  2,645 71.3  763 79.0 
 Current   128 3.4  45 4.6 
 Former  938 25.3  158 16.4 
    Missing  186   40  
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RFTS Study Participants
 
Whites 
N=3,897 (79.5%) 
Blacks  
N=1,006 (20.5%) 
Mean (SD) No. % Mean (SD) No. % 
Alcohol use       
 Never  381 10.3  217 22.5 
 Current   248 6.7  11 1.1 
 Former  3,081 83.0  737 76.4 
    Missing  187   41  
Age of menarche, years 12.7 (1.5)   12.4 (1.9)   
Age of menarche, years       
 ≤ 10  182 5.0  137 14.3 
    11-13  2,568 70.0  589 61.4 
 >13  921 25.0  234 24.3 
 Missing  226   46  
Current outcome miscarriage       
 No  3,409 87.5  870 86.5 
 Yes  488 12.5  136 13.5 
 Missing  0   0  
Has study ultrasound       
 No  190 4.9  76 7.6 
 Yes  3,707 95.1  930 92.4 
 Missing  0   0  
Site       
    North Carolina  2,253 57.8  519 51.6 
    Tennessee  1,492 38.3  397 39.5 
    Texas  152 3.9  90 8.9 
Abbreviations: No., number; SD, standard deviation. 
a
 Body mass index: weight (kg)/height (m)
2
. 
b 
Median for gestational age at enrollment.  
c
 Only among women who experienced a prior miscarriage 808 Whites and 233 Blacks.  
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Table 6-22. Ultrasound characteristics by race for women who experienced miscarriage within Right from the Start, 2000-2012  
  
RFTS Study Participants with 
Miscarriage 
  Whites (n=488)  Blacks (n=136) 
Ultrasound 
Developmental Stage 
Ultrasound 
Characteristics 
No. of 
Losses 
% of 
Loss  
No. of 
Losses 
% of 
Loss 
Loss before Ultrasound N/A 140 N/A  32 N/A 
Anembryonic gestation       
 Empty uterus  23 6.6  11 10.6 
 Gestational sac only  57 16.4  12 11.5 
 Gestational and yolk sac 58 16.7  14 13.5 
Fetal pole present       
 No fetal heart rate 68 19.5  22 21.2 
 Abnormal fetal heart rate  21 6.0  7 6.7 
 Normal fetal heart rate 121 34.8  38 36.5 
Abbreviations: No., number; N/A., not applicable   
  
145 
 
 
Table 6-23. Estimating gestational age of pregnancy loss based on self-reported LMP and GAAD by race and pregnancy intention 
among women who experienced miscarriage within Right from the Start, 2000-2012 
    RFTS Study Participants with Miscarriage 
 LMP (days)  GAAD (days)
 a
  GAAD gap (days)
 a
 
Estimated gestational age at 
Loss Mean (sd) Median  Mean (sd) Median  Mean (sd) Median 
Race         
   Whites 68.8 (20.6) 68  56.0 (13.8) 54  18.6 (13.4) 19 
   Blacks 81.5 (26.1) 79.5  65.2 (22.2) 60  21.7 (19.4) 21 
Pregnancy Intention
b
          
   No  79.1 (24.5) 76  63.5 (19.0) 59  21.5 (16.2) 22 
   Yes 68.9 (19.7) 69  56.3 (14.0) 54  18.7 (14.3) 18 
         
Abbreviations: LMP, last menstrual period; GAAD, gestational age at arrest of development; sd, standard deviation.   
a
GAAD estimated among losses with complete ultrasound data, 344 White and 103 Black losses (4 White women and 1 Black woman 
had ultrasounds, but were missing both mean sac diameter and crown-rump length measurements);  
b
Among women who self-identified as either White or Black and had complete data on pregnancy intention (96 Unintended pregnancy 
losses and 285 Intended pregnancy losses).  
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Table 6-24. Models for miscarriage risk associated with vitamin exposure stratified by race, within Right from the Start, 2000-2012 
 
Abbreviations: No., number; LMP, last menstrual period; GAAD, gestational age at arrest of development; aHR, 
adjusted hazard ratio; CI, confidence interval. 
a
Models for vitamin use adjusted for age(quadratic).  
b
P values from likelihood ratio test of unadjusted models using LMP method to assess for  
effect modification by race.  
c
Vitamins per week missing for 5 women (Whites 1, Blacks 4).  
Vitamin use exposure  
No. 
Adjusted       
Model 1:      
LMP method
a
 
Adjusted 
Model 2:               
GAAD method
a
 P
b
 
 aHR 95% CI aHR 95% CI  
Race x vitamin use interaction       0.060 
Race x pregnancy interaction   0.160 
Whites
 
       
  Vitamin use 
 
       
 No 61 1.0 Referent 1.0 Referent  
 Yes  3,639 0.34 0.21, 0.54 0.43 0.24, 0.76  
  Consistency of vitamin use
c
       
 No vitamin use   1.0 Referent 1.0 Referent  
 <5 times per week  327 0.26 0.14, 0.46 0.35 0.17, 0.71  
 ≥ 5 times per week 3,311 0.34 0.21, 0.55 0.43 0.24, 0.77  
Blacks       
  Vitamin use        
 No 113 1.0 Referent 1.0 Referent  
 Yes  851 0.53 0.33, 0.84 0.44 0.26, 0.74  
  Consistency of vitamin use
c
       
 No vitamin use   1.0 Referent 1.0 Referent  
 <5 times per week  111 0.27 0.11, 0.63 0.11 0.03, 0.40  
 ≥ 5 times per week 736 0.55 0.35, 0.89 0.48 0.29, 0.81  
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Table 6-25. Bootstrap analysis bias ratio for risk of miscarriage associated with vitamin 
exposure, stratified by race in Right from the Start, 2000–2012 
Vitamin exposure  
Model comparison  
Magnitude of bias  
Bias Ratio
 a
 
 aHR (LMP model) 
aHR (GAAD model) 95% CI 
Whites
 
   
  Vitamin use 
 
   
 Yes  0.79 0.62, 0.87 
  Consistency of vitamin use   
 <5 times per week  0.73 0.63, 0.74 
 ≥ 5 times per week 0.78 0.62, 0.88 
Blacks   
  Vitamin use    
 Yes  1.19 1.13, 1.45 
  Consistency of vitamin use   
 <5 times per week  2.25 0.93, 2.56 
 ≥ 5 times per week 1.15 1.07, 1.45 
Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval 
a
 Bias Ratio:
aHR LMP model 
aHR GAAD model 
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Figure 6-9. Aim 3: Study subject inclusion criteria 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total number of subjects in dataset with Last 
Menstrual Period (LMP) before May 5, 2012.   
n=6,105 
First Pregnancies Only 
n=5,772 
Term pregnancies and pregnancy loss  
n=5,513 
Exclude Multiple Enrollees (n=333) 
Exclude other or unknown pregnancy outcomes (n=259) 
 Induced Abortion (n=17) 
 Ectopic/Molar/Other pregnancy outcome (n=11) 
 Missing pregnancy outcome status (n=231) 
 
Outcomes of interest among Whites and Blacks in RFTS 
n=4,903 
 Term pregnancy [≥ 20 weeks gestation] (n=4,279) 
o Live births(n=4,253) 
o Stillbirths (n=26) 
 Pregnancy loss [< 20 weeks gestation] (n=624) 
 
Exclude Other or missing race (n=610) 
 Hispanic (n=361) 
 Other (n=240) 
 Missing (n=9) 
 Missing pregnancy outcome 
status (n=231) 
 
Term pregnancies (n=4,279)  
 Whites (n=3,409) 
 Blacks (n=870) 
Pregnancy loss (n=624)  
 Whites (n=488) 
 Blacks (n=136) 
Exclude pregnancy losses 
prior to ultrasound (n=172)  
 Whites (n=140) 
 Black s (n=32) 
Pregnancy loss with ultrasound in which 
GAAD can be estimated n=447 
 Whites (n=344) 
 Blacks (n=103) 
Missing ultrasound 
measurements (n=5) 
 Whites (n=4) 
 Blacks (n=1) 
Pregnancy loss with 
ultrasound n=452 
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CHAPTER VII  
CONCLUSIONS AND FUTURE DIRECTIONS 
Overall study conclusions  
We were able to establish that there is on average nearly a three week gap between 
gestational arrest and clinical manifestation of loss based on self-reported LMP within a large 
diverse community-based pregnancy cohort. Both Blacks and Whites within RFTS exhibited 
similar trends of developmental stage at loss observed on ultrasound. Nearly 40% of losses had 
anembryonic development at time of ultrasound (i.e. empty uterus, gestation sac only, or 
gestational and yolk sac only; n= 197). The GAAD gap did not differ by most key characteristics 
between those with longer vs. shorter than median GAAD gaps. We were able to demonstrate 
that the gap was greater for Blacks compared to Whites (median GAAD gap 21 and 19 days 
respectively).  Overall this gap biased risk estimates up to 15% for current smokers and 5% of 
former smokers when compared to LMP models. When stratified by race, the bias was nearly 
20% for both Whites and Blacks for miscarriage risk associated with early pregnancy vitamin 
exposure but occurred in opposite directions. This implies that the protective effect of vitamin 
use on miscarriage risk may be overestimated for Whites while a similar protective effect may be 
underestimated for Blacks. We illustrate that effect modification by race disappears for vitamin 
use miscarriage relationship when gestational arrest is properly classified. These results suggest 
that early-pregnancy exposures associated with miscarriage risk are influenced by proper 
classification of gestational arrest prior to loss, and that the direction of bias differs by race, 
while the magnitude was similar.  
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We successfully demonstrate that it is possible for researchers to more accurately identify 
timing of miscarriage prior to clinical pregnancy loss which traditionally use self-reported LMP 
to estimate gestational age and to set aside exposures that occur after developmental arrest but 
before clinical loss and which would not contribute exposure-time when assessing miscarriage 
risk. Next steps for this analysis include assessing time-varying exposures on miscarriage risk 
using GAAD models, and also assessing if the GAAD gap is as large in other pregnancy cohorts 
which have robust miscarriage data and early first-trimester ultrasound data available.  
Study strengths    
Our study has several strengths. RFTS has prospective data collection to assess 
miscarriage risk and improve documentation of exposures and gestational dating. Because 
participants enroll in RFTS very early in pregnancy, we are able to observe a greater proportion 
of pregnancy losses in our study population than if prenatal clinic-based recruitment occurred. 
Community-based recruitment which encompassed women who ultimately sought care in a full 
range of settings, many of whom were not yet engaged in prenatal care at the time of enrollment, 
providing a study population potentially more representative of the general population of women 
trying to conceive than clinic based populations. Women who seek care at academic tertiary care 
centers may be less representative than the general population of women trying to conceive, and 
onset of care is typically later than our enrollment criterion required. Early recruitment also 
provided earlier capture of both covariates and outcomes for use in multivariable models. Prior 
work has shown that clinic-based samples may be demographically different from population-
based samples.
108
 Analyses based on clinical samples may overestimate the occurrence of 
adverse outcomes. Furthermore RFTS avoids overselection of women who may be subtly 
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symptomatic or at high risk by advertising as a study about pregnancy health. RFTS participants 
did not have to alter prenatal care choices for entry into the study; thus, I believe it is unlikely 
that our enrollment procedures and study activities will influence our results. 
RFTS participants have routine study ultrasounds conducted by trained study 
sonographers early in pregnancy; thus, gestational age assignment is accurate in early pregnancy 
and fetal viability can be confirmed. Ultrasound information is available on over 70% of women 
who have miscarriage as an outcome. Additionally, a high proportion of pre-pregnant women 
and those in early pregnancy were enrolled in RFTS. Twenty-six percent of women in our cohort 
were recruited prior to pregnancy (n=1,468). All women in our cohort entered before the end of 
the first-trimester with the median at 10 weeks estimated gestational age based on self-reported 
LMP.  
Furthermore our analysis will provide models that properly reflect total time at risk and in 
view. A study on miscarriage requires careful assessment of gestational time at study entry 
because women who enter a study later will have less opportunity for a pregnancy loss to be 
observed. Only the first phase of RFTS enrollment allowed women to enter the study later than 
the ninth week. Another strength of RFTS is that we can accurately time the occurrence of events 
and exposures in pregnancy in models. Detecting pregnancy loss depends markedly on timing of 
pregnancy recognition (i.e. the earlier it is recognized, the higher the proportion that will result in 
miscarriage). With each recruitment phase, there were increasing proportions of women recruited 
prior to pregnancy because the gestational age at study entry was lower. In RFTS, the proportion 
of miscarriage was greater for women recruited before pregnancy compared to women already 
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pregnant at enrollment (15.4% vs. 11.6%). This allows us to observe more losses, including 
identifying gestational arrest prior to miscarriage.  
Potential limitations of study  
This dissertation aims to better understand gestational arrest prior to loss and the impact 
of bias this may have on risk for miscarriage. This research is the first step in addressing 
different outcomes for miscarriage in the context of gestational arrest (i.e. biological arrest 
compared to clinical loss based on LMP).  An ideal study would address both time-varying 
nature of the outcome (e.g. gestational arrest vs. clinical loss) as well as time-varying nature of 
exposure status during the early pregnancy period. 
This first-step provides a better measurement tool to estimate timing of miscarriage 
outcome. Both a protective factor (e.g. vitamin use) and risk factor (e.g. smoking) were chosen to 
assess this new method for estimating GAAD. These putative factors have been well established 
in literature, described in detail within this cohort, and are associated with miscarriage risk. 
These factors serve as a tool to assess our method and the impact of bias these may have on 
effect estimates associated with pregnancy loss. It is possible that other time-varying exposures, 
for example time-varying exposures that have a high (e.g. alcohol use) or low (e.g. illicit drug 
use) cumulative risk in early pregnancy, or a time-varying exposure that is established in 
literature and known not to affect miscarriage risk (e.g. caffeine use) could have served as 
alternative factors to assess our GAAD method. But my objective was to choose exposures in 
which an effect was established and significant and that were well captured well within RFTS to 
determine if effect estimates change appreciably with new GAAD method.  
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One potential limitation is that gestational age will be estimated based on measurements 
from a single ultrasound visit. However by taking cross-sectional ultrasound information with 
the ability to estimate growth provides an opportunity to estimate probable developmental state 
prior to miscarriage. This can help researchers to more accurately identify which insults have 
occurred prior to pregnancy loss and assess exposures that occur after developmental arrest but 
before the onset of bleeding by not attributing inaccurate exposure time for these exposures.  
Miscarriage was defined based on participant self-report, either based on the day of 
dilatation and evacuation or the day of heaviest bleeding for each woman. Although this was the 
best measure for time of miscarriage available for this project when assessing estimated 
gestational age based on self-reported LMP, this was not a proxy for exact time of embryonic 
demise. We were unable to know the exact time of embryonic demise from the available data for 
women who have normal or abnormal ultrasounds and subsequently go on to miscarry.  An ideal 
study would have repeated ultrasound measures on each subject with a known time of initiation 
until date of loss is detected by ultrasound. However, factors including cost and participant 
burden make such studies difficult and expensive to conduct. A similar study that determines 
developmental state and measures developmental progress variables at one time point could use 
our analysis approach to assess exposure-time misclassification and influence on miscarriage risk 
for risk factors associated with pregnancy loss. 
Another potential limitation is the generalizibility of our findings may be limited by the 
enrollment of subjects. While this study population includes a prospective cohort of women in 
order to study risk factors associated with miscarriage, limitations include the inability to define 
the exact population base of women that is theoretically eligible to be in the study within these 
154 
 
 
communities. RFTS emphasizes community-based recruitment among women who are planning 
a pregnancy. However, women who choose to enroll in a study for early pregnancy health may 
be different than the general population of women trying to get pregnant, potentially leading to 
selection bias into the study. Participants in RFTS tend to be better educated, more health 
conscious with lifestyle factors related to pregnancy planning and have access to care before 
pregnancy.
73
 Given that nearly a third of Black women in RFTS have at least four years of 
college, our sample might be expected to be at a lower risk of miscarriage than Blacks in the 
general population. However, despite this possibility which would attenuate affects, we have 
observed a clear elevation in risk for miscarriages occurring after the tenth week for Blacks in 
our cohort,
2
 but not a difference in timing of gestational arrest. Furthermore, we demonstrated 
that race-stratified estimates in risk of loss associated with vitamin use have a magnitude of bias 
of nearly twenty percent for both Whites and Blacks. However, the bias occurs in opposite 
directions, suggesting that the protective effect of vitamin use  may be overestimated for Whites 
while a similar protective effect may be underestimated for Blacks. With proper classification of 
gestational arrest prior to loss, effect modification by race disappears for the vitamin use 
miscarriage association. This suggests that by misclassifying time at loss we can artificially 
introduce effect modification by race, which does not exist if gestational arrest is properly 
classified. 
Study implications  
This research proposes a novel methods assessment for gestational arrest prior to loss. I 
am aware of no prior studies that have addressed timing of loss in the context of gestational 
arrest using early first-trimester ultrasound information. Research that gives insight to the 
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mechanisms operating during early pregnancy is useful, especially since this time period in 
pregnancy is not well understood. Miscarriage is a common adverse pregnancy outcome 
occurring frequently in early pregnancy. The timing of loss can help to differentiate distinct 
mechanisms of loss.
89
 For example, chromosomal abnormalities have been observed in at least 
half of all pregnancy losses occurring in the first trimester, but represent a higher fraction of 
early losses than of later losses.
57
    
Early fetal growth is important both in epidemiologic studies and clinical settings when 
related to reproductive outcomes such as miscarriage. Development may stop days to weeks 
prior to the onset of clinical recognition of miscarriage. Basing pregnancy loss on the time from 
LMP to clinical recognition of loss ignores the developmental state of the fetus prior to the loss. 
Nearly 40% of pregnancy losses have anembryonic gestation when assessed by early first-
trimester ultrasound.
2
 This results in inappropriate exposure time for common risk factors in 
early pregnancy.  This research provides insight into our foundational understanding of the 
timing of miscarriage and in particular the challenge of accurate and early exposure assessment 
during early pregnancy.  
Furthermore, I have elaborated differences in the timing of miscarriage between Blacks 
and Whites by using ultrasound data from a diverse prospective community-based cohort. 
Retrospective data (from medical records or self-report) used to assess miscarriage risk is often 
times incomplete, due to under-ascertainment of early pregnancy loss. Prospective data can 
provide the most accurate estimates of miscarriage risk, especially if women are enrolled early in 
their pregnancy, since we may be able to identify pregnancies that arrest prior to symptoms of 
miscarriage. There are significant racial and ethnic disparities observed in other adverse 
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pregnancy outcomes that may have origins in early pregnancy, such as events like placentation. 
Such research has potential to advance overall knowledge about causes of pregnancy loss and to 
help to identify risks that may be preventable when differentially distributed by race.   
Future directions 
Next steps in analysis of GAAD and timing of loss could include assessing the influence 
of time-varying exposures such as over-the counter medication use, or anti-depressant use in 
early first-trimester both of which have been associated with increased miscarriage risk. By more 
accurately identifying which insults have occurred prior to pregnancy loss and assessing 
exposures that occur after developmental arrest but before the onset of bleeding we will have 
more optimal method to assess miscarriage risk by not misattributing exposure time. Additional 
steps may also include estimating GAAD and the GAAD gap in other cohorts that have early 
ultrasound data available and include women who experience miscarriage. Since the risk of 
miscarriage diminishes with increasing gestational age, more prospective studies that accurately 
date gestational age are needed, even in cases where LMP dates are certain and when early 
ultrasound assessment is not always feasible.   
Furthermore, we know that first-trimester fetal growth is not uniform. Variation in fetal 
growth in the early first-trimester may be a result of may many maternal factors, such as race, 
age, smoking history, BMI or vaginal bleeding.
18
 The determinants of growth of the early 
embryo need to be explored to assess whether potentially modifiable maternal factors, such as 
obesity and smoking, affect growth and subsequent pregnancy outcomes. If high risk pregnancies 
and associated factors can be identified with high sensitivity and specificity, by assessing very 
157 
 
 
early pregnancy growth, then early interventions, such as lifestyle changes, including before 
conception, may potentially influence the course of the pregnancy. 
Additionally, further research is needed for determining biologically plausible disparities 
in miscarriage risk. The elevated risk in fetal loss in Blacks compared to Whites may involve a 
variety of plausible causal pathways including differences in environmental or product exposures 
that accrue over weeks across a pregnancy, risk of insult from health vulnerabilities such as 
anemia or insulin resistance that vary by race and exert greater influences on fetal rather than 
embryological viability or genetic mechanisms such as inflammatory or immunological 
pathways that may vary by race and influence fetal well-being. Such research has the potential to 
advance overall knowledge on the causes of pregnancy loss and help identify risks that may be 
preventable.  
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APPENDIX 
Appendix 1. Defining common reproductive terminology 
Term  Definition  
Miscarriage terms  
Blighted ovum anembryonic gestation characterized by a normal-
appearing gestational sac but absence of an embryo 
 
Spontaneous 
abortion  
miscarriage, loss of pregnancy before 20 completed weeks of 
gestation  
 
Threatened abortion  first-trimester pregnancy that demonstrates uterine bleeding 
and/or cramping  
 
Recurrent 
miscarriage  
occurrence of three or more pregnancies that end in 
miscarriage 
  
Early pregnancy loss  pregnancy loss before 10 completed weeks of gestation 
  
Early fetal death  pregnancy loss between 10 and 16 weeks of gestation  
  
Late fetal death  pregnancy loss between 16 and 20 weeks of gestation 
 
Reproductive terms  
 
Conceptual age  
 
pregnancy length from time of conception; “true” fetal age 
Gestational age traditionally determined from the first day of the mother’s 
last menstrual period, can be estimated from ultrasound 
findings 
 
Human chorionic 
gonadotropin(hCG)   
hormone produced during pregnancy made by the 
developing placenta commonly detected through urine or 
blood tests 
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Continued… 
Term  Definition  
Ultrasound terms   
Crown rump length Longest measurement of developing human fetus. 
Identified by ultrasound and used to estimate 
gestational age. 
 
Fetal heart rate  the number of heartbeats in the fetus that occur in a 
given unit of time(e.g. beats per minute) 
 
Fetal pole thickening on the margin of the yolk sac of the fetus 
during pregnancy  
  
Gestational sac first definitive structure identified in early pregnancy 
by ultrasound  
  
Mean sac diameter measurement of the gestational sac used to date early 
first-trimester pregnancy 
  
Yolk Sac first anatomic structure identified within the gestational 
sac 
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Appendix 2. Right from the Start ultrasound form
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Appendix 3. Selected questions from first-trimester interview  
3.1 Prenatal and multivitamin use  
L1a.  Do you now take prescription or non-prescription prenatal vitamins? 
L1b.  In the past 4 months have you taken prescription or non-prescription prenatal vitamins? 
L1d.  Did you start taking prescription or non-prescription prenatal vitamins more than 4 
months ago? 
L1e. When did you start taking prescription or non-prescription prenatal vitamins? (Month, 
Day, Year) 
L2a.  Do you now take multivitamins other than prenatal vitamins? 
L2b. In the past 4 months have you taken multivitamins other than prenatal vitamins? 
L2d.  Did you start taking multivitamins other than prenatal vitamins more than 4 months ago? 
L2e. When did you start taking multivitamins other than prenatal vitamins? (Month, Day, 
Year) 
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3.2 Smoking  
C35.  Have you ever smoked cigarettes regularly, and by regularly I mean one or more 
cigarettes every day for at least a month? 
C36.  How old were you when you started smoking at least one cigarette a day? 
C37.  At this time, are you smoking cigarettes regularly, I mean one or more cigarettes every 
day? 
C38.  Do you usually smoke menthol or non-menthol cigarettes? 
C39.  At this time, how many cigarettes do you usually smoke a day? 
C40a. When did you stop smoking? (Month, Day, Year) 
C41. Before you stopped, how many cigarettes did you usually smoke a day? 
C42.  In the past 4 months, has your smoking changed in any way? 
C43a.  When did your smoking change? (Month, Day, Year) 
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3.3 Pregnancy intention  
E4 (4a). We are interested in all birth control methods you used in the 12 months before your 
most recent pregnancy, including methods like natural family planning, condoms or rubbers, and 
hormonal methods like birth control pills.  What are all of the methods you used in the 12 
months before you got pregnant? 
 
G7. Which of the following best describes your situation around the time you got pregnant? 
 You stopped using protection or contraception or weren’t using any because you 
wanted to get pregnant  
 You were not using protection or contraception and you were not really trying to get 
pregnant  
 You got pregnant during a change or gap in using protection or contraception and you 
were not trying to get pregnant [A change could be anytime a woman goes from one 
type of contraception to another; a gap could mean that she missed a few pills or had 
sex with out a condom one time, etc.] 
 You got pregnant while you were using protection or contraception every time you 
had sexual intercourse and you were not trying to get pregnant 
 Don’t know  
 Refused   
 
G12. At the time you got pregnant this most recent time, did you want to have a/another [if 
already has children] baby at some time in your life?  
 No  skip to Section H.  
 Yes   
 Don't know 
 Refused  
 
G13. Did you get pregnant this most recent time, sooner than you wanted, later than you 
wanted, or at about the right time? 
 Sooner 
 Later 
 Right time 
 Didn't care when 
 Don't know 
 Refused 
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